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1. INTRODUCTION. 
1.1 Infrared spectroscopy and clinical analysis. 
From the discovery of infrared (IR) radiation on 1800 by William Herschel, IR 
spectroscopy has been used as an important source of information for chemical and 
physical disciplines. IR spectroscopy studies the electromagnetic radiation in the 
wavelength between 700 nm and 1 mm and the energy of the light in this range matches 
the differences between the rotational-vibrational levels of the molecular bonds [1]. 
According to the selection rules, a vibration mode will be active on IR when the electric 
dipole moment of the molecule changes during the vibration [2]. This fact implies that 
almost all inorganic and all organic molecules can emit or absorb IR light, being the IR 
spectra representative of the different functional groups included on the molecule. 
The high amount of valuable information provided by IR spectroscopy has been used in 
the analytical field for the determination and quantification of main compounds in a great 
variety of samples. IR spectroscopy has been widely applied to the study and analysis of 
petroleum based products[3], the pharmaceutical industry [4], food sciences [5,6], and, in 
general, as an analytical tool to obtain multicomponent information [7]. Besides, with the 
development of powerful Fourier transform-IR (FTIR) spectrophotometers, the direct 
acquisition of the sample spectra could be quickly and easily performed using affordable 
instrumentation.   
In the last years, the development of IR-based methods in clinical analysis has become a 
very active field of research, driven by recent improvements in instrumentation and 
advanced data analysis strategies. In particular, IR spectroscopy has been applied to the 
clinical field in order to obtain information about the composition of biological fluids and 
tissues [8,9]. Relevant components of biological samples such as proteins, lipids, sugars 
and deoxyribonucleic acids (DNA) are active on IR and so, changes in their composition 
or structure is potentially evaluable by means of IR spectroscopy. As an example, Table 
1.1 shows the assignment of a number of mid IR (MIR) and near IR (NIR) bands 
corresponding to functional groups present in clinical samples, related to fundamental 
transitions of the vibrational modes, and the region, related with the overtones and 
combination bands.   
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Table 1.1: IR band assignments to functional groups present in biological compounds. 
Wavenumber (cm-1) Assignment Analytes 
930-1300 νs (C-O) Saccharides 
1000-1150 νs (P-O) Phospholipids, DNA 
1150-1300 νas (P-O) Phospholipids, DNA 
1200-1400 Amide III Proteins 
1430-1480 δ(CH3), δ(CH2) Lipids 
1480-1600 Amide II Proteins 
1600-1720 Amide I Proteins 
1700-1760 νs (C=O) Lipids 
2840-2860 νs (CH2) Lipids 
2860-2870 νs (CH3) Lipids 
2870-2950 νas (CH2) Lipids 
2950-2990 νas (CH3) Lipids 
3000-3020 ν (CH) Lipids 
4000-4550 ν (CH) combinations Lipids 
4550-5000 ν (NH) ν (OH) combinations Proteins, saccharides, 
5600-6050 1º overtone ν (CH) Lipids 
6700-7150 1º overtone ν (NH) ν (OH) Proteins, saccharides 
8000-9100 2º overtone ν (CH) Lipids 
9100-10500 2º overtone ν (NH) ν (OH) Proteins, saccharides 
11520-11760 3º overtone ν (CH) Lipids 
11765-12900 3º overtone ν (NH) Proteins, saccharides, 
 
As it can be seen, clinically relevant compounds present active IR vibrations in different 
spectral regions that may overlap. Nonetheless, the use of multivariate techniques allows 
the extraction of valuable information on the sample composition, structure of the 
compounds of the sample and molecular interactions. Hence, as IR spectra provide a 
‘snapshot’ of the metabolic state of patient biological system, biospectroscopists can 
exploit the changes on the sample spectra for: 
i) Establishing characteristic patterns between control and pathological  samples, aiming 
at the identification of ‘spectral markers’ of the pathology under study [10]. The 
interpretation of those spectral patterns might provide new insights on the biological 
mechanisms of the pathology. Moreover, classification models based on IR spectra could 
be used as a diagnostic tool. Because of the aforementioned reasons, the development of 
IR-based spectroscopic methods for clinical diagnosis has become a very active field of 
research recently reviewed [11–14]. 
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ii) Quantifying biological compounds in clinical samples. The quantification of those 
parameters is indispensable for disease diagnosis and for the monitoring of the response 
to treatments or interventions. While those determinations are currently performed 
using fully automatized enzymatic methods in developed countries, several 
methodologies based on IR spectroscopy have been proposed in the past years as 
alternative or as complementary tools. These low cost and handheld solutions would be 
specially suitable for its use in underdeveloped countries or under special situations [15]. 
On the following sections, the reasons why IR spectroscopy is considered as a promising 
tool for clinical analysis and diagnosis, as well as the advantages and pitfalls IR 
spectroscopy against enzymatic and other reference methods, are evaluated. A review of 
the state of the art is presented, reporting the most relevant available methodologies for 
the analysis of liquid, solid and gaseous clinical samples. This review focuses on recent 
contributions, including the ones presented in this Thesis, based on advanced 
chemometric, optical and sample pre-processing techniques specifically developed to 
overcome some of the limitations of previous IR spectroscopic methods and, 
simultaneously, facilitate its widespread use by the analytical chemistry community in the 
clinical context. 
 
1.2 Advantages of FTIR measurement over current methods. 
Because almost all the clinical compounds are active in the IR range and therefore can be 
potentially quantifiable, versatility, as it has been stressed, is one of the strengths of IR 
methods. In addition modern spectrophotometers are versatile instruments able to 
directly measure solid, liquid or gaseous samples with the use of easily interchangeable 
accessories including a wide variety of attenuated total reflectance (ATR) modules, 
transmission cells for liquids and gasses, and flow cells, all of them for macro and micro-
samples. As an example, Figure 1.1 shows some of the compounds and parameters that 
have been quantified on the different body samples according to the studies commented 
through this revision. As it can be seen, literature reports the determination of a large 
number of clinical parameters in a wide variety of human samples. As an example, glucose 
levels in blood can be determined by direct non-invasive measurements through the skin 
[16,17], or on the blood itself [18,19]. Even if microscopic measurements are required, 
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recent developments of powerful focal array detector enable the fast acquisition of micro 
FT-IR images of tissues. For example, FTIR enables the determination of the secondary 
structure of proteins [20] and, Majzner et al. have extended this ability to a microscopic 
level, quantifying the different secondary structure of proteins in each pixel of vascular 
wall images [21].  
Point of care (PoC) testing is defined as “the ability to move testing closer to the patient” 
[22] and has the potential to provide fast results, thus accelerating clinical decisions, 
implying several benefits in community testing primarily in the pharmacy, the self-
monitoring, general practice and the emergency department. IR based methodologies 
could play an important role on the development of new PoC testing tools. In contrast to 
enzymatic methodologies, IR could perform the analysis directly without the need of any 
reagent or pre-processing of samples and the commonly used bench FT-IR 
spectrophotometers can be replaced by latest generation portable spectrophotometers. 
In addition, the introduction of quantum cascade lasers (QCL) as an IR source is a 
promising improvement in the PoC field, since it avoids the use of a voluminous 
interferometer, also increasing the sensitivity and signal-to-noise ratio. The development 
of compact and portable instrumentation opens new possibilities to use IR based 
methodologies for PoC testing purposes. Brandstetter et al. [23] have performed a 
prototype that integrates a tunable QCL, flow cell and a semi-automated liquid handling 
system easy to be used for the determination of biochemical parameters on plasma from 
critically ill patients from an intensive care unit. Besides, as an example of how IR can help 
to the current point-of-care and personalized medicine trends, the analysis of breast milk 
using human milk analyzers (HMA) currently permits an accurate and personalized 
fortification of the breast milk depending on the nutritional deficiencies and strengths of 
the sample; thus providing the correct amount nutrients to the very low weight infant. 
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Figure 1.1: Graphic summary of the clinical parameters determined in clinical samples by the IR based 
methodologies revised on this work. Note: ALB, albumin; α-AM: α-amylase; CHOL, cholesterol; COR, 
cortisol; CRE, creatinine; CSF, cerebrospinal fluid; GLB, globulin; GLU, glucose; HDL, High density 
lipoprotein; HEM, Hemoglobin; HEM-1ac;Haemoglobin-1ac; Ig, immunoglobulin; IgA, immunoglobulin 
A; LAC, lactate; LDL, low density lipoprotein; PHO, phosphate; SUL, sulfate; TRI, triglycerides; TP, 
Total protein; UAC, Uric Acid; URE, Urea. 
 
Cost effective is another advantage of IR methods in front of enzymatic methods that are 
normally based on colorimetric determinations after derivatization reactions and 
therefore in most of the cases performed by using costly reagents. Due to that, those 
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analysis involve the use of expensive and specific reagents and instrumentation that are 
out of the economical possibilities of many countries, especially for rural regions and the 
third world. Although those assays are performed on high throughput auto-analyzers -
where those analyses are miniaturized and volumes in the range of few microliters are 
used- the high number of determinations carried out on a daily basis justifies the need of 
new and affordable alternative analytical procedures. In this context, IR methodologies 
can extract important information from the direct measurement of untreated samples as 
shown by the determination of several blood parameters using ATR measurements of 
whole blood [18]. 
Last, but not least, IR methodologies based on the direct measurement without sample 
pre-treatment allow important reductions in reagents consumption and waste 
generation. Therefore, IR direct measurements fulfill the principles of green analytical 
chemistry avoiding the use of toxic or dangerous reagents with the exception of the 
inevitable use of sodium hypochlorite employed for the biological passivation of samples. 
In addition, the technique minimizes the use of expensive reagents and can carried out 
using small-size, truly field-portable, and affordable instruments, thus supporting the 
application of the proposed clinical methods in developed countries. This is a major 
concern that permits to spread the benefits of the capability to have analytical data about 
the patients without creating economical nor environmental troubles. 
 
1.3 General limitations. 
Sensitivity and selectivity are, probably, the most important limitations of IR 
spectroscopy in clinical analysis. Figure 1.2 compares the spectra of a urea standard 
aqueous solution at normal concentration in sera (15 mg dL-1), a creatinine standard 
solution also at a normal concentration in sera (1mg dL-1) and real serum samples 
measured on an ATR cell using a blank of water as a reference. As it can be seen, the 
creatinine is below the limit of detection (LOD) at the normal concentration in serum, 
while for the urea the absorption bands are clearly hindered by the amide bands, due to 
the presence of serum proteins at a concentration level two orders of magnitude higher. 
Figure 1.2 resumes and evidences the two main limitations of IR spectroscopy for the 
quantification of clinical parameters in human samples: reduced sensitivity and 
selectivity.  
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Figure 1.2: Comparison of the ATR-FTIR spectra of standard aqueous solutions in water of urea at 15 
mg dL-1 (red) and creatinine at 1 mg dL-1 (green) and the ATR-FTIR spectra of serum samples (blue).  
 
Selectivity is thus a problem for the IR measurements of complex biological samples. The 
fact that matrix constituents and most of the organic analytes present absorption bands 
in the IR region, hinders the development of quantitative methods based on direct 
measurement of clinical samples. The complexity of biological matrices is outstanding and 
spectral overlapping with the target analyte are often unavoidable. Because of that, 
chemometrics is normally required for the extraction of the analytical information from 
the sample spectra or to discriminate the signal of the analyte from the whole signal of 
the sample, normally using multivariate calibrations for the modelling and prediction of 
the parameters. Other recent efforts proposed -that will be discussed within the next 
sections- have been focused on the removal of interferents before the spectra 
measurement by sample pre-processing. However, this approach implies the loss of some 
of the principal benefits of the IR based clinical analysis previously described. Therefore, 
to consider IR-based methodologies as suitable alternative to the existing enzymatic 
assays it is mandatory to minimize the sample pre-processing as much as possible. 
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The sensitivity is probably the bottleneck of IR as compared with other spectroscopies as 
Ultraviolet/Visible (UV/Vis). The lack of sensitivity of IR as compared with colorimetric 
methods is due to the low molar extinction coefficient of the molecules on the IR region. 
In addition, in most of the biological samples water is present in large amounts and taking 
into account that water is a strong IR absorber, the use of reduced pathlengths is 
mandatory, being in some cases non-viable transmittance measurements and only ATR 
can be acceptable for un-processed whole samples. Some new methodologies [23] 
proposed the introduction of high sensitive IR sources as QCLs or the preconcentration of 
the sample in a pre-processing step; such as the elimination of solvents and volatile 
interferences by drying the samples or extracts on the IR measurement crystals. 
 
1.4. Chemometrics in clinical analysis by IR spectroscopy. 
1.4.1 Performing and validating an IR based clinical method. 
The workflow shown in Figure 1.3 summarizes the steps typically employed for the 
development of IR-based methods for the determination of biochemical parameters in 
human samples. As it can be seen, IR clinical methods requiring chemometrics are 
frequently validated using well established reference clinical methods. Using IR spectra 
acquired either directly from the samples or after previous pretreatment steps, 
multivariate models are employed to establish the relationship between the spectral 
information and available reference data for the aforementioned samples. IR signals of 
samples left out during model development are then interpolated in the model providing 
predicted concentrations. The obtained values are used to clearly establish the diagnostic 
value of the model and the accuracy of the predictions (indicated as a red color in the 
scheme). Once validated, the model is ready to be used for the prediction of unknown 
samples at large-scale (indicated as a green color in the scheme). 
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Figure 1.3: The general process employed for performing and validating an IR based clinical method. 
Note: LV, latent variables; Xcal, spectra of the calibration set; Xval, spectra of the validation set; XU.S, 
spectra of the unknown samples; Ycal, reference data of the calibration set; Yval, Reference data of the 
validation set. 
 
It is worth to mention that samples can be collected with different degrees of invasiveness 
(e.g. non-invasive skin measurements or blood extraction) and a first pre-processing step 
might be required in order to tailor the samples to the reference methodology (e.g., 
centrifugation of the blood for obtaining sera or plasma). Since in most of the cases real 
clinical samples employed are used for model development as described above, IR based 
methodologies should be performed on pre-processed samples, often directly obtained 
from clinical laboratories in hospitals. A common strategy involves the split of samples: 
one fraction is evaluated trough the reference methods, and the second fraction is 
employed for the measurement of the IR spectra. This allows the use of different sample 
pre-processing prior to the IR spectra acquisition without losing valuable reference 
information. Considering the versatility of IR spectrophotometers and measurement 
techniques, sample pretreatment is optimized to preserve the status of the sample (i.e. 
avoiding changes in the sample that may bias the results) and, simultaneously to increase 
the selectivity and sensitivity of the technique. 
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When dealing with non-invasive direct IR measurements, all pre-processing steps are 
avoided, thus circumventing unwanted sources of variation introduced during the 
treatment and handling of samples. However, if the objective is to relate the spectra 
acquired from an external sample to the reference concentrations obtained from other 
samples -as in the case of the determinations of glucose or blood hemoglobin A1c using 
oral mucosa [109] or lip [69] spectra-, there is always a handicap on relating 
concentrations of the samples employed of the IR measurement and the concentration of 
the analyte on the samples employed for the acquisition of reference data. 
One of the most common algorithms employed for regression and modeling of IR signals 
is PLS [110], a linear regression method with widespread use on chemometrics. 
Alternative algorithms have been also proposed, such as the locally weighted PLS (LW-
PLS) [53], principal component regression  (PCR) [57], or PLS with chemometrical-based 
selection of spectral regions [31,41]. In addition, the selection of the optimal method 
depends not only on the prediction performance, but also on the cost of calibration in 
terms of sample objects and reference data needed to build and optimize the calibration 
models [111]. Along with the sample algorithm, other parameters should be selected; such 
as the signal pre-processing, the spectral range used or other parameters specific of the 
selected algorithm (e.g. the number of PLS latent variables (LV)). 
For a reliable estimation of the prediction capability of chemometric models built for IR 
signal treatment, preliminary, data set including the spectra matrix (X) and the reference 
concentration data (Y) must be divided into a calibration (blue on Figure 1.3) and a 
validation (red on Figure 1.3) set. Calibration data are used during the optimization of 
the model parameters (e.g. variable selection, data scaling). This task typically involves 
the use of cross validation (CV)-based approaches in which a set of models calculated 
using different model parameters are evaluated by means of some internal figures of 
merit such as the root mean square error of cross validation (RMSECV). After the selection 
of the optimal parameters, the model must be evaluated using an independent set of data 
obtained from samples included in the validation set, which have not been employed on 
the building and optimization of the model, thus avoiding over-optimistic figures of merit. 
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1.4.2 Chemometric algorithms used on this Thesis.  
In this Thesis different chemometric methodologies have been applied. On this section, a 
brief introduction of the main algorithms used on the treatment of the data summarized 
on this thesis is performed. For more information, there are included references where a 
deep explanation of the algorithms can be found. 
Exploratory analysis. 
Principal components analysis (PCA): PCA is among the most widely used methods for 
initial exploratory data analysis. It provides an unbiased overview of the data structure 
and is a common strategy for identifying outliers, trends or clusters present in 
multivariate data sets. The PCA scores plot provides an overview of the latent patterns in 
the data sets as the distances among samples can be related to their similarity with 
respect to what patterns the model describes [112]. 
Hierarchical clustering Analysis (HCA): Hierarchical clustering groups data by creating a 
cluster tree or dendrogram. The tree is a multilevel hierarchy, where clusters at one level 
are joined as clusters at the next level. The level or scale of clustering can be choose 
according to the number of classes needed or other factors under consideration. For 
performing the cluster, it is firstly determined the similarity or dissimilarity between 
every pair of objects in the data set, normally by calculating the distance between objects. 
There are several ways to calculate this distance and different kinds of distance (e.g. the 
most commonly used Euclidean or Mahalanobis distance) and the selection of those 
parameters can critically affect the classification. Then objects are grouped into a binary, 
hierarchical cluster tree according to their proximity, being firstly paired into binary 
clusters, and then into larger clusters until a hierarchical tree is formed [113].  
Regression. 
Classical Least Squares (CLS): CLS modeling is based on the bilinear relationship of the 
spectra of N samples with the concentration of P components to be determined in each 
sample, and the reference spectra of the components measured at J wavenumbers 
[114,115]: 
 =  +      (Equation 1.1) 
Where X (N x J) is the matrix containing the spectra, C (N x P) contains the vectors of 
concentrations, S (P x J) is the matrix containing reference spectra, and E is the matrix 
representing the residual noise.   
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The sample concentrations are calculated by multiplying their spectra with the 
transposed of a regression vector in the same way as described for Equation 1.3 (see 
below). However, in CLS B, the matrix (P x J) of regression vectors is calculated using 
Equation 1.2: 
	 = 
    (Equation 1.2) 
The main advantage of CLS is its simplicity and ease of calibration, which only requires 
access to reference spectra of the components at their reference concentrations. As CLS 
refers to a ‘closed system’ limited to n components, the main drawback is its lack of 
robustness, and its sensitivity to any interferences whose spectra are not included in S.  
PLS: In PLS, regressions are computed via least squares algorithms. PLS aims to establish 
a linear relationship between the predictive X-block of spectra, and the predicted y-vector 
of analyte concentrations by extracting a set of LV, which explain the sources of variation 
in the X-block correlated to the y-vector [116,117]. This can be explained by the 
representation of the spectra in the space of wavenumbers in order to reveal directions 
that are linear combinations of wavenumbers (i.e., LVs), which best describe the studied 
property. 
In case of the prediction of a concentration vector of N samples through their spectra of 
J wavenumbers, the relation between the spectra matrix X (N x J) and the concentration 
vector y (N x 1) may be described as: 
y = Xb + e     (Equation 1.3) 
where b (1 x J) is the vector of regression coefficients calculated by the LVs and e (N x 
1), is the error vector (i.e., residuals). Since latent variable selection is performed 
according to the covariance matrix between the data and the investigated parameter, 
PLS may be described as a powerful predictive version of principal component 
regression (PCR). However, the main drawback of this technique is the necessity for a 
robust calibration data set with an X matrix composed of representative spectra of the 
samples to be analyzed, and their potentially time- and cost-extensive laboratory 
reference values.  
Science Based Calibration (SBC): SBC is a relatively new multivariate method that, 
according to Marbach[118], “combines the best features of classical calibration and 
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inverse calibration”. For this purpose, SBC assumes that a measured spectrum may be 
described as: 
 =  +   (Equation 1.4) 
where the  vector is the measured spectrum, Y is the concentration of the analyte, 
 is the reference spectrum of the analyte of interest, and  is every feature in the 
experimentally obtained spectrum that is not resulting from an analyte, i.e., including 
instrumental noise and spectra of interferants.  
For estimating ,a so-called ‘noise matrix’ of M spectra and J wavenumbers (MxJ) is 
experimentally recorded, where the differences between the spectra are only due to 
variations in the concentration of constituents other than the target analytes, and 
variations of the instrumental noise [119]. Once this experimentally obtained noise 
matrix is mean centered, it represents only ‘spectral noise’: 
 =    (Equation 1.5) 
In a next step, the covariance of the spectral noise may be estimated: 
∑ ≅ 
 

   (Equation 1.6) 
The optimum regression vector b (1xJ), i.e., the vector providing the minimum squared 
prediction error, is calculated as: 
 =
∑ 
∑ 
   (Equation 1.7) 
According to Marbach [118], by statistically estimating the spectral noise after the 
spectral signal has been obtained via experimental analysis, the prediction accuracy of 
the inverse model may be combined with the simple and easily interpreted CLS 
regression model. Although the method is only applicable whenever the response 
spectrum of the analyte of interest is available, SBC can eliminate “cost of calibration” as 
a roadblock to the more widespread use of multivariate calibration. 
Curve Resolution 
Multivariate Curve Resolution Alternative Least Squares (MCR-ALS): MCR-ALS has 
matured to a commonly applied chemometric method used for resolving multiple 
component responses of unknown and unresolved mixtures [120]. MCR-ALS methods 
are mathematically based on the same bilinear model represented in Equation 1.1. 
However, MCR-ALS iteratively solves this equation by an alternating least squares 
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algorithm, thereby calculating the reference spectra matrix S and concentration matrix 
C for optimum fit to the experimental data X. This optimization process progresses via a 
suggested number of components n, and an initial estimation of either the reference 
spectra or concentration matrix. The iteration is finished once the relative differences in 
standard deviations of the residuals between values predicted by ALS and the 
experimental data are less than a deliberately selected cut-off value. 
In contrast to the CLS, MCR-ALS modeling can be highly complex and several variables 
must be selected. For the calculation of the initial estimation of the reference spectra, 
several algorithms such as simple-to-use interactive self-modeling mixture analysis 
(SIMPLISMA) or evolving factor analysis (EFA) are available. Furthermore, constraints 
may be introduced including e.g., non-negativity, unimodality, closure, or other relevant 
modeling constraints. 
Classification. 
Partial Least Squares- Discriminant Analysis (PLS-DA): PLS-DA is a variant of the 
aforementioned PLS algorithm used when the Y is categorical, replaced by the set of 
dummy variables describing the categories, expressing the class membership of the 
objects under study. A number is assigned to the y value of each class (Normally +1 and -
1) and a PLS regression is performed. When other samples are introduced on the PLS-DA, 
a Y value is predicted and the probability to be in the classes is calculated as a function of 
this Y value. Since this methodology is based on PLS regression, latent variables are built 
to find a compromise between i) describing the variables spectra (X) and ii) predicting 
the classes (Y). This technique is tailored to deal with a much larger number of predictors 
than observations and with multicollineality [121], as in the case of IR spectra. 
Linear Discriminant Analysis (LDA): This traditional way of doing discriminant analysis 
was introduced by R. Fisher [122]. It has similarities with PCA because it is also based on 
a decomposition of data in new vectors, but instead of searching those that best describe 
the data, LDA searches for the vectors in the underlying space that best discriminate 
among classes. In other words, given a number of independent variables which describe 
the observations, LDA creates a linear combination of the variables which yields the 
largest mean differences between the desired classes [123], with the aim of maximizing 
the between-class variance while minimizing the within-class variance. 
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Selection of representative subset of data. 
Kennard Stone: Kennard Stone is a well-known method for the selection of 
representative subset of samples based only on the instrumental response matrix.  The 
selected subset should cover the experimental region homogeneously by choosing 
objects which are ‘uniformly’ distributed in the experimental space. The first sample 
selected is the closest to the mean of all the samples and the following objects were 
selected sequentially, based on the squared distances to the objects already assigned to 
the calibration set. Further information can be obtained in the literature [124,125]. 
Successive Projection Algorithm (SPA): SPA is an iterative forward selection method that 
was proposed to minimize collinearity [117] problems.  The method uses a first sample 
data set (K0) and searches an additional one which has the largest projection on the 
subspace orthogonal to K0. Then, this new sample is included in the representative subset 
and it becomes K0 for the selection of a third object. SPA was originally used for the 
variable selection in the instrumental response matrix (X). Araújo et al. [125] applied the 
algorithm to the transpose of X for the selection of a representative sample subset for 
calibration. Further information can be obtained in [125]. 
Variable selection. 
Uninformative variable elimination (UVE): In this procedure, the original data matrix is 
augmented column-wise by a matrix containing normally distributed artificial random 
variables of very small magnitude (e.g. 109 times lower than the real variables [126]). 
Then, the standard deviation vector of the regression coefficients (s") is obtained from 
the variation of the PLS regression coefficients by leave-one-out CV. The obtained values 
are used to calculate a reliability coefficient (c$, which is an equivalent to the calculated 
t-value, for each original variable according to Equation 1.8:  
c$ =
"%
&'(
"%
    (Equation 1.8) 
Different criteria have been proposed to establish the cut-off level for classification of real 
variables as informative using the reliability values of the artificial (uninformative) 
variables (cartif,j). In this work, the UVE approach was employed where |(cartif,j)| are 
ranked and a cut-off level corresponding to a defined α-quantile [126,127] is selected. Due 
to random generation of artificial variables, results found by UVE-PLSDA show certain 
variability as real variables with cj values close to the cut-off level might be retained or 
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not in the final model depending on minor differences in cartif,j. Daszykowsky et al. [127] 
improved the performance of UVE-PLSDA by using a Monte Carlo approach in which UVE-
PLSDA was repeated a number of times and in each run a randomly selected model set 
was used for model construction and feature selection.  
Variance of the b regression vector: This approach uses the set of PLSDA regression vectors 
obtained after M random K-fold cross-validations. The number of LVs included in a PLSDA 
model is selected from dQ2 values obtained after each K-fold CV. Then, the mean vector 
(b)) and the standard deviation vector (s") of the regression coefficient vectors (b) are 
calculated. Variables were selected as informative according to 
*b+,-  *−d s",$ > 0 (j=1,…, 
J)  
 
1.5 State-of-the-art of IR based clinical analysis. 
1.5.1 Quantifications on liquid samples. 
Currently, the enzymatic-colorimetric methods used around the world are optimized to 
be used in liquid samples such as blood, urine and cerebral-spinal-fluid and the analysis 
of the composition of those samples is one of the most important sources of clinical 
information for both, doctors and patients. The main parameters studied in a clinical 
biochemistry blood test are the concentration of several proteins, lipids, sugar or other 
molecules that are indicative of several diseases, thus informing also about the general 
status of the patient and assessing the correct function of vital organs, such as liver and 
kidney [128]. Due to the importance of those determinations and the high amount of 
analysis performed, IR spectroscopy has been proposed as an alternative to those 
methods as early as the eighties with, for example, the analysis of total protein, 
triglycerides, glucose, urea, total cholesterol and uric acid in plasma [34]. Available 
literature also reports a review of the different IR proposed methodologies for the IR 
based analysis of clinical biofluids until 1996 [129]. Since then, several studies with large 
amounts of samples have been performed, and the multiparametric analysis has been 
extended to other analytes and fluids, such as urine, breast milk, saliva or cerebrospinal 
fluid. In addition, new technologies for the pre-treatment of the sample or the acquisition 
of the spectral data are being applied in order to improve the quality of the IR based 
methodologies. 
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Figure 1.4 evidences the most commonly used approaches for the IR spectra acquisition 
of biological fluids, with an illustrative scheme of the way to acquiring the spectrum 
together with their main advantages and drawbacks. The most comfortable way to obtain 
the spectra is using an ATR unit, which only requires few microliters and it is easily 
cleanable. The pathlength in an ATR cell is computed as the penetration depth of the IR 
beam in the sample (around µm, the wavelength of the radiation in the IR region) 
multiplied by the number of reflections of the IR beam in the support crystal also called 
internal reflection element, which normally ranges between 1 and 9. Therefore, the 
pathlength employed in ATR is relatively small and the presence of water does not 
saturate the spectra. In contrast, in the case of direct transmission measurements the use 
of microvolumes of sample is required to work with a reduced pathlength. Both ATR and 
transmission measurements, could be automatized by using flow cells. In order to 
eliminate the contribution of water to the measured sample spectra, a blank of water or 
saline solution measured in the same conditions than the sample must be subtracted. 
 
Figure 1.4: Interaction of the IR beam and liquid sample on the different approaches for obtaining the 
IR spectra. Note: ATR, attenuated total reflectance; DF, dry film. 
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Another approach employed for eliminating the contribution of water (or liquid matrix) 
is to evaporate it by drying the sample on an ATR or a CaF2 crystal. The resultant dry film 
(DF) could be measured by ATR or transmission, respectively. With this procedure, 
analytes are also preconcentrated in the surface of the crystal providing significant 
improvements in sensitivity. On the other hand, the introduction of a drying step implies 
also some drawbacks, because the formation of the DF can involve a lack of reproducibility 
in the measurement step and, in addition, renouncing to the direct measurement involve 
the loss of some of the main advantages of the IR based analysis in front of reference 
procedures. Because of that, Bruker has developed a module (HTS-XT FT-IR High 
Throughput Screening Extension) that includes in the same instrument the automatized 
process of sample drying and spectra measurement and recent studies [130] based on 
atomic force microscopy reveals that the high reproducibility of the DFs performed using 
this system. 
Serum, plasma and whole blood. 
As we have stressed before, a lot of efforts have been focused on the determination of 
blood and its related fluids; plasma and serum. Plasma is the liquid obtained after 
centrifugation of whole blood in the presence of an anticoagulant (e.g. with heparin, 
citrate or ethylenediaminetetraacetic acid (EDTA)) to prevent the fibrinogen clotting 
cascade and then, removing cells and platelets by centrifugation. Serum is obtained after 
centrifugation without the presence of any reagent and has the same composition as 
plasma with the exception of fibrinogen. For PoC applications, measurements of whole 
blood are more appropriate since they do not involve any pre-processing of the sample. 
However, several studies evidence that the presence of cells can interfere with the 
determination of some clinical parameters. For example, leucocytes interfere in the 
quantification of  glucose [50] in blood by transmission measurement and hemoglobin 
only can be measured by ATR-FTIR in red blood cells previously lysed [30]. In addition, 
since the reference data are normally obtained from plasma or serum, the use of whole 
blood is limited. Additionally, samples commonly employed to build IR models are 
normally obtained from the hospital analysis and thus, serum and not blood is available 
in a high number of cases.  
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Regarding the MIR range, Table 1.2 provides an overview of the state of the art of the 
application of MIR spectroscopy to the analysis of routine biochemical parameters in 
serum. In this table, references are sorted by date of publication. As it can be seen, 
between the work of Janstch [34] et al. and 2006, efforts were mostly focused on the direct 
analysis based on ATR measurement, transmission measurements and transmission 
measurements of DFs. The number of analytes investigated was extended from general 
classical parameters like glucose, total proteins, albumin, urea, cholesterol and 
triglycerides to other analytes as lipoproteins [15,58] and different kind of proteins [44]. 
PLS was normally the regression method selected for modeling IR spectra and only other 
non-conventional approaches were used in some cases, as the selection of spectral 
regions based on the loading vector [36] or the complex iterative algorithm developed by 
Petibois [44] et al. based on the direct correlation of the spectra bands with concentration 
of the components, that combines: i) the selection of the most correlated analyte to the IR 
bands, ii) calculation of the concentration and contribution of this component to the 
spectra using standards, and iii) the subtraction of this contribution in order to simplify 
the determination of the next component.  
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Table 1.2: MIR based methodologies proposed in the literature for clinical analysis of serum, plasma 
and whole blood.   
Year Calibration method Matrix Analyte Sample pre-processing 
Measurement 
Mode Reference 
1989 PLS Plasma TP, TRI, GLU, URE, CHOL Direct ATR [34] 
1994 PLS Plasma TP, GLU, CHOL, TRI, URE Direct ATR [35] 
1998 PLS Serum TP, HSA, TRI, CHOL, GLU, URE Sample Drying 
Transmission-Dry 
films [29] 
1998 PLS Whole blood GLU Direct Transmission [45] 
2001 PLS Whole blood GLU, URE Sample Drying 
Transmission-Dry 
films [46] 
2001 Iterative Spectra Subtraction Plasma 
16 different kinds of 
plasma proteins, GLU, 
LAC, URE 
Sample Drying Transmission-Dry films [44] 
2002 PLS Serum HDL LDL Sample Drying Transmission-Dry films [58] 
2002 
PLS Selection region 
based on loading 
vector. 
Serum TP, HSA, GLB, CHOL, TRI, GLU, Sample Drying Transmission [36] 
2003 PLS Blood GLU Direct Transmission [47] 
2005 PLS Serum 
TP, HSA,  CHOL, 
HDL, LDL, TRY, 
GLU, URE 
Sample Drying Transmission-Dry films [15] 
2005 PLS Serum GLU Drying Of The Sample 
ATR/Transmission 
Dry films [48] 
2006 PLS Serum CRE LFDI Protein Elimination 
Transmission-Dry 
films [42] 
2007 PLS Whole blood 
TP, HSA, CHOL, TRI 
GLU, URE Direct ATR [18] 
2008 Band Quotient b Whole blood GLU Direct 
Two CO2 laser-
Transmission [49] 
2009 PLS Plasma CRE LFDI Protein Elimination 
Transmission-Dry 
films [43] 
2010 PLS Blood GLU Direct Transmission  [50] 
2012 PLS Detoxification fluid 
URE, GLU, LAC, 
CRE Direct ATR [51] 
2012 PLS 
Serum HSA, IG, GLB, AGC Direct ATR 
[30] Whole 
blood HEM Lysis ATR 
2013 PLS Serum TRI, GLU, LAC Direct Transmission-QCL [52] 
2013 PLS Plasma TP, HAS, CHOL,TRI, GLU, LAC Direct Transmission-QCL [23] 
2013 PLS Serum HSA, CHOL, HDL, LDL, GLU, URE Direct ATR [19] 
2013 LW-PLS Serum TP, TRI, GLU, URE Direct ATR [53] 
2014 PLS Serum HDL, LDL, CHOL, TRI Liquid Extraction ATR-Dry films [37] 
Note: ALB, albumin; ATR, attenuated total reflectance; CHOL, cholesterol; CRE, creatinine; GLB, 
globulin; GLU, glucose; HDL, high density lipoprotein; HEM, hemoglobin; Ig, immunoglobulin; LAC, 
lactate; LFDI, laminar fluid diffusion interface; LDL, low density lipoprotein; LW-PLS, Locally 
weighted partial least squares; PLS, partial least squares; QCL, quantum cascade laser; TRI, 
triglycerides; TP, total protein; UAC, uric Acid; URE, urea.  
 
A comparison among results obtained by using the different spectra measurement modes 
or chemometric algorithms is difficult to do due to: i) the lack of coherence among the 
different kind of errors reported -standard error of prediction, standard error of cross 
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validation, root mean square error of prediction (RMSEP) and RMSECV-, ii) differences of 
size and composition of the validation sets, and iii) only in some cases an independent 
sample set  was employed to validate the proposed methodology. However, it is clear that 
the bottle-neck of the aforementioned methods, based on direct or DF measurements, is 
the lack of sensitivity of IR. In order to illustrate that, Figure 1.5 shows errors obtained 
from three different studies, two of them using ATR measurements of serum [19,30] both 
studies indicated in this thesis) and the other one based on transmission measurements 
of DFs [15]. As it can be seen, prediction errors increase on decreasing the concentration 
of the target compound under consideration. The best predictions were normally found 
for total proteins but, for compounds under the 10 mg dL-1 level, the predictive 
performance of the PLS-IR models is well below the level of acceptance of a clinical 
environment.   
Figure 1.5: Representation of the relative root mean square error of prediction (RRMSEP)or the 
relative root mean square (RMSEP) of PLS-IR models as a function of the mean concentration of the 
target analyte for direct ATR measurements [19,30] (a)  and for a study performed by transmission on 
dry films by Rohleder et al. [15] (b), with permission of J Biomed Opt. Note: ALB, albumin; CHOL, 
cholesterol; CRE, creatinine; GLB, globulin; GLU, glucose; HDL, High density lipoprotein; HEM, 
Hemoglobin; Ig, immunoglobulin; LAC, lactate; LDL, low density lipoprotein; RMSEP, root mean 
square error of prediction; RRMSEP, relative root mean square error of prediction; TRI, triglycerides; 
TP, total protein; UAC, uric Acid; URE, urea.  
 
The aforementioned works, based on direct ATR or transmission of DF measurement, 
were performed before 2006 and have been already reviewed by several monographs 
[131] and reviews [132,132,133]. Because of that we have focused on this review on 
technical and chemometric improvements made during last years to overcome the 
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sensitivity limitation as well as to improve the features of the IR-based methodologies 
through:  
i) The inclusion of high number of samples in the calibration set and the evaluation 
of other chemometric models as locally weighted PLS (LW-PLS) regression. By 
increasing the size of the calibration set, the representativeness of the calibration 
might increases and therefore the prediction capability should also increase  [134]. 
Those issues has been addressed by the studies addressed in this thesis (Section 
3.1) 
ii) The introduction of lasers as an intense IR sources, improves the IR method 
sensitivity by increasing the signal-to-noise ratio, and also allows the minimization 
of the instrumentation thus facilitating its use in clinical laboratories. The main 
drawback of the use of a classical laser source is that only allows the acquisition of 
single wavenumbers and so, considering the strong overlapping spectra of the 
complex blood related matrix, the information provided is limited to few 
wavelengths. However, using the quotient of two wavenumbers provided by two 
CO2 lasers, Meinke et al.  proposed an IR based methodology for quantifying glucose 
on whole blood [49]. In addition, Brandstetter et al. are currently applying recently 
developed tunable external cavity-QCL, which are able to acquire IR spectrum in the 
range between 1030-1230 cm-1, with a spectral resolution of 2 cm-1, in only 40 
seconds [135]. Although this region is not where most of the biochemical 
parameters present their highest absorbance, the absence of contribution of water 
permits the use of pathlengths higher than 100 µm with a high signal-to-noise ratio, 
and some studies report the analysis of different biochemical parameters using a 
compact dispositive based on this IR source [23].  
iii) The use of microfluidic for sample pre-processing. Other important technical 
improvement has been the application of microfluidics for eliminating the proteins 
previous to the formation of DFs for transmission measurements. Although the 
evaporation of the solvent preconcentrate the serum components on the surface of 
the crystal, the low concentrated compounds are “diluted” on the protein film, and 
therefore their determination could still be troublesome. Shaw et al. have developed 
[42] and optimized [43,136] a microfluidic card based on a laminar fluid diffusion 
interface (LFDI) for the elimination of proteins from the serum samples before the 
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formation of the DFs. This approach provided the first quantification IR method for 
creatinine in a range between 0.7-16 mg dL-1, concentration level that cannot be 
achieved with direct IR measurements. 
iv) ATR measurements of DFs from solvent sample extracts. This methodology has 
been developed and applied in this Thesis (see Section 3.3) 
The introduction of all those aforementioned new techniques have improved the 
selectivity and sensitivity of the IR based clinical methodologies, but as it has been 
previously mentioned, the introduction of sample pre-processing or new instrumental 
developments could also increase the complexity of the methodology, thus losing the field 
of application of the IR based methodologies in the PoC testing and the cost-effective 
screening analysis. Figure 1.6 compares the theoretical selectivity, sensitivity and 
complexity of the different methodologies proposed for the analysis of blood, plasma and 
serum using IR spectroscopy. Although the figure represents only theoretical relative 
assignations, it can be seen that the recent application of modern technologies provides a 
wide range of possibilities depending on the analytical performance required. 
 
Figure 1.6: Evaluation of the main analytical characteristics and applications of IR based 
methodologies for the analysis of biochemical parameters in blood, plasma and serum. Note: ATR, 
attenuated total reflectance; DF, dry film; QCL, quantum cascade laser. 
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In a complex matrix as serum, NIR region is not especially selective and it is difficult to 
make a clear assignation of NIR spectral bands to specific compounds. Therefore, in the 
application of the IR spectroscopy, the use of NIR is not as popular as MIR for the 
determination of routine clinical parameters in blood. However, after an adequate 
chemometric data treatment, the NIR range also offers important information suitable for 
the quantification of relevant compounds typically analyzed in clinical samples. In 
addition, as compared to MIR, the spectral acquisition is easier to adapt to the sample 
requirements as it can be carried out inside glass vials, standard flow-cells, or micro-flow 
cells, either by total reflectance or transmission spectroscopy. Proposed NIR based 
methodologies in the published literature have not focused on improving the acquisition 
or sample preprocessing parameters but on the enhancement of the selectivity by the 
introduction of chemometric improvements (see Table 1.3). Apart from the mainstream 
use of PLS, other regression algorithms have been applied as the multiple linear 
regression (MLR) or artificial neural network (ANN) [60]. In a recent study, Al-Mbaideen 
and Benaissa [57] improved the results obtained for serum analysis by NIR-PLS using 
independent component regression (ICR). In other works, PLS regression was improved 
by applying algorithms as the searching combination moving window partial least 
squares regression for the selection of the regions from the overlapped IR spectra [31,41]. 
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Table 1.3: Published literature about NIR determination of biochemical parameters in human serum 
plasma and blood.  
Note: ALB, albumin; ANN, artificial neural network; CHOL, cholesterol; CRE, creatinine; GLB, 
globulin; GLU, glucose; HDL, high density lipoprotein; HEM, hemoglobin; ICR, independent 
component regression; Ig, immunoglobulin; LAC, lactate; LDL, low density lipoprotein; MLR, multiple 
linear regression; PCR, principal component regression; PLS, partial least squares; SCMWPLS, 
searching moving window partial least squares; SW-NIR, short wavelength-NIR; TRI, triglycerides; TP, 
total protein; UAC, uric acid; URE, urea.  
 
As indicated previously, MIR range offers a priori more reliable information, since bands 
on NIR range are highly overlapped and the assignment of the bands is difficult. Therefore, 
when studying the weights of each band on the model –e.g. the loadings on the PLS- it is 
difficult to investigate a relationship between the model and the bands of the analyte and 
verify a scientific basis of the model. In contrast, from an experimental point of view, NIR 
spectra can be recorded using more accessible instrumentation and direct transmission 
measurements avoid the problems connected to biofilms on ATR-MIR measurements.   
Additionally than classical serum parameters, anecdotic analytes have been also 
measured in blood by FTIR. Enrichment of deuterium has been quantified in plasma for 
the determination of total body water [137] and chromium(VI) has been analyzed in 
serum combining single drop microextraction with hydroxyamidine in dichloromethane 
and measurements of diffuse reflectance (DRS)-FTIR [24], thus corroborating the 
versatility of IR spectroscopy for measuring a wide range of analytes in blood and related 
blood samples. 
 
Year Calibration 
method Matrix Analyte 
Sample  
pre-processing 
Measurement 
mode/technique Reference 
1987 MLR Serum CHOL Direct Reflectance [38] 
1988 MLR Serum TP Direct Reflectance [61] 
1992 PLS Whole blood GLU Direct Transmission [56] 
1993 PLS Plasma GLU Direct Transmission [54] 
1992 PLS Serum TP, TRI, GLU Direct Transmission [55] 
1995 PLS Plasma TP,CHOL, TRI Direct SW-NIR Transmission [39] 
1998 PLS Serum TP, ALB, CHOL, TRI, GLU, URE Direct Transmission [32] 
1998 PLS--Vector Choices Plasma TP, GLU, CHOL Direct Transmission [40] 
2001 PLS, MLR, ANN Plasma TRI Direct Transmission [60] 
2003 SCMWPLS Serum ALB, IG Direct Transmission [31] 
2005 PLS Serum LDL Direct transmittance [59] 
2006 SCMWPLS Serum CHOL, GLU, URE Direct Transmission [41] 
2011 ICR, PLS, PCR 
Phosphate 
buffer 
solution 
GLU Direct Transmission [57] 
2014 PLS Serum 
TP, HAS, TRI, 
CHOL, GLU, 
URE, HDL, LDL, 
VLDL 
Direct Transmission [33] 
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Urine. 
In urine there are also important routine biochemical parameters that can be determined 
from their IR spectra obtained from the same direct measurements than those performed 
on blood. For example, NIR spectra of urine have been used for modelling content of 
protein, creatinine, and urea [90] and, working in the MIR range, ATR measurements have 
been used for quantifying urea, creatinine, uric acid, phosphate and sulfate [18,91]. In 
addition, since the pH is related with the equilibrium between di- and monobasic 
phosphate, the pH can be also predicted [91] and, hyphenating single drop 
microextraction and diffuse reflectance spectroscopy-FTIR, it can be also determined Cr 
(VI) concentration on urine [24]. On the other hand, albumin, one of the most important 
renal failure indicators in urine, has been also determined using NIR and ANN or PLS [89].  
The determination of exogenous compounds (e.g. drugs or components of cosmetic 
products/formulations and their metabolites), which are normally excreted on the urine, 
is also very important in the clinical field. These compounds are usually determined by 
enzymatic methods or by chromatography separation with mass spectrometry detection 
and since they are normally found at low ppm, ppb or even ppt levels, their quantification 
via IR spectroscopy is a really difficult task. Only few recent studies report methodologies 
for the appropriated analysis of the aforementioned compounds in urine, for example the 
quantification of ibuprofen using solid phase micro extraction and MIR+ transmission 
measurements of the organic extract [92] or the semiquantitative determination of cocoa 
polyphenol metabolites in urine samples using ATR-IR microspectroscopy of dried urine 
samples [94]. In a Thesis, it has been also proposed a simple liquid-liquid microextraction 
coupled with an ATR measurement of the DF obtained from the organic extract for the 
determination of lidocaine in urine (see Section 3.3). 
Milk. 
MIR transmission spectroscopy is the reference method for the analysis of milk in the 
dairy industry [138]. This knowledge has been applied to the clinical field and the ability 
of IR spectroscopy for determining macronutrients –i.e.  fat, proteins and carbohydrates- 
in human milk is also known since the end of the eighties [82] being these methods highly 
valuable to evaluate the special needs of protein for infants [83]. In some cases new-born 
infants need special nutritional requirements, which are fulfilled by spiking the human 
milk. However,  due to the strong variability of the human milk composition [139], an 
impersonalized spiking can result in either over- or under-fortification. IR methodologies 
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have solved those problems by providing affordable instrumentation that can provide 
feasible quantitative information about the mother milk composition in minutes and 
thereby, the exact fortification amount needed can be adjusted according to the samples 
[140]. An example of the so-called commercial Human Milk Analyzers is that developed 
from Miris AB (Upsala, Sweden) [141], which uses a system of filters and transmission 
measurements for the determination of fat (at 1754 and 2857 cm-1 for C=0 and  C-H 
groups, respectively), protein ( at 1538 cm-1 for amide groups) and lactose (at 1041 cm-1, 
characteristic for O-H groups). The feasibility of these instruments has been confirmed 
[84], and different research groups have employed them for studies of the composition 
changes of milk after container storage [85], milk processing [142] and repeated breast 
extraction sessions [86]. 
In recent years, new IR based methodologies have been proposed for human milk 
analysis. Some efforts have been focused on extending the analysis to other parameters 
than nutritional ones and, for example, literature reports the quantification of cholesterol 
using ATR measurements [77,78]. Besides, the combination of the measurement of the 
whole spectra in the NIR range combined with chemometrics has been confirmed also as 
a powerful tool for determining macronutrients in human milk [87,88].   
Saliva. 
By evaporating saliva on an ATR crystal and modelling the recorded spectrum by using 
projection on latent structures, Khaustova et al. have quantified glucose, urea, secretory 
IgA, cortisol, inorganic phosphorus and α-amylase [62]. Using this approach, these 
authors have studied the response to physical stress by monitoring the changes of those 
concentrations during short-term intensity exercises [63]. Additionally, saliva 
measurements of deuterium enrichment by IR are also needed for determining the total 
body water measurements [137]. On the other hand,  Schultz et al. have taken advantage 
of the isolated band of thiocyanate at 2058 cm-1 for the determination of this anion using 
transmission spectra of saliva [71]. Finally, cocaine have been semi-quantified on saliva 
using ATR measurements [64–66]  or by the integration of liquid-liquid extraction and  
the IR detection on a chip [67,68]. 
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Other liquid samples. 
Literature reports IR based methodologies for the quantification of parameters in almost 
all the available human samples that those considered in previous sections. For studies of 
amniotic fluid, IR is a promising tool for early diagnosis of prenatal disorders [143], and 
glucose, lactate and lecithin/sphingomyelin ratios have been measured  by PLS modelling 
of IR spectra of this fluid [81]. Besides, biochemical changes in eye tears can be monitored 
by measuring phosphate and fatty acid characteristic bands from spectra recorded using 
ATR [144] and recently, a method has been proposed for IR determination of Chromium 
(VI)  in cerebral spinal fluid (CSF) [24]. 
1.5.2 Quantifications on solid samples. 
The use of NIR spectroscopy for the determination of the oxygen saturation of hemoglobin 
in brain, muscles and other human tissues is also well-known and scientific literature 
provides many studies, especially from Japanese researchers, which have been reviewed 
by Murkin and Arango [145].   
For the analysis of solid clinical samples, IR measurements can be easily made through 
ATR accessories in the case of MIR range and diffuse reflectance for NIR range. If a large 
pathlength is required, transmission measurements can be also obtained in the MIR range 
using a pellet of sample mixed/diluted with KBr or, alternatively in the NIR range, using 
commercial compacted spectrophotometers, such as the FQA-NIRGUN from Japan Fantec 
Research institute (Shizuoka, Japan) [146]. In addition, miniaturized sensors can be 
designed based on silver halide fibers technology, which enables remote sensing for the 
in-vivo measurement of  biological tissues [147]. 
Renal calculi. 
Middle IR spectroscopy is a widespread technique used for the characterization of urinary 
calculus. In 2009, Basiri et al. revised and compared the different methodologies 
employed for the analysis of urinary stones [148].  In this review, Basiri et al. empathised 
the advantages of IR spectroscopy against traditional methodologies as chemical analysis. 
Using KBr pellets, IR spectroscopy characterizes successfully the main constituents of 
kidney stones [95–101,149], avoiding the use of any reagent and providing a cost-effective 
and green method. However, analytical procedures based on transmission measurements 
of KBr-pellets involves time-consuming sample preparation. This handicap can be solved 
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with the use of ATR measurements that offers an excellent and practical tools for urinary 
calculi characterization based on direct single reflection measurements [102–104] or, 
alternatively, acquired through FTIR-microscopic measurements [105]. As compared with 
other powerful methodologies, as energy dispersive X-ray analysis or scanning electron 
microscopy, one of the limitations of FTIR spectroscopy was the difficulties on 
investigating the spatial distribution of the compounds in mixed stones [106]. However, 
the development of chemical imaging analysis based on FTIR hyperspectral 
measurements makes possible these studies. On concluding, at present IR provides a 
more affordable and compact technology than the previous ones and enables their use in 
small clinical laboratories. 
Hair, skin, and tissues. 
IR spectra from every surface of the human body can be easily acquired and, therefore, all 
exposed surfaces are potential sources of information that can be exploded for clinical 
diagnosis. In addition, all those measurements can be performed with available non-
invasive IR technologies and, during last years, several studies have been especially 
focused on the analysis of hair and tissues. 
FT-IR is able to extract quantitative information of the state of the hair. As early as 1985, 
Strassburger and Breuer demonstrated that the oxidative damage and the related 
concentrations of sulfonate and thiosulfate concentrations can be measured using bands 
ratio from the IR spectra of hair obtained through transmission measurements [26]. 
Recent studies evidence the capability of the amide bands for determining the secondary 
structures of hair proteins using ATR-MIR [27] and have been applied to study the effects 
of age [150] and surfactants [151] in hair. Other physical parameters related with the  
characteristics of hair such as friction, twist and gloss of hair can be also quantified from 
diffuse reflectance measurements and PLS modelling [28]. Although those parameters are 
in the borderline between the study of the dermatology effect of cosmetics and related 
products and the clinical field, it seems clear the high amount of information than can be 
obtained from the non-invasive measurement obtained from hair samples. 
Other cosmetic parameters such as lotion transfer levels can be also quantified by ATR-
FTIR in skin [107]. Nevertheless, this matrix offers much more possibilities for the non-
invasive determination of critical clinical parameters by means of IR spectroscopy. For 
example, using NIR diffuse reflectance measurements of skin and PLS regression, blood 
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glucose [16] or water [108] can be determined through skin and, in a recent study, Pleitez 
et al. propose and evaluate successfully a system based on MIR pulsed photoacoustic 
spectroscopy for the non-invasive monitoring of blood glucose concentration acquiring 
the spectra from human skin [17]. 
Non-invasive measurements can be also obtained from thumbs, lips or nasal mucus. For 
example, Sakudo et al. have performed predictions of hematocrit levels using PLS models 
applied to transmission NIR and visible spectra obtained from thumbs [146], obtained 
using the above-mentioned FQA-NIRGUN portable spectrophotometer. Yoshida et al. also 
proposed a tool for the screening of diabetes mellitus based on the determination of blood 
hemoglobin A1c levels using ATR-FTIR spectra from the lip surface [69]. In contrast, Heise 
and Marbach did not found any prediction capability in the non-invasive direct 
measurement of blood glucose from oral mucosa ATR-FTIR spectra [109]. Authors 
stressed the fact that “non-invasive spectroscopic methods exploiting trace signals 
require special attention paid to the variability due to person-to-person differences and 
changes in physiological conditions”. This fact evidences that biospectroscopists should 
take into account that the capability of IR spectroscopy is also limited -especially when 
minor compounds are studied- and they should be careful when extrapolating promising 
results obtained from a small number of samples to the real world [109]. Finally, on a 
recent study, Armenta et al. developed a two tier procedure for the semi-quantitative 
evaluation of cocaine on nasal mucus combining ion mobility spectrometry and 
transmission IR measurements [152]. 
Lipids are important compounds in biological systems and are present in all the tissues of 
the human body. The MIR spectra of lipids are easily recognizable due to the prominence 
of the characteristic CH3 bands, and this fact can be used to determine them in several 
samples. Regarding this group of analytes, Frank et al. measured total fecal fat using direct 
ATR-FTIR measurements of stool and PLS [153] and, on the other hand, Dreissig et al. 
determined cholesterol, galactocerebrosides, sphingomyelin, phosphoatidylcolyne and 
phosphatedietanolamine in brain by combining an organic extraction with PLS modeling 
of the transmission FTIR spectra. In this case the spectra of the organic extracts were 
measured directly on KBr pellets [25]. Besides, Yoshida et al. were beyond and proposed 
a methodology for the speciation of fatty acids in oral mucosa, obtaining accurate models 
for the prediction of several groups of fatty acids, including saturated C14–C17 acids, 
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monounsaturated C16 and C17 acids, stearic acid (C18:1), linoleic acid (C18:2) and C20-
C28 acids [70].  
1.5.3 Quantifications on gaseous samples. 
Breath is the mean gaseous sample that provides information about the human health. It 
contains a fraction of several volatile metabolites present in blood and therefore its 
analysis can be used for extracting relevant biochemical information [154]. In addition, 
extraction of large amounts of breath is non-invasive and therefore breath analysis is a 
promising tool for monitoring the individual's health status over extended periods of time 
[155]. IR breath spectra can be obtained introducing the breath in typical commercial gas 
IR cells or in hollow-waveguides (HWG). HWG is a hollow light-pipe system with the 
inside surface coated with a high IR-reflective layer which can serve simultaneously as an 
optical waveguide and also as a gas cell [156]. A new generation of these dispositive has 
been recently developed, the so called integrated HWG (iHWG), which compacts a large 
pathlength in highly miniaturized devices [157]. Regarding the light sources, classical FTIR 
spectrophotometers can be used, but the use of high power IR laser sources is becoming 
widespread in the analysis of gas in general and in the breath analysis in particular. 
Modern and multi-wavenumber lasers as QCL or continuous-wave optical parametric 
oscillator based IR lasers [158] are called to improve the sensitivity and portability of the 
breath sensors in the future. 
In the clinical field, the determination of isotopic ratio of 13CO2/12CO2 in exhaled breath is 
very useful for the study and diagnosis of several diseases. After the ingestion by the 
patient of food marked with 13C, the 13CO2/12CO2 in exhaled breath is motorized in order 
to follow the patterns of the metabolic changes of the patient. The isolated bands of 13CO2 
and 12CO2 at 2225-2335 and 2300-2400 cm-1 respectively can be used for measuring this 
ratio using IR spectroscopy, thus offering a cost-effective and compact alternative to the 
traditional mass spectrometry based methodologies. Literature reports proposed 
methodologies for the measurement of this ratio based on the use of QCL [72,73] and HWG 
[74]. The clinical application of this approach based on IR measurements has been used 
for the diagnosis of Helicobacter pylori infection [127]and the study on diet changes in 
preterm neonates [160]. 
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IR based technologies are commercially used for the determination of ethanol in breath 
[161]. Endogenous volatile organic compounds and other biomarkers (NO, CO, NH3, etc.) 
are difficult to be analyzed using IR spectroscopy due to its low concentration in human 
breath. The concentration of those compounds in breath varies with gender, state of 
health, age, and potential smoking habits and ranges from trace levels (i.e., few hundreds 
of ppb) to ppt concentrations [162,163]. Therefore IR based methodologies have been 
limited to the use of high sensitive laser sources. Some examples are the determinations 
of NO, CO and N2O [75], NH3 and CH3OH [76], ethane [164,165], or NO [80]. Finally, in this 
thesis, it is included a work where iHWG has been exploited and, after a pre-concentration 
of breath volatile compounds, the authors have been able to determinate isoprene in 
breath (see Section 3.4). 
1.5.4 IR based diagnosis. 
IR spectroscopy provides useful information about the presence, concentration and 
structure of a huge number of biologically relevant (macro)molecules. Therefore this 
technique shows a clear potential as a tool for diagnosis, prognosis and to evaluate 
therapeutic responses based on spectral information contents obtained from different 
biofluids and tissues. Because of the high amount information that can be extracted from 
FTIR spectra, in recent years the technique has shown potential as a powerful tool for the 
diagnosis of different diseases, including cancer [12], renal failure [11] or endometriosis 
[166]. In addition, the introduction of advanced focal plane array detectors and powerful 
sources have permitted the acquisition of hyperspectral microscopic images, and 
nowadays the high-quality IR spatial information can be obtained quickly and easily. 
Previous studies have shown that by combining IR microspectroscopy with chemometric 
techniques, multivariate models can be generated for the study of tissue samples 
including the discrimination of intraerythrocytic stages of the malaria parasite [167], the 
diagnosis of colon cancer [168], the attempt to predict secondary structures of proteins 
in vascular wall in diabetic animals [21] and the characterization of tissue samples 
including cervical cancer, prostate cancer, brain cancer, heart tissue and liver disease 
[169].  
Due to large number of references available on the literature, it is impossible to perform 
a detailed revision of every methodology proposed for the IR based diagnosis. This fact 
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indicates the high potential of FT-IR for the diagnosis and study of pathologies in tissues 
and cells. In a critical revision available in the bibliography Trevisan et al. have anticipated 
that in the future IR-based diagnosis methods will be incorporated to the regular clinical 
practice [14], but there are still some challenges which should be faced, particularly on 
the development of deep clinical studies with a representative and large number of 
samples. 
Prior to extracting any conclusion, it has to be taken into account the high variability of 
clinical samples, the impact of this variability in the “spectral patterns” under study. In 
addition, in the case of microscopic measurement, there are other problematic related 
with the IR spectroscopy which could interfere on the diagnosis, such as the presence of 
scattering [170,171] or electric field wave standing (EFWS) [172] in transflection 
geometry. IR imaging measurements are normally performed on transflection mode 
instead of transmission due to the cost-effective proprieties of the reflective substrates as 
compared with the IR transparent slides, especially when diagnosis studies are performed 
and several samples should be measured in order to provide reliable validations. 
Nevertheless, Filik et al. evidenced that the presence of a Electric field standing wave 
(EFSW) artefact on the transflection measurement, which introduces no linear behaviors 
in the spectra [172]. This effect has been recently studied and theoretically modeled by 
Bassan et al. [173], where authors, using prostate tissue sample, alerted about the 
problems that the EFSW can potentially introduce in the classifications of tissue. In 
contrast, Wrobel et al. demonstrated that this effect is diluted with some experimental 
factors inherent to the transflection system, such as the “integration over the range of 
incidence angles, varying degrees of coherence of the source and inhomogeneities in 
sample thickness”.  
The importance of this discussion is enormous. Specially in the case of the diagnosis based 
on transflection measurements, where the biological variations connected with the illness 
could be hindered by the spectral variations related to the thickness of the sample 
introduced by the ESFW and other spectral artefacts as scattering or reflection 
contributions. Nevertheless, after a better understanding of the biological variability and 
the interaction of IR light and clinical samples, it seems clear that in the next years IR 
spectroscopy will be able to compete with classical diagnosis techniques. 
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The promising benefits attributed on the past to the alliance between clinical chemistry 
and vibrational spectroscopy [132] are nowadays a reality on the diagnosis field as 
exemplified in the recent themed issue “optical diagnosis” guest-edited by Wood and Don 
McNaughton [174]. Based on the fast and cost-effective measurements of IR based 
methods, hundreds of measurements could be done in a large number of samples at an 
affordable cost and on the other hand IR is considered as one of the metabolic 
fingerprinting approaches that exhibits potential applicability to the “omics” science 
[175]. Although clearly outperformed by LCMS and GCMS in terms of sensitivity and 
specificity, the IR provides a “shotgun” analysis tool which has been already used for the 
study of   metabolic changes related with the undernourishment on rats [176] or the 
assessment of the metabolic effects caused by the intake of intervention breakfasts fried 
with different kinds of oil [177]. As evidences Bellisola and Sorio [178];  "The mid-IR 
absorbance spectrum is one of the most information-rich and concise way to represent 
the whole “… omics” of a cell and, as such, fits all the characteristics for the development 
of a clinically useful biomarker.". 
  
D. Perez-Guaita |Challenges in clinical analysis by infrared spectroscopy 
 
41 
  
2. RESUM.  
2.1 Introducció i Objectius. 
Des que William Herschel va descobrir la radiació infraroja (IR) en 1800, l’espectroscòpia 
vibracional s’ha convertit en una important font d’informació en diverses disciplines 
científiques. La llum infraroja es defineix com la part de l'espectre electromagnètic amb 
una longitud d'ona més llarga que la llum visible però més curta que la radiació de 
microones, comprenent la radiació amb longitud d'ona entre 700 nm i 1 mm. L’energia 
dels fotons d’aquesta radiació correspon a diferències entre els nivells vibracionals dels 
enllaços moleculars [1] i les regles de selecció de les teories quàntiques suggereixen que  
els modes vibracionals són actius quan el dipol elèctric de la molècula canvia durant la 
vibració[2]; per tant, la gran majoria de molècules orgàniques i inorgàniques absorbeixen 
la radiació de l’IR i el seu espectre és representatiu del grups funcionals de la molècula. 
La informació continguda en l’espectre IR ha estat utilitzada com a eina analítica per a 
l’avaluació, detecció i quantificació de diferents anàlits en una gran varietat de mostres, 
especialment després del desenvolupament dels espectròmetres de transformada de 
Fourier (FT). Així, a dia d’avui les anàlisis per IR són àmpliament utilitzades per a l’estudi 
dels productes derivats del petroli[3], la indústria farmacèutica [4] i alimentària [5,6]  i 
en general per a determinacions multicomponents en mostres complexes [7].  
La disciplina clínica no ha estat una excepció i en les últimes dècades s’han desenvolupat 
nombrosos mètodes basats en l’espectroscòpia d’IR per a l’anàlisi de mostres clíniques. 
Les mostres biològiques estan principalment formades per proteïnes, lípids, carbohidrats 
i DNA, que presenten absorbàncies característiques en el rang d’infraroig i que, per tant, 
són potencialment avaluables a partir de l’espectre, que proporciona un “snapshot” de la 
composició metabòlica d’aquestes mostres. Mitjançant la utilització de metodologies 
multivariants per al tractament de dades espectrals, es pot aïllar el senyal corresponent a 
la presència, estructura i quantitat dels compostos d’interès per a: 
• Establir diferències entre els espectres de mostres de pacients afectats d’alguna 
malaltia i pacients control. Mitjançant aquest procediment es poden detectar 
marcadors espectrals característics de la infermetat que poden ajudar a 
comprendre els seus mecanismes o servir com a eina de diagnòstic[10]. 
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• Quantificar els components presents a les mostres. La quantificació de diferents 
paràmetres clínics és actualment una ferramenta essencial en el diagnòstic i 
monitorització de malalties, i l’espectroscòpia d’IR ofereix avantatges en 
comparació als tradicionals mètodes basats en derivatitzacions enzimàtiques. 
D’aquests avantatges, el més significatiu és l’absència de complexos preprocessaments de 
la mostra. En molts casos, les anàlisis per infraroig són directes o quasi directes, evitant 
l’ús de reactius que, en el cas dels mètodes enzimàtics, suposen una important despesa 
sanitària que està fora de les possibilitats econòmiques dels països en desenvolupament 
o amb menys recursos dedicats a l’atenció primària dels seus habitants. A més a més, 
actualment els espectrofotòmetres IR comercials estan integrats per instrumentació 
econòmica i compacta que s’ajusta a les demandes de la medicina moderna, sent ideal per 
a l’ús en l’anàlisi en el punt d’atenció (també anomenat PoC, per les sigles en anglès). 
Una altra important virtut de l’espectroscòpia d’IR és la seua versatilitat. A més del fet que 
tots el compostos tenen una signatura pròpia a l’IR, l’espectre es pot mesurar en mostres 
sòlides, líquides i gasoses sense utilitzar instrumentació complexa. Per aquestes raons, 
mitjançant l’espectroscòpia d’IR es pot obtindre informació de totes les mostres 
disponibles, des de mesures no invasives de cabells fins a mesures de teixits biopsiats. 
D’altra banda, si es requereix informació microscòpica, actualment també existeixen 
microscopis acoblats als espectrofotòmetres d’IR que poden adquirir imatges 
hiperespectrals amb precisió en el rang de les micres. 
Malgrat el que s’ha dit, l’espectroscòpia d’IR també presenta els seus desavantatges que 
estan relacionats amb una baixa selectivitat i sensitivitat. La baixa sensitivitat està 
connectada amb el baix coeficient d’extinció molar i produeix que només siga possible 
l’avaluació  directa dels compostos majoritaris. En el cas de la selectivitat, el fet que quasi 
tots els compostos siguen actius en l’IR és una espassa de doble fil que produeix que 
l’espectre siga una combinació de bandes solapades de l’anàlit i la matriu. Per a extraure 
la informació “encriptada” a l’espectre i aïllar el senyal dels compostos d’interès de la resta 
de compostos de la matriu es imprescindible l’ús d’eines potents de tractament de les 
dades espectrals, basades en la quimiometria, entesa com un conjunt de processos 
estadístics que construeixen models que relacionen l’espectre amb  la composició de la 
mostra. En el cas de determinacions quantitatives, el model fa una regressió entre 
l’espectre i la  concentració dels anàlits en estudi, mentre que quan l’anàlisi està destinada 
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al diagnòstic, l’espectre es relaciona amb classes discretes amb el propòsit de classificar 
les diferents mostres. 
En conseqüència, l’objectiu d’aquesta Tesi doctoral ha sigut la de millorar i ampliar els 
mètodes d’anàlisi clínica basats en l’espectroscòpia d’IR, aprofitant les virtuts i enfrontant 
els desavantatges i limitacions d’aquesta. La Tesi s’ha dividit en quatre blocs en 
concordança amb els objectius inicials i els plantejats durant el seu desenvolupament: 
a) L’espectroscòpia d’IR com a eina complementària en l’anàlisi de paràmetres clínics en 
sèrum. La primera qüestió adreçada ha sigut l’anàlisi simultani d’una sèrie de compostos 
del sèrum humà, que en el present és àmpliament emprat als hospitals i als ambulatoris 
per al diagnòstic i monitorització d’infermetats. En contrast amb les metodologies actuals, 
que utilitzen reactius específics, l’espectroscòpia d’IR pot mesurar nombrosos 
paràmetres a partir de mesures directes. Una de les principals problemàtiques d’aquestes 
determinacions multiparamètriques és la necessària utilització de tractaments 
multivariants, que produeix que les estratègies convencionals de calibratge i validació per 
a mètodes univariants, que són les normalment usades en l’anàlisi clínica, no es puguen 
aplicar normalment a les metodologies basades en l’espectroscòpia d’IR. Aquest fet 
provoca, d’una banda, que hi haja dificultats a comparar les metodologies de referència i 
les basades en IR, de l’altra, que noves qüestions relacionades amb el tractament 
multivariant,  com la natura del set de calibratge i validació o el tipus d’algoritme utilitzat, 
hagen de ser adreçades amb cautela. 
Com els estudis publicats fins ara romanien a escala de laboratori, el principal objectiu 
d’aquesta part de la Tesi va ser el d’anar més enllà i realitzar una avaluació profunda de  
l’anàlisi de paràmetres clínics per IR des d’un punt de vista d’escala real, amb els següents 
objectius: 
• L'avaluació de la grandària dels conjunts de calibratge necessaris per a l'obtenció 
d'un model robust i representatiu, establint quantes mostres són necessàries en 
aquest conjunt de calibratge per a l'obtenció d'un error raonable en la predicció de 
les mostres. 
• L’estudi de l'impacte de la procedència de les mostres de calibratge per a la 
capacitat predictiva de noves mostres. 
• La identificació dels paràmetres que es poden analitzar amb una precisió 
comparable als mètodes de referència, d’aquells per als cuals la metodologia està 
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limitada com a tècnica de cribratge o els casos en què els models no tenen cap 
capacitat de predicció.  
• Comparació entre la utilització de l’algoritme clàssic de mínim de quadrats parcials 
(PLS, per les seus sigles en anglès) i l’algoritme ponderat localment (LW, per les 
seues sigles en anglès)-PLS en la predicció dels paràmetres clínics en el sèrum.  
• L'avaluació dels mètodes de classificació, com és el cas de l’anàlisi discriminant 
lineal (és a dir, LDA), com a mètodes de cribratge per a la identificació de les 
mostres que són dintre del rang normal dels paràmetres clínics, evitant així la 
necessitat de la seua anàlisi pels mètodes de referència. 
b) La millora de la sensibilitat i selectivitat de les aplicacions clíniques de l’espectroscòpia 
vibracional mitjançant el mesurament de pel·lícules seques d'extractes orgànics formades al 
cristall de l’accessori de reflectància total atenuada (ATR, per les seues sigles en anglès). En 
aquesta secció, els estudis s'han centrat en la millora de la sensibilitat i la selectivitat 
mitjançant la introducció d'un mínim pretractament de la mostra. Es va proposar una 
nova estratègia per a l'eliminació de proteïnes i preconcentració dels anàlits, utilitzant 
una extracció orgànica seguida de l'evaporació de l'extracte orgànic sobre el cristall ATR 
i mesurant l’espectre IR a partir de la pel·lícula seca obtinguda (DF-ATR, per les sigles en 
anglès). Així, només els compostos apolars són extrets i preconcentrats en la superfície 
ATR, eliminant les contribucions de les proteïnes i, sobretot, de l’aigua i millorant 
d’aquesta manera tant la sensibilitat com la selectivitat de l’espectre. Per a establir les 
bases de l'aplicació d'aquesta tècnica per a l'anàlisi clínica, els objectius d'aquesta secció 
han estat: 
• La comparació dels diferents dissolvents en l'extracció dels anàlits, en termes del 
tipus de molècules extretes, l'eficiència de les extraccions, les interferències 
extretes, l’homogeneïtat de la pel·lícula seca formada i les característiques 
“verdes” dels dissolvents i del mètode en general. 
• L’estudi d'aquesta tècnica en l'anàlisi dels paràmetres lipídics en sèrum: colesterol, 
lipoproteïnes d’alta i baixa densitat (HDL i LDL respectivament, per les seues sigles 
en anglès) i triglicèrids i la comparació amb els mesuraments directes de sèrums 
estudiats en l'última secció. 
• La introducció d'aquesta tècnica en el camp de la metabolòmica i la comparació de 
la informació obtinguda a partir de la metodologia proposada amb la informació 
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obtinguda per cromatografia líquida i espectrometria de masses en l’anàlisi de 
plasma.  
• L'ús de la metodologia proposada per a millorar suficientment la sensibilitat i la 
selectivitat com per poder analitzar per IR drogues als nivells en què es poden 
trobar en l'orina humana. 
c) Estratègies quimiomètriques per a l'extracció d'informació clínica dels espectres IR. El 
tractament multivariant és obligatori per a obtenir la informació rellevant dels espectres 
IR i excloure-la del "soroll" introduït pels senyals d'altres components presents a la 
matriu. En tots els casos han d’adreçar-se tres passos crítics:  
• El preprocessament de les dades amb la finalitat d'adequar-les per a la construcció 
dels models, eliminant fonts de variació externes, com per exemple la contribució 
de gasos atmosfèrics a l’espectre.  
• La modelització basada en algoritmes de regressió o classificació que relacionen 
variacions de l’espectre amb canvis biològics a les mostres. 
• La validació dels models desenvolupats. Aquest pas és necessari, especialment en 
el cas dels mètodes supervisats, per tal d’obtenir conclusions fiables entre les 
dades espectrals i la composició de les mostres.  
Si en la secció anterior s’ha intentat millorar les prestacions dels mètodes clínics basats 
en l’espectroscòpia d’IR mitjançant l’ús de mesures DF-ATR, l'objectiu d'aquesta secció és 
millorar la qualitat de la informació obtinguda del tractament multifactorial de la mesura 
directa a través  dels tres passos esmentats anteriorment: 
• Preprocessament. Introducció d'un algoritme per a l'eliminació d’interferències 
dels gasos atmosfèrics, fonamentalment vapor d’aigua i diòxid de carboni. 
L'eliminació d’aquestes contribucions abans de la modelació és molt útil en 
l'anàlisi exploratòria i per a establir la posició del màxim de les freqüències 
d’absorció, fonamental en l’assignació de les bandes a estructures secundàries de 
les proteïnes o als compostos de la mostra. 
• Modelació. Un dels objectius de la tesi ha estat comparar les metodologies 
quimiomètriques disponibles per a la determinació simultània de diversos 
components orgànics a partir de mescles complexes, simulant les determinacions 
en mostres clíniques. Tenint en compte la dimensió a gran escala de les aplicacions 
clíniques basades en espectroscòpia d’IR, aquesta comparació no es va limitar a 
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l’avaluació de l’exactitud, sinó també a altres característiques dels algoritmes, com 
ara el cost del calibratge en termes de nombre de mostres i de valors de referència 
necessaris, un factor important en l'aplicació de l'espectroscòpia d’IR com una 
alternativa econòmica en l'anàlisi clínica de rutina. 
• Validació dels models. Malgrat que els potents algoritmes quimiomètrics s'han 
establert com una eina indispensable per a l'aplicació de l'espectroscòpia d'IR en 
l’àmbit clínic, aquests també poden produir resultats massa optimistes. Tenint en 
compte els riscos relacionats amb el diagnòstic, és molt important que els 
investigadors validen els resultats d’una manera adequada i fiable, en especial 
quan la quantitat de mostres en l’estudi és reduïda i no és possible utilitzar un 
conjunt de validació independent i representatiu. Un altre dels objectius d'aquesta 
secció ha estat el de proposar un mètode, basat en proves de permutació, per a 
l’avaluació de la significança estadística dels models després de la selecció de 
variables espectrals, sense haver de recórrer a un conjunt de validació extern.  
d) Versatilitat de l’espectroscòpia d’IR en l’anàlisi clínica. Mesures de sòlids, gasos i imatge 
química. Com s'ha comentat abans, l'espectroscòpia infraroja és una eina versàtil que pot 
extraure informació de diversos compostos en gairebé totes les mostres del cos humà. Per 
corroborar aquesta versatilitat, l'última secció de la Tesi es va centrar en l'aplicació de 
l'espectroscòpia d'IR en l'anàlisi dels diferents tipus de mostres clíniques presents en 
estat sòlid i gasós. Aquestes mostres no són tan comunes com la sang i l'orina per a 
l'anàlisi de rutina, però igualment contenen informació essencial per al diagnòstic, estudi, 
monitorització i tractament de diverses malalties. Com la complexitat de les mesures varia 
segons el tipus de mostra i problema analític, els resultats es presenten en funció del grau 
de sofisticació dels objectius analítics afrontats, de més simple a més complex. 
• Estudis clàssics d'identificació i classificació dels càlculs urinaris per IR. Es 
caracteritzaren càlculs urinaris utilitzant mètodes d'agrupament jeràrquic a partir 
dels espectres de càlculs renals mesurats directament en un accessori d’ATR. Els 
resultats es compararen amb els obtinguts a l’hospital mitjançant mètodes 
químics.  
• Anàlisi de compostos orgànics volàtils en mostres d'alè. L'anàlisi d'alè era un repte 
més complicat, perquè els anàlits d'interès en aquesta mostra (metabòlits volàtils 
orgànics i inorgànics) es troben a nivells de ppb i fins i tot, ppt, inassolibles amb 
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els espectrofotòmetres amb configuracions convencionals. Per tant, va ser 
necessària la combinació d’un sistema de preconcentració i una guia d’ones 
compacta, de baix volum però amb un llarg pas òptic, per a l'anàlisi d’isoprè en alè 
a nivell de ppb. Aquest treball es va realitzar en col·laboració amb l’Institute of 
Analytical and Bioanalytcal Chemistry en Ulm (Alemanya). 
• Anàlisi de  teixits a través d'imatge química. La versatilitat de l’espectroscòpia d'IR 
també permet l'adquisició d'informació microscòpica valent-se  de microscopis 
FTIR acoblats que permeten l'adquisició d'imatges hiperespectrals en pocs minuts, 
una eina molt potent per a l'estudi clínic de teixits. En col·laboració amb el Centre 
of biospectroscopy de la Universitat de Monash a Melbourne (Austràlia), es va 
realitzar un estudi per a la diferenciació entre limfomes que presentaven i que no 
presentaven resistència a la quimioteràpia. La identificació de diferències 
espectrals entre limfomes quimioresistents i quimiosensibles pot aportar una 
valuosa informació dels possibles mecanismes de quimioresistència dels teixits i, 
d’altra banda, proporcionaria eines per al diagnòstic de tumors amb alta 
resistència a la quimioteràpia. L’estudi també va incloure una anàlisi comparativa 
de la mesura d’imatges de transflexió i transmissió, per tal de descartar la 
presència d’artefactes espectrals com ara l’ona estacionària de camp elèctric 
(EFWS per les seues sigles en anglès) que dificulten l’extracció adequada 
d’informació. 
 
2.2 Metodologia experimental. 
Generalment els experiments realitzats en aquesta Tesi comprenien dues etapes 
principals, l’adquisició de l’espectre i el tractament de les dades mesurades. 
Mesuraments directes d’espectres de sèrum: Per a mesurar en IR proper (NIR, per les 
seues sigles en anglès) es va utilitzar una cel·la de flux per mesures de transmissió i un 
espectrofotòmetre FTIR de Bruker model FPA. Les mostres s’introduïen en la cel·la 
mitjançant una bomba peristàltica i els espectres es mesuraven utilitzant un blanc de 
sèrum salí com a referència. En el cas de les mesures en l’IR mitjà (MIR, per les seues sigles 
en anglès), es va utilitzar un accessori ATR instal·lat en un espectrofotòmetre FTIR de 
Bruker model “Tensor 27”. L’espectre es mesurava directament depositant una gota de 
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sèrum en el cristall, utilitzant com a refèrencia la cel·la ATR . Un espectre de sèrum salí, 
mesurat en les mateixes condicions es sostreia per a compensar l’absorbància de l’aigua. 
Mesuraments de sèrum, plasma i orina pel mètode DF-ATR: Les mostres es varen 
addicionar a l’extractant orgànic i es varen agitar amb un vòrtex. L’emulsió resultant es 
va centrifugar per a separar les fases i uns microlitres (entre 1 i 3 depenent de la mostra) 
d’aquest extracte orgànic es varen depositar en el cristall ATR mitjançant una 
microxeringa. Després de deixar, a temperatura i pressió ambient, que el dissolvent 
s’assecara, es va mesurar l’espectre de la pel·lícula líquida resultant. En aquest cas 
l’espectrofotòmetre utilitzat era un model iF66 de Bruker, equipat amb un detector de 
mercuri-cadmi-tel·luri (MCT) d’alta sensibilitat i selectivitat, utilitzant l’accessori ATR 
buit com a referència. En el cas de les mostres d’orina, extretes de diferents voluntaris, 
varen ser dopades amb lidocaïna a les concentracions normals trobades en orina. 
Mesuraments de mescles complexes de gasos: La mesura dels espectres de gasos es va 
realitzar utilitzant una cel·la integrada en una guia d’ones de 3 centímetres de llargària. 
La cel·la es va situar en una taula òptica, entre un espectrofotòmetres IR CUBE de Bruker 
i un detector MCT. Les mescles de gasos es varen realitzar a partir dels patrons de gasos 
purs, utilitzant controladors de flux per a regular les concentracions dels diferents 
components (ciclopropà, diòxid de carboni, isobutilè, metà i butà) diluïts en nitrogen. 
Mesurament d’espectres de sèrum i orina en presència de gasos atmosfèrics: Els espectres 
es varen mesurar utilitzant l’accessori ATR de líquids instal·lat a l’espectrofotòmetre 
model Tensor 27de Bruker. Després de mesurar les mostres sense contribucions de gasos, 
els dispositius d’aïllament es varen obrir per a deixar que el vapor d’aigua i el diòxid de 
carboni de l’ambient s’introduïren en el camí òptic, obtenint espectres amb una gran 
contribució d’aquests gasos.  
Mesuraments directes d’espectres de càlculs renals: Els càlculs renals es varen moldre i 
es varen introduir en un accessori d’ATR adaptat per a la mesura de sòlids,   instal·lat en 
un espectrofotòmetre Tensor 27 de Bruker. Els espectres es van obtenir després de 
premsar la mostra, utilitzant com a referència l’accessori buit. 
Mesuraments d’espectres d’alè preconcentrat: L’alè o els patrons d’isoprè es varen fer 
passar per una columna de preconcentrament d’alumini farcida d’un polímer (DOWEX 
OPTIPORE) amb capacitat de retenir de forma efectiva l’isoprè i altres compostos orgànics 
volàtils. Seguidament, la columna es calfava controladament per alliberar l’isoprè del 
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polímer utilitzant una cinta calefactora que embolicava la columna, que havia sigut aïllada 
de l’exterior amb dues vàlvules. A continuació les vàlvules s’obrien i un flux baix de 
nitrogen espentava l’isoprè preconcentrat introduint-lo en una guia d’ones de 40 cm de 
pas òptic, on es monitoritzava l’espectre. Aquests eren mesurats utilitzant un 
espectrofotòmetre IR CUBE de Bruker, i un detector MCT.  
Imatge química de teixits de limfoma: Els teixits de limfoma van ser tallats amb un 
citocrom i fixats en cristalls de CaF2 i substrats reflectius per a les mesures en transmissió 
i transflexió respectivament. Les mesures es van realitzar amb un microscopi d’IR Cary 
620 d’AGILENT, equipat amb un conjunt de detectors de pla focal que permetia 
l’adquisició de  128 × 128 espectres utilitzant un objectiu tipus Cassegrain  amb una 
magnificació de 32.  
Tractament de les dades de sèrum mitjançant PLS: Es construïren models basats en 
l’algoritme PLS que relacionaven els espectres de les mostres amb les concentracions de 
referència obtingudes a l’hospital. Es crearen models amb sets de calibratge de diferents 
grandàries i amb mostres de diferent procedència. Els paràmetres estudiats varen ser les 
concentracions d’àcid úric, albúmina, colesterol, creatinina, globulina, glucosa, 
immunoglobulina, lipoproteïnes d’alta i baixa densitat (HDL i LDL), proteïnes totals i urea. 
El tractament de dades es va realitzar utilitzant el software OPUS de Bruker. 
Tractament de les dades de sèrum mitjançant LW-PLS i LDA: Es va comparar la predicció 
clàssica obtinguda per PLS amb els resultats obtinguts a partir dels models locals 
construïts utilitzant LW-PLS en les determinacions de glucosa, colesterol, proteïnes totals 
i urea. En aquest cas el tractament de dades es va realitzar amb la interfície PLS Toolbox 
de Engeinvector, integrada al software Matlab de Mathworks. També es varen crear 
models basats en LDA per classificar les mostres, a partir del seus espectres, com a 
mostres amb valors per damunt, per baix o dins del rang normal dels paràmetres en 
estudi. Els LDA es varen construir mitjançant el software XLSTAT de addinsoft. 
Tractament de les dades obtingudes dels mesuraments per DF-ATR: Els espectres de 
sèrum es varen utilitzar per a construir models PLS  per a la predicció dels paràmetres 
lipídics: colesterol, HDL, LDL i triglicèrids. La informació continguda als espectres de 
plasma es va comparar amb l’extreta de l’anàlisi per cromatografia líquida i 
espectrometria de masses (LC-MS) mitjançant anàlisi exploratòria basada en anàlisi de 
components principals (PCA, per les seues sigles en anglès). En el cas de les mostres 
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d’orina, es va realitzar una calibratge univariant utilitzant excel i modelitzacions 
multivariants utilitzant PLS, l’algoritme del calibratge basat en ciència (SBC, per les seues 
sigles en anglès) i l’algoritme del senyal analític net (NAS, per les seues sigles en anglès), 
els tres utilitzant la interfície toolbox i funcions d’elaboració pròpia en MATLAB. 
Tractament de les dades obtingudes dels espectres de mescles complexes de gasos: Es 
varen realitzar models basats en PLS, mínims quadrats clàssics (CLS, per les seues sigles 
en anglès) i resolució de corba multivariant – mínims quadrats alternants (MCR, per les 
seues sigles en anglès), per a la determinació simultània dels compostos de les mescles. 
També es va estudiar la robustesa dels models quan es varen introduir interferències com 
ara vapor d’aigua o ciclopropà, fent servir funcions d’elaboració pròpia amb MATLAB. 
Tractament del les dades obtingudes dels espectres de sèrum i orina en presència de 
gasos atmosfèrics: Els estudis de la correcció de la contribució dels gasos atmosfèrics als 
espectres d’IR es va realitzar utilitzant un nou algoritme proposat per Quintas et al. [179], 
que va ser aplicat mitjançant funcions d’elaboració pròpia amb MATLAB. Els espectres es 
van comparar amb els corregits usant la funció disponible al software OPUS. 
Tractament dels espectres de càlculs renals: Es va realitzar una classificació per una 
anàlisi per clúster (HCA, per les seues sigles en anglès) sobre els espectres de les mostres 
i dels patrons dels minerals que principalment componien els càlculs. La classificació 
obtinguda a partir del dendrograma es va comparar amb la informació proporcionada per 
les anàlisis químiques realitzades a l’hospital Dr. Peset Aleixandre de València. Per al 
tractatament de les dades espectrals es va utilitzar la interfície PLS Toolbox.  
Tractament dels espectres d’alè preconcentrat: Es va realitzar una calibratge univariant 
amb patrons, interpolant els espectres obtinguts a partir de mostres reals obtingudes d’un 
voluntari.  
Tractament de les imatges hiperespectrals de limfoma: Les imatges obtingudes per 
transflexió i transmissió de seccions adjacents de teixit es varen integrar en una matriu 
ampliada i es va realitzar l’anàlisi exploratòria, basada en HCA i PCA, amb el propòsit 
d’avaluar les diferències entre les dues geometries. Després, utilitzant imatges de 20 
limfomes mesurats per transflexió (10 quimioresistents i 10 quimiosensitius), es van 
extraure espectres representatius de la regió perifèrica per a construir models de 
classificació basats en l’algoritme d’anàlisi discriminant per PLS (PLS-DA), per les seues 
sigles en anglès). 
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2.3 Resultats. 
a) L’espectroscòpia d’IR com a eina complementària en l’anàlisi de paràmetres clínics en 
sèrum: En general, l’error de predicció dels models disminuïa a mesura que els sets de 
calibratge contenien més mostres, fins a quedar estabilitzat a un valor mínim. El nombre 
de mostres necessàries per a l’estabilització de l’error era diferent depenent de l’anàlit 
estudiat. En el cas de les modelitzacions basades en MIR, per exemple, l’error d’albúmina 
i proteïnes s’estabilitzava amb només 150 mostres, mentre que en el cas de glucosa, 
colesterol, urea, HDL i LDL es necessitaren més de 500 mostres per a arribar al plateau. 
Pel que fa a l’error mínim que es podia obtindre, aquest estava relacionat amb la 
concentració dels anàlits, evidenciant que la sensitivitat era el principal coll de botella de 
la tècnica. Els paràmetres també es podien dividir en grups: els paràmetres proteics (amb 
concentracions superior a 500 mg/dl), com ara proteïnes totals, albúmina, globulina total 
i coeficient d'albúmina/globulina podien ser fàcilment modelats amb errors de predicció 
relatives per sota del 5%; la predicció de triglicèrids i colesterol produïa errors entre 5 i 
10 %, només quan es mesuren utilitzant l'espectroscòpia NIR; la  determinació de 
lipoproteïnes, glucosa, immunoglobulines i urea, presentava errors entre 10 i 20 % i la 
creatinina i l'àcid úric no mostraven cap capacitat de predicció raonable i acceptable per 
als dos rangs espectrals. 
La predicció de paràmetres utilitzant LW-PLS millorava lleument l’obtinguda per la 
modelització PLS clàssica. Utilitzant la regió específica de l’anàlit o la regió sencera de 
l’empremta dactilar, els errors obtinguts pel LW-PLS eren entre un 4 i un 14% i un 5 i un 
22% menors que els del PLS respectivament. D'altra banda, l’ús modificat de l’algoritme 
LW-PLS, que combina el càlcul del PCA fent servir regions específiques de l’anàlit i el càlcul 
dels models PLS utilitzant la regió sencera de l’empenta dactilar, va aconseguir obtindre 
errors un 30, 29, 5 i 11% més baixos que els obtinguts per PLS per glucosa, urea, proteïnes 
i triglicèrids respectivament. 
En relació a l’LDA, el percentatge de mostres correctament classificades en la validació 
creuada es va situar entre el 70% i 79%. Encara que el mètode no va poder classificar 
correctament totes les mostres, els resultats derivats d'aquest estudi van evidenciar que 
l’LDA podria ser útil per a detectar la majoria de les mostres de sèrum amb els valors dins 
del rang normal, evitant així la seua anàlisi pel mètode de refèrencia. En tots els casos el 
percentatge de mostres classificades en el rang normal i per tant el nombre d'anàlisis que 
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hipotèticament s’haurien estalviat va ser major que 55%. No obstant això, dins d'aquest 
grup de mostres classificades com a mostres amb valors normals, es varen trobar entre 
un 10 i un 18% de falsos negatius. En canvi, els valors de les concentracions d'aquests 
falsos negatius no estaven lluny dels valors normals de referència. Cal assenyalar que 
aquest estudi acadèmic es va validar utilitzant validació creuada, i per tant, els resultats 
s'han de confirmar amb una validació independent. 
b) Millora de la selectivitat i la sensibilitat de les aplicacions clíniques de l’espectroscòpia 
vibracional mitjançant el mesurament de pel·lícules seques d'extractes orgànics formades 
en el cristall d’un accessori de reflectància total atenuada (DF-ATR). 
En la predicció de paràmetres lipídics en sèrum, els errors de predicció dels models creats 
a partir dels espectres obtinguts utilitzant la metodologia DF-ATR eren entre un 27 i un 
72 % millors que els obtinguts a partir del mesurament directe per ATR. Pel que respecta 
a les anàlisis de plasma, el PCA va evidenciar que l’acetona era el dissolvent que millor 
extreia els lípids i fosfolípids i el metanol les proteïnes i els aminoàcids. Aquests resultats 
estaven en bona concordança amb els resultats obtinguts per cromatografia líquida i 
espectrometria de masses.  
Pel que fa a l’anàlisi IR de mostres d’orina, el calibratge univariant obtingut a partir de la 
integració d’una banda dels espectres d’una orina dopada amb lidocaïna va resultar lineal 
en un rang entre 2 i 30 mg L-1. El límit de detecció calculat utilitzant 7 blancs d’orina va 
ser de 0.5 mg L-1. En contrast, quan aquest calibrat va ser emprat per a mesurar altres 
mostres, es va evidenciar que la contribució dels blancs era massa alta per a determinar 
amb exactitud la concentració de lidocaïna. Llavors, es va realitzar un tractament 
multivariant dels espectres per a aïllar el senyal de la lidocaïna de la resta de components 
de la mostra. Els models multivariants basats en algoritmes PLS i SBC varen proporcionar 
errors de predicció mitjans menors de 2.5 mg L-1. El límit de detecció multivariant calculat 
utilitzant el mètode NAS, va ser de 1.7 mg L-1. 
c) Estratègies quimiomètriques per a l'extracció d'informació clínica dels espectres IR. 
Pel que fa a la correcció de gasos atmosfèrics, l’algoritme proposat va corregir la 
contribució de diòxid de carboni i aigua, com evidenciava una inspecció visual dels 
espectres de sèrum i orina. El coeficient de correlació entre els espectres mesurats sense 
contribució atmosfèrica i els corregits va ser 0.9988±0.0006 i 0.99954±0.0007,  per als 
espectres de sèrum i d’orina respectivament. El mètode de correcció  proposat millorava 
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sensiblement l’eina disponible al software OPUS, on els coeficients de correlació obtinguts 
varen ser 0.9971±0.0007 i 0.99957±0.00004.   
D’altra banda, dels tres mètodes comparats per a la determinació simultània de 
components en mescles complexes de gasos, les prediccions foren comparables per a tots 
tres i no es va trobar diferencies significants (α=0.05) en un test t aparellat entre els errors 
de predicció dels tres mètodes en estudi. Quan es va incloure el vapor d’aigua com a 
interferent conegut, es va observar que SBC i CLS eren molt més sensibles a la presència 
d’un interferent que el PLS, però que si l’espectre de l’interferent era conegut, aquest es 
podia incloure en la modelització i corregir el seu efecte. Quan un interferent desconegut 
es va incloure (aïllant l’espectre de ciclopropà del calibratge però no de la validació), es 
va observar que els errors de SBC i CLS augmentaven entre dos i tres vegades en 
comparació al PLS. En canvi, aquest efecte es podia corregir en el cas del CLS incloent 
espectres de mescles amb ciclopropà en la matriu de soroll. Per altra banda, l’ús de MCR-
ALS proporcionava errors entre 40 i 100 % més grans que els obtinguts pel PLS, però 
aquest algoritme també proporcionava informació addicional de l’espectre del compost 
interferent. Els coeficients de correlació entre l’espectre patró mesurat de ciclopropà i el 
calculat es varen situar entre 0.9577 i 0.9847.  
Amb relació als resultats de l’avaluació del mètode per a la determinació de significança 
estadística dels models de diagnòstic emprant permutacions de classes, es va evidenciar 
que després de la selecció de variables els models PLS-DA classificaven correctament les 
mostres amb conjunts de dades sense correlació entre classes (models Null). Aquestes 
falses classificacions tenien més eficiència quan s’augmentava el nombre de variables. En 
canvi, l’estratègia proposada va suggerir en tots els casos que les modelitzacions no tenien 
significança estadística (p>0.05). Quan es varen avaluar sets de dades en què s’havien 
addicionat artificialment variables amb poder discriminatori, es va observar que la 
tècnica d’avaluació proposada en aquest cas sí que donava lloc a significança estadística 
als models. 
d) Versatilitat de l‘espectroscòpia d’IR en l’anàlisi clínica. Mesures de sòlids, gasos i imatge 
química. 
En l’estudi dels càlculs renals, la classificació dendogràfica va proporcionar quatre grups: 
la classe 1, que correspon a les mostres d'oxalat; la classe 2, què incloïa oxalats en 
combinació amb fosfat de calci i traces d'altres compostos; la classe 3, que corresponia als 
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càlculs d'àcid úric, i la classe 4, que incloïa oxalat barrejat amb altres sals com ara el fosfat 
de calci o d'amoni i el fosfat de magnesi. La comparació dels espectres mitjana de cada 
classe amb els espectres dels estàndards evidenciaren bona concordança. Per a algunes 
mostres, la classificació obtinguda pel clúster no era la mateixa que l’obtinguda pel 
mètode químic de l’hospital Peset. Una inspecció profunda dels espectres va revelar que 
en la majoria de casos la metodologia utilitzada a l’hospital presentava greus errors 
d’assignació.  
En el cas de l’estudi d’alè, els senyals obtinguts pels patrons d’isoprè van ser lineals en el 
rang estudiat (entre 0.25 i 1 ppm) i van permetre la construcció d’una recta de calibratge. 
Els valors calculats pel  coeficient de correlació, la pendent i l’ordenada en l’origen  van 
ser 0,9997, 0.162 ± 0.005 ppm  i -0,01 ± 0,003 ppm, respectivament. El límit de detecció i 
quantificació, estimats com les concentracions corresponents a 3 i 10 vegades 
respectivament, la desviació estàndard de 5 blancs varen ser 32 i 106 ppb. Les bandes 
d’isoprè de l'espectre de l'alè obtingut del voluntari varen evidenciar que les mostres reals 
contenien una concentració d’isoprè dins del rang de concentracions del calibratge. La 
concentració calculada va ser de 467 ± 18 ppb, comparable amb els valors reportats a la 
literatura. 
Pel que fa a les anàlisis de limfomes, una anàlisi exploratòria basada en  classificació 
dendrogràfica i PCA va evidenciar que ambdues geometries, transflexió i transmissió, 
proporcionaven imatges comparables. No es va detectar la presència crítica del EFSW o 
d’altres artefactes com la dispersió Mie. De fet, la major font de variació era l’eficiència de 
fixació del teixit, i no el mode de mesura. La variació en els espectres també estava 
influenciada per la composició proteica, com evidencia que els espectres d’infraroig 
estigueren estadísticament correlacionats amb els espectres obtinguts per la tècnica 
d’anàlisi proteica MALDI (p<0.05 per l’anàlisi procrusters i el test Mantel).  
La classificació basada en PLS-DA per la discriminació de mostres quimioresistents i 
quimiosensitives va ser significativa (p<0.05) inclús abans de realitzar una selecció de 
variables, evidenciant que existien característiques espectrals diferents entre les dos 
classes. Després de realitzar una selecció de variables, el model va classificar el 90 % de 
les mostres.  
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2.4 Conclusions. 
Dels resultats obtinguts en aquesta tesi es pot concloure que: 
- L’anàlisi IR pot extraure informació de qualitat de les mostres clíniques sòlides, líquides 
o gasoses, incloent càlculs renals, teixits, l’alè, l'orina o el sèrum. 
- Quant a l'anàlisi de paràmetres clínics en mostres de sèrum, s'ha evidenciat que la 
naturalesa de les mostres integrades en el conjunt de calibratge és crítica, i es necessita 
una àmplia col·lecció de mostres amb diferents gammes de concentració dels anàlits i 
interferències per a proporcionar bones prediccions de mostres obtingudes de diferents 
orígens. 
- El principal coll de botella de les determinacions de paràmetres de rutina en sèrum és la 
sensibilitat. Els errors disminueixen en augmentar la concentració dels anàlits d'interès. 
Per als paràmetres proteics, triglicèrids i colesterol, les tècniques basades en IR estan 
preparades per a competir amb l'anàlisi pels mètodes de referència; en el cas de les 
lipoproteïnes, la glucosa, la immunoglobulina i la urea, la tècnica està limitada com a eina 
complementària de cribratge i per als anàlits amb concentració inferior a 10mg/dl és 
impossible realitzar qualsevol model predictiu amb l’adequada fiabilitat. 
- El problema endogen de la sensibilitat es por resoldre mitjançant la introducció de noves 
tècniques de pre-processament de mostres i mesures espectrals. Combinant una eficaç 
microextracció i la tècnica DF-ATR es va proposar una metodologia per a la determinació 
de lidocaïna en orina amb un límit de detecció al voltant d'1 ppm, i un límit de detecció de 
32 ppb es va obtenir per a la quantificació d’isoprè en l'alè utilitzant una columna de 
preconcentració i una guia d’ones integrada (iHWG, per les seues sigles en anglès). 
-La metodologia DF-ATR proposada és una eina simple i eficaç per a millorar la selectivitat 
i la sensibilitat de les mostres clíniques. Aquesta estratègia millora la predicció dels 
paràmetres lipídics en sèrum i a més a més pot utilitzar-se per a  establir un mètode ràpid 
per a l'elecció de les millors condicions de precipitació de proteïnes prèvies a l’anàlisi per 
cromatografia líquida i espectrometria de masses. 
- Altres tractaments quimiomètrics poden millorar la qualitat de la informació obtinguda 
a partir dels espectres IR dels sèrums. Els models locals basats en LW-PLS milloren els 
resultats obtinguts per PLS i els models de classificació bastats en LDA poden detectar la 
majoria de les mostres que es troben en el rang de normalitat dels paràmetres clínics.  
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- Avui en dia hi ha una àmplia gamma d'algoritmes quimiomètrics (com PLS, LW-PLS, SBC, 
CLS o MCR-ALS) que es poden aplicar a determinacions multiparamètriques en mostres 
clíniques. Si es coneixen tots els components de la mostra, CLS proporciona prediccions 
simples i precises, i l’elecció entre PLS i SBC depèn de què és més fàcil, si  mesurar un 
conjunt d’espectres i dades de referència representatiu o una matriu de soroll. MCR-ALS 
sembla ser el mètode adequat per a l’obtenció d’informació de les interferències. A més, 
la contribució dels gasos atmosfèrics a l’espectre es pot compensar fàcilment mitjançant 
un mètode de substracció directa.  
- Els potents algoritmes esmentats anteriorment poden conduir a resultats excessivament 
optimistes, especialment quan hi ha involucrat un procés de selecció de variables. L'ús 
d'un test de permutació pot ser utilitzat per a avaluar la significació estadística del model 
quan no es pot emprar un conjunt de validació externa. 
- Les mesures dels teixits de limfoma per transmissió i transflexió mostren imatges 
hiperespectrals comparables. A la regió de l'empremta digital no hi ha evidència de EFSW 
i les principals diferències estan connectades amb problemes de fixació de la mostra al 
suport . 
- Per als teixits de limfoma, existeixen diferències significatives entre els espectres de les 
mostres sensibles a la quimioteràpia i les quimioresistentes. Encara que els resultats són 
prometedors, es requereix un estudi més detallat i amb més mostres, per a establir models 
de diagnòstic fiables o connectar les diferències espectrals amb mecanismes biològics. 
Aquesta Tesi doctoral consolida l’espectroscòpia d'IR com una poderosa tècnica per a 
l'extracció d'informació d’una gran varietat de paràmetres clínics en una àmplia gamma 
de mostres. A dia d’avui, la instrumentació IR és assequible i compacta i la quantificació 
de compostos majoritaris es pot realitzar mitjançant el tractament quimiomètric de 
mesures directes o gairebé quasi-directes. D'aquesta manera, l’IR proporciona una 
alternativa econòmica i utilitzable en el PoC per a l’anàlisi clínica tradicional o per al 
desenvolupament de noves estratègies de diagnòstic com per exemple les basades en 
l'anàlisi no-invasiva de l’alè. 
Tot i que la tècnica té problemes de sensibilitat i selectivitat, els resultats obtinguts en 
aquesta Tesi demostren que les tecnologies modernes poden assolir aquestes limitacions. 
Nous avanços en la mesura (DF-ATR o iHWG) o en la preparació de mostres 
(microextracció) han estat utilitzats per a millorar les característiques analítiques dels 
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mètodes sense renunciar als beneficis generals de les metodologies basades en IR. Entre 
d’altres, els pròxims reptes més importants són, d’una banda, la introducció de 
l'espectroscòpia IR a nivell comercial en la determinació de paràmetres clínics de rutina 
en sang i orina, que implicaria l'estalvi de grans quantitats de recursos i permetria 
realitzar anàlisis ràpides en farmàcies i ambulatoris. D’altra banda, l'ampliació de 
l’aplicació dels mètodes als estudis clínics. Les característiques d’aquests mètodes, que 
extrauen informació clínica de qualsevol mostra de forma econòmica i ràpida, els fan 
ideals per a la realització d’amplis estudis clínics, a un cost raonable i en un gran conjunt 
d’individus. 
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3 SUMMARY OF RESULTS. 
On the following, we present a summary of the results obtained from the experiences, 
serving as a guide of the main scientific outcomes of the Thesis. The results are divided on 
4 sections according with the general objectives of each section, which are established 
prior to the presentation of the results. The first section focus on the straightforward 
application of IR to the determination of clinical parameters in sera using IR spectroscopy, 
the second section studies the application of the ATR measurement of DFs of organic 
extracts of serum and urine for improving the selectivity and sensitivity of IR based 
clinical methods, the third section aims to improve the selectivity by improving the 
features of the chemometric treatment and the last section evidences the versatility of IR 
measurements by proposing methodologies for the analysis of solids, breath samples and 
microscopic analysis of tissues. A more detailed explanation of the results and 
methodologies can be found on section 5, where the articles and chapters are available. 
3.1 FTIR spectroscopy as a complementary tool in the routine analysis of 
clinical parameters in serum. 
As it has been stressed on the Introduction, FTIR provides a promising tool for the analysis 
of clinical parameters on serum. In contrast to FTIR, enzymatic methods involve the use 
of high amounts of expensive and specific reagents which are out of the economical 
possibilities of many countries. Taking into account the big number of clinical 
determinations required each day, the need of new and cheap alternative analytical 
procedures is clear, especially as screening tools, as a feasible indicator in situations 
where economical resources are limited and point-of-care diagnostic evidences are 
required. The main challenge of FTIR analysis of clinical compounds of sera is to establish 
a multivariate relationship between the MIR and/or NIR spectra of the serum and the 
concentration of clinical parameters. Figure 3.1 represents a set of serum spectra after 
water subtraction in the MIR and NIR range. It is also represented some of clinical 
parameters contained in sera with the area in concordance with their normal 
concentration. As it can be seen, sera is a complex mix of different compounds. From the 
non-aqueous portion of sera, proteins are the main constituent, and therefore normally 
dominate the spectra. Other constituents include lipids, saccharides, and other 
metabolites in a wide range of concentrations. Consequently, this complex matrix 
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produces an overlapped spectra of several bands and thus chemometric treatment of the 
data will be critical on the analytical procedure. This necessary multivariate treatment 
approach makes that the conventional univariate calibration and validation strategies, 
normally used on the traditional techniques applied to clinical chemistry, could not be 
employed on the IR based methods, and therefore new concerns related with the 
chemometric treatment, such as the nature of calibration and validation set, should be 
addressed in order to set up the methods and implement them in the clinical field. 
 
Figure 3.1: MIR and NIR spectra of serum samples and images of the structure of the main analytes 
which are found in serum.  
 
Since the studies available on the literature regarding the direct IR measurements of 
serum using PLS have been performed on a bench-scale, the first objective of the thesis 
was to go a step further and perform a deep analysis from a real-scale point of view. 
Therefore, the general objectives of this chapter are the following ones: 
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i) The evaluation of the size of the calibration set needed for obtaining a robust and 
representative model, thus establishing how many samples are needed on the 
calibration set for obtaining a reasonable error. 
ii) The assessment of the impact of the origin of the calibration samples on the 
modeling. 
iii) The identification of the analytes that can be analyzed with comparable accuracy 
to the reference methods, the cases where the methodology is limited to screening 
purposes or the analytes whose models do not have any prediction capability. 
iv) The comparison between the classical PLS and the locally weighted (LW)-PLS 
algorithms on the prediction of clinical parameters in serum.  
v) The evaluation of classification methods (i.e. LDA), as screening methods for 
identifying samples within the normal range of clinical parameters, thus avoiding 
their analysis. 
Those questions will be addressed in this block, with the aim of providing the basis for the 
implementation of all the advantages of the FTIR analysis of serum samples to the real 
world.  
For this propose three set of serums were acquired from the hospital Dr Peset Aleixandre 
(see Table 3.1). The concentration of several clinical parameters on the samples was 
measured using the reference methods of the hospital laboratory. Samples were 
transported from the hospital to the IR laboratory, where the spectra was measured 
between 1-5 days after the analysis with reference methods. A first set (Set 1) was 
integrated by MIR spectra acquired from 1500 samples, including subsets of 50 samples 
provided by the primary care (500), hospital (900) and pre-dialysis (100) sections of the 
laboratory obtained on two different years.  This set was used for the evaluation of the 
impact of the nature of the samples on the calibration. A second set (Set 2) was integrated 
by NIR spectra from 447 samples obtained from the biochemical laboratory of the 
hospital. For those sets, concentration of albumin, cholesterol, creatinine, glucose, high 
and low density lipoproteins (HDL and LDL), total protein, triglycerides, uric acid and very 
low density lipoproteins (VLDL) -obtained through enzymatic methods at the hospital- 
were predicted using PLS models based on the information of the IR spectra. A third set 
(Set 3) was composed by MIR spectra of 320 serum samples provided by the protein 
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section of the hospital being used for predicting the concentration of protein parameters 
–Albumin, globulin, immunoglobulin and albumin-globulin coefficient- obtained on the 
hospital by capillary electrophoresis. MIR spectra of Set 1 and Set 3 were obtained 
depositing around 75 µL of serum on an ATR cell and subtracting a blank of water 
previously measured. NIR spectra of Set 2 were obtained through transmission 
measurements performed by introducing 50 µL of serum on a flow cell using water as a 
background. 
Table 3.1: Serum sets used on the studies performed on this section. 
Set 
Number 
of 
samples 
Prominence Parameters 
under study Reference Spectra Articles 
1 1500 
Primary care 
Hospital 
Pre-dialysis 
Albumin 
Creatinine 
Cholesterol 
Glucose 
HDL 
LDL 
Total protein 
Triglycerides 
Uric acid 
 VLDL 
Enzymatic 
methods 
ATR-MIR 
(800-4000 cm-1) 1,4,5 
2 447 Hospital Transmission NIR (4000- 12000 cm-1) 2 
3 320 Protein Section 
Albumin 
A/G coefficient 
Globulin 
Immunoglobulin 
Capillary 
Electrophoresis 
ATR-MIR 
(800-4000 cm-1) 3 
Note: ATR, attenuated total reflectance; MIR, mid infrared; NIR, near infrared 
 
3.1.1 Prediction of clinical parameters using classical PLS and direct IR 
measurements.  
Impact of the nature and size of the calibration set. 
One of the main aims of the studies compiled on this thesis was to establish the prediction 
errors of several parameters whose reference data was available on the hospital. As it can 
be seen in the Introduction, most of the analytes studied through the thesis had been 
already evaluated in previous studies, but with homogenous small sets of calibration. As 
it has been stressed, the purpose was to take a step further and evaluate the PLS-NIR and 
PLS-MIR methodologies in the same conditions than those founded daily in the hospitals. 
For that, it is really important to consider the impact of the nature of the samples of the 
calibration set on the models. Petrich [134] demonstrated that the RMSEP and RMSECV 
decreased as the number of objects in the calibration set increased, stabilizing in a value 
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when the number of objects was big enough to be a representative set of the sample 
population.  
The relationship between the prediction error and the size of the calibration set is 
evidenced also on the study of the speciation of proteins included on this thesis and 
reported on a scientific publication referred as “Article 3”. Using the MIR spectra of the 
Set 3 and the reference data obtained by capillary electrophoresis, PLS models were built 
to determinate protein parameters in serum samples. Randomly selection, Kennard–
Stone, and SPA methods were assayed to select an appropriate sample calibration set. The 
aim was to compare the models built from a calibration set composed with m samples 
selected through the three methods above commented and to validate those models with 
the rest of 320-m samples. The number of samples in the calibration set was increased in 
ten samples each time from 20 to 170, monitoring the relative error of prediction when 
increasing the size of the calibration set. As an example, the prediction error obtained for 
albumin as a function of the size of the calibration are shown in Figure 3.2. The prediction 
error decreases slightly when increasing the number of samples employed for calibration, 
being this evolution slower for the use of a randomly selection. It can be concluded that 
the error decreased because, the more samples has the calibration set, the more 
representative was the model, and Kennard stone and SPA algorithms ‘accelerate’ this 
improvement of the representativeness by selecting the specific representative samples.  
 
Figure 3.2: Evolution of the RMSEP on the prediction of albumin as a function of the size of the 
calibration set for different strategies used for its selection: randomly selection (green), Kennard–Stone 
(red), and SPA (blue).  
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However, this representativeness can be lost when external factors as the origin of the 
samples or inter-year variability of spectra acquisition are included in the calibration step. 
In the first case, the variations could be connected to the fact that the samples belong to 
different sections with patients with different metabolic patterns and in the second case, 
mainly to the variations concerning the stability of the instrumentation.  In the 
aforementioned case of the models for the prediction of the protein parameters, samples 
were acquired from the same section of the hospital and the same kind of patients (Set 3), 
a scenario far removed from reality. A clinical routine laboratory must analyze everyday 
serum samples with an extremely variable composition and origin, which include normal 
and pathological values and are provided by different sections of the hospital. The 
variability within samples together with the complexity of the matrix can cause troubles 
in multivariate calibration. When different section of the hospital were involved on the 
composition of the calibration and validation set, as in the case of the study corresponding 
to the study included on the Article 1, the complexity of the situation increased. 
In this work, PLS models based on an increasing number of samples obtained from 
different sources (Set 1) were developed, and the prediction error obtained for 
independent new sample subsets was monitored. For this propose, a first model 
performed with a subset of 50 samples and validated with a new subset of samples. Then, 
the validation subset was incorporated to create an extended model which was validated 
again with a new subset and so on (see Figure 3.3).  
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Figure 3.3: Graphical explanation of the experimental procedure used on the study of the impact of the 
size and nature of the samples on the calibration set. 
 
Since the order of the inclusion of the models was random, models were in some cases 
validated with samples from an origin not integrated on the calibration set. The 
monitoring of the prediction error of the cholesterol is shown in Figure 3.4a. It can be 
seen that the relative error decreased on increasing the number of the samples of the 
calibration set, but in this case the error showed irregularities and anomalous points 
when set of samples of diverse origins were integrated on the calibration and validation. 
It has to be remarked that in this case relative root mean square error of prediction error 
(RRMSEP) is used because the average concentration of the prediction sets strongly 
varied depending on the origin of samples considered, and therefore a relative error was 
needed for comparing models validated with different datasets. Figure 3.4b evidenced 
that the abnormal low value of prediction error obtained in the case of model 2 (100 
samples for calibration) could be explained by the close similarities between the 
cholesterol values of samples integrated in the validation and calibration sets; both sets 
being obtained from primary care samples. In the first case in which a calibration set 
composed by primary care samples was assayed to predict hospital samples (model 4, 
180 samples for calibration), the RRMSEP increased due to the high variability of those 
samples (see Figure 3.4c). This effect was mainly due to the different distributions of 
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analyte values in both, calibration and validation data sets. When a pre-dialysis set of 
samples was evaluated with a model built with primary care and hospital samples (model 
13, 500 samples for calibration), the prediction error increased even when the 
concentration range of cholesterol values of this set was perfectly integrated in the 
calibration set (see Figure 3.4d) and this effect could be attributed to the great variability 
of samples, provided by patients with metabolic disorders, that contained extremely high 
levels of creatinine and urea which could interfere in the PLS-FTIR prediction of 
cholesterol. 
 
Figure 3.4 Evolution of the RRMSEP of the PLS-FTIR model with the size of the calibration set for the 
prediction of cholesterol from the MIR spectra (a). Distribution of sample reference values of 
calibration (blue) and validation (orange) for model 2, validated with a primary care sample set (b), 
model 4, validated with a hospital sample set (c) and model 13 validated with a pre-dialysis sample set 
(d). Note: PC; primary care; H, hospital; PD, pre-dialysis.  
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Those problems can be also explained from the exploratory multivariate data analysis 
also reported on the Article 1. A 50–50 MANOVA study evidenced the strong influence of 
the origin of samples and the inter-year variability of data, being the group of samples 
statistically different for both factors with p-values less than 0.001 under study. Besides, 
PCA decomposition (see Figure 3.5) showed a clear separation between samples 
analyzed in two different years (see Figure 3.5 left). The PCA decomposition made 
separately for the first year (see Figure 3.5 right) also evidences a slight division among 
the three different origins of samples. Those results evidenced that the inter-year 
variability of spectra acquisition and the provenience of the samples is the main 
parameter which affects the calibration set. 
 
Figure 3.5. PCA score plots of the PCA performed on the spectra of serum samples from different 
origins measured in different years. Left: Comparison of the spectra acquired the first year (blue) and 
those acquired the second year (orange). Right: Spectra of samples obtained the first year, colored 
according to their origin:  Primary care (orange), hospital (blue) and pre-dialysis (green).  
 
All this discussion serves as a necessary starting point to establish the real capability of 
IR spectroscopy in the determination of clinical parameters. Studying the evolution of the 
prediction error with the number of samples of the calibration set is mandatory for 
establishing i) the minimum error that can be obtained with a reasonable number of 
samples and ii) the minimum number of samples required for obtaining a reasonable 
error. In the next section, the prediction capability of PLS-FTIR models is evaluated after 
a systematic study of the effect of the number of samples on the prediction error and 
therefore ensuring that both, calibration and prediction sets are representative. 
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Which analytes can be predicted by IR spectroscopy? 
In order to introduce all the aforementioned advantages of FTIR spectroscopy on the 
routine analysis of clinical parameters on sera, the main need is to establish which 
analytes could be predicted by models built using PLS modelling from MIR and NIR 
spectra. In Table 3.2 are available errors obtained on the evaluation of the ‘best’ models 
performed on the studies of MIR (Article 1) and NIR (Article 2) based methodologies for 
the determination of clinical parameters in sera included in this Thesis. The adjective 
‘best’ refers to the fact that those models are obtained with enough number of samples on 
the calibration set to reach the plateau observed on the RRMSEP versus size of calibration 
set graph. From this table two main conclusions can be extracted: 
i) IR range provides more accurate predictions for some analytes even when a 
smaller calibration set is used.  A comparison of NIR and MIR results is a difficult 
task due to the disparity of the prediction sets employed on the evaluation of both 
studies. Nevertheless, from results included on Table 3.2, it can be suggested that 
NIR measurements provide more accurate results than MIR for lipidic parameters 
(total cholesterol, triglycerides, HDL and LDL) and glucose while for total protein, 
albumin and urea results are comparable. MIR range offers a priori more reliable 
information due to the fact that bands on NIR range are highly overlapped and the 
assignment of the bands is difficult. However, it is clear that in practical terms NIR 
spectroscopy provides models better or as good as those provided by MIR 
spectroscopy. This fact can be also connected with the measurements modes 
compared, especially taking into consideration that ATR measurements could suffer 
from irreproducibility problems with the formations of biofilms on the active 
surface of the crystal [50]. 
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Table 3.2: Predictive capability of PLS-NIR transmittance and PLS-ATR-MIR for the prediction of the 
analytes under study. See attached articles for more details. 
Analyte 
NIR Region MIR Region 
NCAL NVAL RRMSEP (%) NCAL NVAL RRMSEP (%) 
Total Protein 125 30 2.3 403 30 3.0 
Albumin 107 30 4.4 325 28 3.3 
Total cholesterol 261 30 5.1 1065 89 15.2 
HDL cholesterol 227 30 18.0 788 75 22.0 
LDL cholesterol 207 30 11.0 761 74 21.9 
VLDL* 210 30 10.9 N.E. 
Triglycerides 264 30 6.2 1056 80 34.1 
Uric acid N.E. 1062 87 34.3 
Creatinine N.E. 1219 90 37 
Glucose 288 30 16.2 1200 91 22.0 
Urea 288 30 16.0 1200 85 13.2 
Note: RRMSEP, root mean square error of prediction; NCAL, number of calibration samples; NVAL, 
number of validation samples; N.E. not evaluated. *In the case of VLDL, it was evidenced that the 
prediction capability is connected with the triglycerides bands and the high correlation (R2=0.999) of 
triglycerides and VLDL concentrations. 
 
ii) The prediction error is strongly dependent on the concentration of the analyte. 
In other words, the method suffers from a lack of sensitivity that strongly limits its 
prediction capability. The aforementioned situation has been already reported on 
the bibliography [28] and is well described in Figure 3.6, which shows the 
dependence of the RRMSEP on the mean concentration of the target analytes in the 
samples for the MIR study (Article 1) in red and for the NIR study (Article 2) in 
green. This graph suggested that all the analytes with concentrations above 1% will 
be accurately predicted with less than a 10 % of RRMSEP. This fact encouraged the 
investigation of the prediction capability of highly concentrated analytes in serum, 
such as protein-related parameters. Using data from the Protein section of the 
hospital obtained from capillary electrophoresis, a methodology based on PLS 
modelling of ATR measurements of sera (Article 3) was developed providing 
satisfactory results for albumin, gamma-globulin, total globulin and albumin 
globulin coefficient (A/G) with RRMSEP values of 4.9, 14.9, 7.1 and 4.5 %, 
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respectively (Blue colors in Figure 3.6). In this study the prediction of hemoglobin 
in whole blood was also studied. The main conclusion was that hemoglobin can be 
accurately determined (RRMSEP<5%) only when it is extracted from the red blood 
cells.  
 
Figure 3.6: Representation of the relative root mean square error of prediction (RRMSEP) of PLS-IR 
models built as a function of the mean concentration of the target analyte for the studies performed 
using the MIR range (left) and the NIR (right) ranges. Blue indicates results from the Article 1, green 
indicates results from the Article 3 and orange indicates results from the Article 2. Note: ALB, albumin; 
CHOL, cholesterol; CRE, creatinine; GLB, globulin; GLU, glucose; HDL, high density lipoprotein; 
HEM, hemoglobin; Ig, immunoglobulin; LDL, low density lipoprotein; TRI, triglycerides; T.P., total 
protein; UAC, uric acid; URE, urea.  
 
On summary, according to the results obtained on the three studies aforementioned 
(Articles 1-3), it can be concluded that the prediction capability of the PLS-IR based 
methodologies depends on the concentration of the target analyte. Protein parameters 
(>500 mg dL-1) such as total protein, albumin, total globulin and A/G can be easily 
modelled with relative prediction errors below 5%; The prediction of triglycerides and 
cholesterol also showed errors between 5 and 10 % only when are measured using NIR 
spectroscopy; determination of lipoproteins, glucose, immunoglobulin and urea present 
errors between 10 and 20 % and creatinine and uric acid do not show any prediction 
capability for both spectral ranges. Taking into account that the tolerance of the 
measurements of the controls of the reference techniques in the hospital in terms of 
relative standard deviation is 10%, it can be concluded that: 
i) for protein parameters  (with the exception of immunoglobulin) triglycerides and 
cholesterol, IR based techniques are ready to compete with the reference analysis, ii) in 
the case of lipoproteins, glucose, immunoglobulin and urea the technique is limited as a 
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screening complementary tool and iii) for analytes less concentrated than 10 mg dL-1 
(0.01%)  methodologies based on PLS modelling of  direct measurements of spectra of 
sera do not show any prediction capability and chemometrical and technical 
developments are required for improving sensitivity and selectivity.  
3.1.2 Basic chemometrical strategies for improving the quality of the 
information of the MIR spectra of serum. 
The aforementioned sensitivity problems of IR on the analysis of clinical parameters of 
serum are difficult to face without introducing sample preprocessing steps. However, 
there are some chemometrical strategies that could be used for improving the IR based 
serum analysis without renouncing to the direct measurement. Although in all cases the 
regression method used for the predictions was PLS, in this section it will be discussed 
the use of two different chemometrics approaches for improving the IR based 
determination of concentration levels of clinical parameters in untreated serum: LW-PLS 
and discrimination methods such as LDA and PLS-DA. Results obtained, that are reflected 
in the published papers referenced as Articles 4 and 5, were based on the treatment of 
ATR-MIR spectra and reference data available on the Set 1 previously described. 
LW-PLS. 
The high heterogeneity of the sera samples obtained from different sections of the 
hospital, previously evidenced on the PCA shown on Figure 3.5, suggested the use of local 
models as a more appropriate strategy. LW-PLS can be seen as a suitable approach to 
overcome a lack of linearity of the relationship between signals and analyte 
concentrations and to facilitate the selection of proper calibration sets. Local regression 
approximations are based on the assumption that the use of specific calibration equations 
for each new sample to be analyzed, using small calibration sets tailored to the unknown 
sample from a large library of samples. 
In order to evaluate the advantages and drawbacks of the application of LW-PLS to the 
direct determination of clinical compounds in human serum from the ATR-FTIR spectra, 
it was performed a study, published on the Article 4. The prediction of triglycerides, urea, 
total protein and glucose was investigated trough the modelling of the spectral data from 
the Set 1, but in this case samples from all origins were randomly divided into calibration 
and validation sets for PLS and LW-PLS model calculation and comparison of their 
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respective prediction capabilities.  Briefly, the LW-PLS approach consisted in four steps: 
(i) development of a PCA model at F components, (ii) computation of the Euclidean 
distance between the query and the calibration samples in the scores space, (iii) selection 
of the N nearest neighbors to the query and (iv) calculation of a local PLS regression 
employing the selected samples and LV latent variables (see Figure 3.7). Three LW-PLSR 
models, employing different spectral regions for the selection of samples used for 
calibration and PLS regression, were calculated for each compound under study: 
- LW-PLSw: models were constructed using the whole region (900–1750 cm−1) for sample 
selection and model calibration 
- LW-PLSa: analyte characteristic spectral regions were employed for sample selection 
and model calibration  
- LW-PLSm: the selection of the samples used for calibration was carried out employing 
analyte specific regions and PLS was performed using the whole spectral region. 
For the comparison of the different algorithms, the aforementioned approaches and the 
classical PLS method (using in this case the analyte region and therefore named PLSa) 
were used for building models using in all the cases the same 320-600 samples for the 
calibration depending on the analyte considered. Models were then validated using a 
prediction set with 320-600 independent samples. 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Explanatory scheme of the LW-PLS approach. 
PC2 
PC1 
PCA PLS Regression 
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While for classical PLSa the optimal number of latent variables is easy to establish using 
the RMSECV error, for the LW-PLS the selection of internal parameters is not so simple. 
One of the drawbacks of the LW-PLS algorithm is its complexity, being necessary to select 
three critical parameters for the modelling; namely, N (number of samples for the 
calibration of the local model), F (Number of factors of the PCA) and LV (Number of latent 
variables of the PLS). The effect of the combination of the three parameters under study 
on the predictive capabilities of LW-PLSR models estimated by RMSECV for the urea is 
shown in Figure 3.8. This plot evidences that those parameters strongly affected the 
outcome of the analysis. Results found using the approaches LW-PLSw, LW-PLSa and LW-
PLSm for the determination of triglycerides, total protein, urea and glucose confirmed the 
existence of local minima in the response surfaces, thus allowing the selection of the best 
parameters based on RMSECV results -analogous to the selection of the LV on a regular 
PLS regression- and simplifying the selection process of the optimal values of N, F and LV. 
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Figure 3.8. Parameters affecting the prediction capability of LW-PLS modeling for the prediction of 
urea using the analyte specific spectral region, (warm and cold colors indicate high and low RMSECV 
values respectively): F vs. LVs (for N=240) (a) LVs vs. N (for F=6) (b) and F vs. N (for LVs=5) (c) 
Note: F, PCA factors for the selection of local models; N, number of samples in the local models; LV, 
number of latent variables for the PLS.  
 
The comparison of RMSEP values obtained by classical LW-PLS and PLS evidenced a slight 
improvement of the predictive capability of models when local regression was applied, as 
summarized in Table 3.3. LW-PLSa provided RMSEP values between 4 and 14% lower 
than those obtained by PLSa (corresponding to a classical PLS regression performed on 
the analyte region). A similar trend was observed for LW-PLSw where the improvement 
was slightly higher and the RMSEP values decreased between 5 and 22% with respect to 
those obtained for PLS (with the exception of triglycerides determination). On the other 
hand, problems of PCA for the selection of samples for local models when the whole 
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spectrum was used were identified. Therefore, the alternative two-steps strategy (LW-
PLSm) -which combined the calculation of a PCA model using analyte specific regions for 
the selection of appropriate calibration subsets, and a subsequent calculation of PLS 
models using the whole spectrum- accomplished significant improvements in accuracy. 
The RMSEPs obtained for glucose, urea, proteins and triglycerides were 30, 29, 5 and 11% 
respectively lower than those obtained for PLSa. Although the optimization of LW-PLS 
parameters can be computing intensive, this study evidences that LW-PLS provides 
improved predictive capabilities for the determination of clinical parameters based on 
direct FTIR measurements of untreated serum samples.  
Table 3.3: Evaluation of the predictive capability of different multivariate approaches for the 
determination of glucose, urea, proteins and triglycerides in sera.  
 
Note: Urea region corresponds to 1683-1560 and 1495-1405 cm-1, Glucose region corresponds to 990-
1200 cm-1 and whole spectrum to 900-1750 cm-1; Protein region corresponds to 1380-1690 cm-1, 
Triglycerides region corresponds to 1708-1760, 1420-1480 and 1128-1199 cm-1; RMSEP, root mean 
square error of prediction; Improvement, improvement respect the results obtained from the PLSa. 
 
 
 
 
Analyte Approach 
Region 
employed for 
PCA (cm-1) 
Region employed 
for PLS (cm-1) 
RMSEP 
(mg dL-1) Improvement 
Glucose 
PLSa - Glucose 24.7  
LW-PLSRa Glucose Glucose 22.2 10% 
LW-PLSRw Whole spectrum Whole spectrum 19.7 20% 
LW-PLSRm Glucose Whole spectrum 17.1 31% 
Urea 
PLSa - Urea 13.4  
LW-PLSRa Urea Urea 11.6 13% 
LW-PLSRw Whole spectrum Whole spectrum 11.3 16% 
LW-PLSRm Urea Whole spectrum 9.5 29% 
Proteins 
PLSa - Protein 0.253  
LW-PLSRa Protein Protein 0.243 4% 
LW-PLSRw Whole spectrum Whole spectrum 0.240 5% 
LW-PLSRm Protein Whole spectrum 0.240 5% 
Triglycerides 
PLSa - Triglycerides 45.0  
LW-PLSRa Triglycerides Triglycerides 43.2 4% 
LW-PLSRw Whole spectrum Whole spectrum 50.6 -12% 
LW-PLSRm Triglycerides Whole spectrum 40.1 11% 
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Classification method (LDA). 
As it can be seen, the general aim of the aforementioned works was to evaluate IR 
spectroscopy as an alternative technique to the commercially available enzymatic 
methods by performing prediction models in order to obtain the concentrations as 
accurately as possible. However, the use of ATR-FTIR hyphenated with classification 
algorithms as a screening tool for determining which samples contains the parameters 
under study inside the so called normal values was not been investigated. Therefore, in 
this thesis it was performed a study with the aim of evaluating the diagnostic capability 
of ATR-FTIR measurements of serum samples in the detection of samples with normal 
values of sera components, thus obtaining fast and cheap responses reducing the need of 
confirmation analysis of samples far from pathological values.  
For this propose, serum sample spectra from the set 1 were divided on three classes 
according to the concentration of the clinical parameters under study: “pathologically 
low” for the samples with a level of the parameter lower than the normal range, “healthy” 
for samples with a concentration of the parameter within the normal range and 
“pathologically high” for those samples with a higher concentration than the normal 
range. A different grouping was performed for each parameter under study (cholesterol, 
creatinine, glucose, HDL, LDL and urea), using as a cut-off values for defining the normal 
range the values indicated by the hospital. Then, LDA was applied in order to assess 
whereas from the IR spectra, models could be established for classification the samples 
among the aforementioned pathological and healthy groups, using cross validation as an 
evaluation method. A detailed description of this study and a complete discussion of 
results is presented in the research paper referenced as “Article 5”. 
An example of the distribution of samples in the space generated by the discriminant 
functions is shown in Figure 3.9, which refers to the re-classification of the samples based 
on its urea content. The first function discriminated among the three classes of samples 
and the second function differentiated samples with values inside the normal range and 
samples with abnormally high or low values of urea. In addition, samples with an 
abnormally high level of urea (193-300 mg dL-1) were reclassified very far for the other 
classes (see Figure 3.9); evidencing the manifested discrimination capability of the ATR-
IR spectra of serum samples.  
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Figure 3.9:  Canonical coordinates for LDA discrimination of sera samples based on urea values. Note: 
samples indicated with arrows on the blue circle correspond to those with concentrations from 193 till 
249 mg dL-1.  
 
Confusion matrices obtained in the evaluation of the LDA models through leave one out-
cross validation considering two or three levels are available at Tables 3.4 and 3.5. The 
percentage of samples well classified in all the cases ranged between 70 % for creatinine 
and 79% for LDL, being obtained the best predictions for classes with a low number of 
samples such as samples with low values of urea, cholesterol and glucose (less than 100 
samples), possibly due to the automatic weight correction applied.  
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Table 3.4: Confusion matrix obtained for cross validation of LDA models performed on analytes with 
three classes considered 
Analyte From/to P. Low Healthy P. High Total % Correct 
Cholesterol 
P. Low 10 0 0 10 100.00% 
Healthy 5 534 174 713 74.89% 
P. High 0 80 263 343 76.68% 
Total 15 614 437 1066  
% correct 66.67% 86.97% 60.18%  75.70% 
Creatinine 
P. Low 117 47 1 165 70.91% 
Healthy 210 579 33 822 70.44% 
P. High 18 36 146 200 73.00% 
Total 345 662 180 1187  
% correct 33.91% 87.46% 81.11%  70.94% 
Glucose 
P. Low 22 2 0 24 91.67% 
Healthy 102 580 96 778 74.55% 
P. High 22 112 244 378 64.55% 
Total 146 694 340 1180  
% correct 15.07% 83.57% 71.76%  71.69% 
Urea 
P. Low 42 9 0 51 82.35% 
Healthy 136 680 31 847 80.28% 
P. High 16 85 184 285 64.56% 
Total 194 774 215 1183  
% correct 21.65% 87.86% 85.58%  76.58% 
Note: P. High, pathological High; P. low, pathological Low 
 
Table 3.5:  Confusion matrix obtained for cross validation of LDA models performed on analytes with 
two classes considered 
 
 
 
 
 
 
 
 
Note: P. High, pathological High; P. low, pathological Low 
 
Although the method could not classify successfully all the samples in their corresponding 
classes, results evidenced that LDA could at least identify the majority of serum samples 
HDL 
From/to P. Low Healthy Total % Correct 
P. Low 177 60 237 74.68% 
Healthy 100 425 525 80.95% 
Total 277 485 762  
% Correct 63.90% 87.63%  79.00% 
LDL 
From/to Healthy P. High Total % Correct 
Healthy 388 131 519 74.76% 
P. High 43 163 206 79.13% 
Total 294 431 725  
%  Correct 90.02% 44.56%  76.00% 
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within normality values. Therefore, this method can be useful as a screening tool for 
detecting samples with values inside the normal range and its exclusion of the 
confirmation analysis. Table 3.6 summarizes results obtained related to this approach. In 
all the cases the percent of samples classified as normal and consequently the number of 
analysis saved was higher than 55 %. However, inside this group of samples classified as 
samples with normal values which not need to be analyzed, we found around 10-18% of 
false negatives with concentrations of the analytes outside the normal ranges. 
Nevertheless, concentration values of these false negatives were not far from the normal 
range. It has to be noted that this academic study was validated using cross-validation, 
and therefore results should be confirmed with an independent validation. 
Table 3.6: Confirmation analysis saved and errors made considering the cross validation for LDA as a 
screening tool of abnormal concentration of sera parameters based on ATR-FTIR spectra.  
 
Analyte 
Cut-off 
Values 
(mg dL-1) 
Total 
Samples 
Classified 
as 
Normal 
Analysis 
saved 
(%) 
FN 
(%) 
False negative by 
excess 
False negative 
by defect 
N 
Value 
(X±S in  
mg dL-1) 
N’ 
Value 
(X±S in 
mg dL-1) 
Cholesterol 80-200 1066 614 57.60 13.0 80 221±24 0  
Creatinine 0.7-1.2 1187 662 55.77 12.5 36 1.50±0.44 47 0.62±0.06 
Glucose 70-105 1180 694 58.81 17.9 122 116±12 2 60±1 
HDL >40 762 485 63.65 12.3   60 35±4 
LDL <130 725 431 59.45 9.9 43 151±18   
Urea 19-50 1183 762 64.41 12.3 85 59±9 9 16±3 
Note: N and N’, number of samples for which false negative errors by excess (N) or by defect (N’) were 
made using the screening proposed procedure. FN: false negatives. 
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3.2 Improving the selectivity and sensitivity of FTIR spectroscopy in clinical 
determinations by measuring dry films of organic extracts using ATR. 
After establishing in the previous section that sensitivity is one of the main limitations of 
the FTIR spectroscopy on the direct analysis of clinical parameters on sera, studies were 
focused on improving this sensitivity by introducing a minimum preprocessing of the 
sample. For this propose, a new strategy was proposed for eliminating proteins and 
preconcentrating the analytes, based on an organic extraction followed by the 
evaporation of the organic extract on the ATR-crystal and measurement of the DF 
obtained. Figure 3.10 summarizes a scheme of the process, together with a microscopic 
image of the DF formed by a lipidic extract of the serum, which resulted homogeneous 
and with a thickness smaller than the penetration depth of the IR beam on the ATR.  With 
this approach, nonpolar extracted compounds are preconcentrated on the ATR surface 
and contributors to the interferences on the IR spectra of clinical samples –e.g. proteins 
and water presents in sera- are removed also, improving both selectivity and sensitivity.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Graphical scheme of the methodology applied to the analysis of serum and urine based on 
the organic extraction and DF-ATR-FTIR measurements.  
 
  
ATR Cell 
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The versatile proposed technique implied the selection of experimental parameters, such 
as the kind of solvent, the volume of solvent and sample employed on the liquid-liquid 
extraction and the volume of extract deposited on the ATR cell. In the following studies, 
those parameters were tailored to the analytical problem under study (See Table 3.7) 
Table 3.7: Liquid/liquid extraction parameters of the different studies performed on this section. 
Sample Solvent employed Target Parameters 
Solvent volume/ 
Sample volume 
(µL) 
Volume 
deposited 
(µL) 
Article 
Serum 
Ethyl acetate-ethanol 
3:1 (v/v)  
 Hexane-Isopropanol 
3:1 (v/v) 
Cholesterol 
HDL 
LDL 
Triglycerides 
800/80 2 6 
Plasma 
Acetone 
Acetonitrile 
Methanol 
Amino-acids 
proteins 
Lipids 
Phospholipids 
Saccharides 
150/50 1 7 
Urine Chloroform/Methanol 2:1 (v/v) Lidocaine 40/500 3 8 
 
 With the general aim of applying this technique to the IR based clinical analysis, the objectives of this 
sections were: 
i) The study of the behavior of different solvents for the extraction of the analytes, 
in terms of the type of molecules extracted, the efficiency of the extractions, the 
interferences avoided, the utility of the dry film formed and green features of the 
solvents. 
ii) The application of this technique for the analysis of lipidic parameters in serum 
(cholesterol, HDL, LDL and triglycerides) and the comparison with the direct 
measurements of sera studied in the last section. 
iii) The introduction of this technique on the metabolomic field. The comparison of 
the information obtained from the proposed methodology with the information 
obtained from liquid chromatography-mass spectrometry of plasma samples. Since 
it is anticipated that IR is outperformed by the LC-MS in terms of the selectivity and 
sensitivity, studies will focus on the application of this technique for assessing the 
impact of the protein precipitation of samples in metabolomics studies, establishing 
a cost-effective and fast back-up method for choosing the best protein precipitation 
conditions prior to LC-MS. 
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iv) The use of the proposed approach for improving the selectivity and sensitivity 
sufficiently to analyze drugs at the normal levels found in human urine. 
3.2.1 DF-ATR analysis of serum and plasma samples. 
From serum and plasma samples, the nature of compounds extracted depends on the 
nature of the extracting solvent. Nonpolar solvents should extract the major lipids and 
related compounds, i.e. those involved in important clinical parameters (triglycerides, 
cholesterol and lipoproteins), whereas polar compounds such as acetone, acetonitrile and 
methanol should extract different kind of compounds. This fact is evidenced in the Figure 
3.11, where a comparison of spectra of the dry serum extracts using two nonpolar 
mixtures (hexane-isopropanol and ethyl acetate-ethanol) and spectra from dry plasma 
extracts using three polar organic solvents (acetone, methanol and acetonitrile). As it can 
be seen, spectra obtained from the extract of nonpolar solvents are dominated by typical 
lipid characteristic bands corresponding to the ν(C-H) at the region between 2800-3200 
cm-1 and the ν(C=O) at the region between 1700 and 1780 cm-1, while the spectra of the 
polar solvent extracts show bands from other compounds such as amino-acids and 
proteins (amide bands) and sugars (ν (C-O)).  
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Figure 3.11. Comparison between ATR-FTIR spectra of dried extracts of samples obtained using ethyl 
acetate-ethanol (EtOH/EtAc), hexane-isopropanol (Hexane/Isop), acetone (Acet), methanol (MeOH) 
and acetonitrile (ACN) with the spectra of L-α-Lysophosphatidylcholine (blue), cholesterol (red) and 
triolein (green) standards. Horizontal magenta lines indicate the regions related to the absorption bands 
of the chemical bonds. Note: Spectra were shifted for clarifying and untreated serum spectra have been 
divided by 3. Standard spectra were obtaining by drying two µL of a standard solution of 10 mg dL-1 in 
hexane-isopropanol on the ATR crystal. 
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In concordance with those results, nonpolar solvents were used for evaluating the use of 
PLS-ATR IR spectra of serum organic extract as a fast and PoC approach to determine the 
concentration of lipidic parameters (i.e. cholesterol, triglycerides, HDL and LDL) in serum. 
The results of this study are integrated on the research publication referred as Article 6. 
Since the method is designed for the screening and control of several samples on a large 
scale, a carefully selection of the solvents to be used for sample pretreatment was realized 
considering hexane and mixtures of ethyl acetate-ethanol 3:1 (v/v), hexane-isopropanol 
3:1 (v/v) and chloroform-methanol 3:1 (v/v). As a result and considering ‘green’ factors, 
serum samples were only extracted using hexane-isopropanol and ethyl acetate-ethanol 
mixtures. Figure 3.11 also shows the ATR-FTIR spectra obtained from the extracts of 
three standards representing the analytes under study, i.e., cholesterol, triolein as a 
molecular model of triglycerides and L-α-Lysophosphatidylcholine as a typical 
phospholipid (one of the main family of components of HDL and LDL). It can be seen 
strong differences among the samples in the absorption regions of the standards, i.e. the 
regions of absorption of lipids above mentioned, evidencing that changes in spectra are 
caused by the different composition in cholesterol, triglycerides, HDL and LDL content of 
the samples. For example, the maximum position and intensity of the CH2 and CH3 bands 
located in the 2800-3050 cm-1 range varied widely among the samples, specially the 
maximum of the band assigned to the νas(CH2). Standards spectra evidence that this 
variation can be explained taking into account the different size and shape of the bands of 
the different components under study present in the sample. Something similar occurs in 
the fingerprint region, where it was observed strong variations in the size and shape of 
the ν (C=O) and the ν (P-O) bands. In this region bands of triolein and L-α-
Lysophosphatidylcholine standard were also located. In short, the visual comparison of 
spectra shown in Figure 3.11 reveals that the differences in the bands found in sample 
spectra are presumably due to differences in the concentration and composition of the 
compounds under study. 
ATR spectra of the dried sample extracts were acquired and modelled using PLS and 
reference concentrations obtained by enzymatic methods. PLS models built from the 
extracts of the two solvent mixtures were compared with those obtained from direct 
measurements of sera samples. The 50 serum employed for the study were randomly 
divided between a calibration and a validation set with around 30 and 20 samples 
respectively. PLS models were performed using the calibration set, being used the 
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RMSECV for selecting the best parameters of the modelling, such as the number of latent 
variables or the spectral range used for the regression. Then models were validated using 
the prediction set and the RMSEP and the ratio prediction to deviation (RPD) of the 
prediction set were used for the comparison among the models.  In all cases the worst 
prediction capability was found for the direct measurement, being always the RMSEP of 
the models obtained from the extract spectra from 27 to 72 per cent lower than those 
obtained from the direct measurement. This fact is graphically denoted in the Figure 
3.12, where the plots of reference values vs. predicted ones are represented. It can be 
seen that the sample concentration values for both calibration and validation sets cover a 
wide range of concentrations. Besides, the regression line of the prediction samples (red 
lines) fitted better to a straight line with slope and intercept values equal to 1 and 0 
respectively (green lines) for the models built through lipid extract measurements than 
in the case of models performed using direct measurements.  
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Figure 3.12: (Top) Predicted values versus reference ones for cross validation (grey circles) and 
prediction (red triangles) obtained for all the models built in this study. For lipidic components 
determination in sera green line indicates a straight line with slope=1 and intercept=0 and red line 
represents the regression line for the prediction set. (Bottom) Radial plot of ratio of performance to 
deviation values obtained for all the models performed in the PLS-ATR-FTIR determination of lipidic 
compounds in sera. Note: EtAc-EtOH, ethyl acetate-ethanol; Hex-Isop: hexane-isopropanol, DM: 
direct measurement; P, predicted concentration value; R, reference concentration value.  
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Figure 3.12 also represents the RPD calculated for the validation of the analytes under 
study. RPD values for cholesterol and triglycerides were found to be two times higher than 
those obtained for the lipoproteins. It can be seen also a similar profile of RPD for models 
created using the extract spectra, which improve in all the cases the RPD values obtained 
by the direct measurement. 
The evaluation of the use of ATR-FTIR spectroscopy of sera organic extracts as a PoC tool 
for the fast determination of triglycerides, cholesterol, HDL and LDL has evidenced that 
prediction errors obtained using the proposed approach improves considerably those 
obtained by the direct ATR measurements of sera. The main drawback of this technique 
is that it implies a preprocessing extraction step which involves time and solvent 
utilization. However, the process can be miniaturized and the integration of the extraction 
step in the centrifugation of the blood for obtaining the serum could be also studied. Thus, 
the presented PoC method provides, in a few minutes and with minimum cost, important 
information about the lipidic profile of the serum of the patient with a screening level 
confidence. 
Regarding the use of the nonpolar organic solvents, Figure 3.11 evidenced that the 
composition of the extracts was very different depending on the solvent used. Those 
solvents could not be used for quantification procedures, because of the time-consuming 
drying process and the non-homogenous dry-film obtained. However, this method offers 
a qualitative information about the presence of the different kinds of biological 
compounds on the extracts, and those solvents are normally the ones used in 
metabolomics for precipitating proteins and extracting plasma samples prior to LC-MS 
analysis. Because of that, in a study included in this thesis, referred as Article 7, it was 
proposed the use of the analysis of organic extracts using ATR of DFs and multivariate 
exploratory data analysis for the evaluation of the effect of different sample preparations 
in LC-MS metabolomic studies. Solvent precipitation is among the most widely used 
methods for sample preparation for metabolomic profiling of plasma due to its simplicity, 
high throughput and reproducibility. For exploratory analysis of the effect of the protein 
precipitation step on the samples, the use of high resolution LC-MS itself, present some 
disadvantages, being costly in terms on funds and time required and generating large 
multidimensional datasets that require time consuming statistical analysis. Therefore, 
there is an interest in the development of analytical tools for a straightforward and cost-
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effective evaluation of the main effects of sample pretreatment on the biochemical sample 
composition. 
As a model example, the study was performed using a mix of plasma samples from 3 mice. 
Three aliquots of the sample were extracted by triplicate using acetonitrile, methanol and 
acetone, being each extract analyzed by ATR-FTIR (by triplicate) and LC-MS (by duplicate) 
analysis in parallel. Data obtained by both methodologies were thoroughly compared to 
evaluate the strengths and shortcomings of using FTIR spectroscopy during the initial 
steps of metabolomic method development. 
Figure 3.13a shows the scores plot obtained from the PCA of the LC-MS data set, and 
reflected a clear separation among the three types of samples, supporting that the main 
source of variation were differences in the metabolomic profiles due to the solvent used 
for protein precipitation. The analysis of the loadings (See Figure 3.13b) revealed that 
variables responsible for the separation of plasma samples along PC1 and PC2 had 
characteristic distributions of m/z and RT values. The first PC allowed a separation of 
acetonitrile-precipitated samples and, since the separation observed in the scores plot 
along PC1 could be attributed to polar compounds of low molecular weight (e.g. amino 
acids and derivatives), it can be concluded that acetonitrile was connected to high 
concentration of amino-acids. On the other hand, the second PC clearly discriminates 
acetone-precipitated plasma samples and loading spectra of the PC2 separation along this 
PC was highly influenced by lipophilic compounds of high molecular weight (e.g. lipids, 
phospholipids), evidencing that acetone extracted with more efficiency lipidic 
compounds 
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Figure 3.13.  Left: PCA scores (a) and loadings (b) of PC1 and PC2 of LC-MS data. Histograms of the RT (min) and m/z values of the variables encircled in 
the figure are highlighted as responsible for the separation of plasma samples along PC1 and PC2. Note: color bars reflecting either the retention time 
(RT) (top) or the m/z (bottom) of each variable were included to facilitate interpretation of the plot. Right: PCA of the ATR-FTIR spectra of plasma samples 
after protein precipitation. c) Scores plot of PC1 vs. PC2 and d) mean FTIR spectra of plasma samples. Color scale corresponds to the value of the loading 
of PC1 (top) and PC2 (bottom) for each variable.  
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The PCA performed on the IR spectra of the samples is available on Figure 3.13c and d 
shows a similar behavior to the analysis of the data obtained by the LC-MS.  PC1 
discriminates plasma samples precipitated using acetone from acetonitrile and methanol. 
The loadings plot of the PC1 showed that the regions with a higher contribution to this PC 
were centered on 2925, 2855, 1735 and 1460 cm-1. Both, 2925 and 2855 cm-1 bands are 
located in the spectral interval that covers ν(CH), νas(CH3), νas(CH2), νs(CH3), νs(CH2) 
stretching vibrations associated with methylene groups from long aliphatic chains and 
therefore indicate an effective extraction of lipids. In addition, absorption at 1735 cm-1 
was attributed to ν(C=0) stretching vibrations also present in lipid spectra. Besides, 
results obtained are comparable with those found by the LCMS, which established acetone 
as the best lipid extractant. The higher scores values of methanol-treated samples on the 
second principal component allowed their differentiation from acetonitrile and acetone-
treated samples.  Examination of the loadings plot suggests that discrimination was based 
on the absorption bands centered at 2955, 2920, 2852, 1655, 1448, 1315 and 1085 cm-1. 
Those bands are related with a protein/aminoacidic profile, being the 3200-2800  cm-1 
region and the band at 1448 cm-1 associated to ν(CH), νas(CH3), νas(CH2), νs(CH3), νs(CH2) 
stretching vibrations and the  band at 1650 cm-1 associated to the Amide I band (C=O 
stretch). Absorption bands centered around 1085 cm-1 was assigned to ν(C-O) and ν(P-O) 
stretching vibrations of e.g. carbohydrates and phospholipids. Again, IR and LCMS 
analysis obtained the same results, both evidencing that methanol was the solvent which 
provided the most efficient extraction of aminoacids. 
In order to obtain more evidences about the good concordance between LC-MS data and 
ATR-FTIR data, Figure 3.14 shows mean LC-MS intensities of a set of metabolites 
classified as: amino acids and derivatives, fatty acid esters, monosaccharaides, 
glycerophospholipids, imidazopyrimidines and indoles. Intensities of most of the 
identified amino acids, monosaccharides, imidazopyrimidines and indoles decreased in 
the methanol>acetone>acetonitrile series and mean intensities of glycerophospholipids 
and fatty acids were, as expected, higher in plasma samples precipitated using acetone. 
This is in accordance with the conclusions withdrawn from the PCA of ATR-FTIR spectra.
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Figure 3.14. Mean intensities of selected metabolites identified according to the m/z using a tolerance of 5 mDa or 5 ppm. From left to right and from top 
to bottom: Pyroglutamic acid; Creatine; Isoleucine; 2-Aminooctanoic acid; Phenylalanine; Iminoaspartic acid; Arginine; Tyrosine; Glutamine; Argininic acid; 
Histidine; Tryptophan; Tryptophan (isotope); N-Heptanoylglycine; Arginine; gamma-glutamyl-isoleucine; Pyro-L-glutaminyl-L-glutamine; Carnitine; 
Carnitine (isotope); Lysine; 3-Mercaptohexyl hexanoate; Acetylcarnitine; Propionylcarnitine; Phosphatidylcholine (18:3/18:1); Phosphatidylcholine 
(18:3/18:1) (isotope); LysoPC; LysoPE; LysoPE; LysoPE; LysoPE; Adenine; Hypoxanthine; Xanthine; Uric acid; 3-Methylene-indolenine; 1-H-Indole-3-
carboxaldehyde; Indoleacrylic acid; Indoleacrylic acid (isotope); Glucose (three isotopes) 
 
7
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Overall, these results supported the hypothesis that major changes in the LCMS metabolic 
profiles can be anticipated by ATR-FTIR spectroscopy. Therefore, this information 
extracted from FTIR could be used e.g. to select the procedure providing the highest 
protein or lipid removal from the sample matrix. It has been evidenced the feasibility of 
ATR-FTIR biospectroscopy for the evaluation of major trends in the plasma composition 
after sample pretreatment, providing information in terms of amino-acids, protein, lipid 
and carbohydrate overall contents comparable to that found by LCMS. The partial trade-
off for time saved during data acquisition and analysis is reduced specificity and 
sensitivity. The biochemical information extracted from ATR-FTIR data could be useful 
for the comparison and optimization of sample preparation in metabolomics studies and 
it might be used to tailor the clean-up steps to the objective of the study. 
3.2.2 DF-ATR analysis of urine samples. 
The inherent lack of sensitivity of IR spectroscopy hampers the determination of clinical 
parameters at low concentration levels. Thereby, methodologies based on IR 
measurements  are limited to the determination of main compounds and, in contrast, the 
determination of exogenous compounds (e.g. drugs or ingredients of cosmetic 
products/formulations and their metabolites), which are normally found at low ppm, ppb 
or even ppt levels in clinical samples, is a difficult task. Taking advantage of the 
improvement of the sensitivity of the DF-ATR approach, it was performed a study with 
the aim of proposing a technique that enhanced the IR determination sensitivity to reach 
the low ppm levels of lidocaine found in human urine, but also simple enough for retaining 
the advantages of IR analysis. For this purpose it was used dispersive liquid micro 
extraction -which minimizes the volume of solvents employed- as an extraction 
procedure, being only used 40 µL of extracting mixture and 500 µL of urine. Selecting 
lidocaine as a target drug, the main aim of the study was to combine the DF-ATR 
methodology and an effective microextraction for the detection of this molecule in urine 
samples at the levels found in humans. Results of this study, which are included on the 
article denoted as Article 8 on this thesis, were based on urine samples of 15 volunteers. 
6 urine samples were used as a blanks and the other 9 samples (5 for calibration and 4 for 
validation) were spiked at 6 levels of concentration (approximately 0, 2, 4, 8, 15 and 30 
mg L-1) for multivariate analysis. 
D. Perez-Guaita |3. Summary of Results 
 
92  
 
The first step was to determine the LOD of lidocaine in the urine without taking into 
account the variability of the urine composition.  Using the intense band at 1505 cm-1 
assigned to the aromatic C=C stretching, a univariate calibration curve was built from 7 
blanks and the spiked samples of one urine, using the integrated peak area between 1480 
and 1530 cm-1 (corrected with a baseline established in the same range).  The spectra of 
the urine sample spiked with different concentrations of lidocaine (from 2 to 30 mg L-1) 
and 7 blanks of the same urine are shown on the inset of the Figure 3.15. This approach 
provides an acceptable univariate calibration with a minimum contribution of the matrix, 
as it is evidenced in the seven spectra corresponding to the urine blank samples (red 
spectra in the inset on Figure 3.15). Using those blanks and the calibration curve a LOD 
of 0.5 mg L-1 was calculated as the concentration corresponding to three times the 
standard deviation of the signal of the blanks. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 Dried film ATR-FTIR spectra of lidocaine in chloroform extracts: Spectra of extracts 
obtained from 10 urine samples (a), a standard of 15 mg L-1 of lidocaine dissolved in chloroform (b) 
and extracts of urine samples spiked with 15 mg L-1 of lidocaine (c). Inset: Dried film ATR-FTIR spectra 
of spiked lidocaine samples and blanks from 0 mg L-1 (red spectra) to 30 mg L-1 (light blue spectra) used 
for the univariate calibration.  
 
D. Perez-Guaita |Challenges in clinical analysis by infrared spectroscopy 
 
93 
  
However, the univariate calibration obtained spiking a single urine sample assumes that 
the blanks of all urine samples are similar. Solvent mixture extracted different compounds 
from urine as evidence the spectra of the blanks of the samples available in Figure 3.15a. 
This fact can be connected with several non-polar compounds found in the urine. 
Although the dispersive liquid microextraction of lidocaine was very effective and the 
contribution of the lidocaine at 15 mg L-1 (see Figures 3.15b and 3.15c) dominates the 
spectra in the region of the band at 1505 cm-1, it can be seen that the spectra of different 
blanks are not comparable and therefore the univariate calibration cannot be applied to 
other urine samples with different matrix contributions. Thus it is clear than the LOD 
calculated using the univariate calibration is an over-optimistic estimation and further 
studies should be performed validating with a set of urine samples with a variable 
composition. 
The aforementioned presence of other compounds in the spectra of urine extracted 
samples suggested the use of multivariate analysis to improve the results obtained by the 
univariate approach. A multivariate treatment could isolate the contribution of the 
lidocaine from the “noise” produced by the presence of interferences in the urine extract. 
Because of that, two chemometrical algorithms, PLS and SBC, were used for creating 
models which were evaluated with an independent test of urine spiked samples. Table 
3.8 summarizes the errors obtained for both algorithms. As it can be seen, PLS and SBC 
based regressions showed comparable results, with prediction errors below or equal to 
2.5 mg L-1 and ratio-to-prediction deviation values above 3.6. It has to be noted that the 
central benefit of SBC in front of PLS is that for SBC, prediction values where obtained 
without the need of any urine spiked samples for the calibration, improving in a great 
extent the versatility of the methodology. 
Besides, PLS calibration samples were also used for performing a NAS based univariate 
calibration and, employing 15 urine blanks, a multivariate LOD of 1.7 mg L-1 was obtained. 
This value is 4 times higher than the univariate LOD for a single urine sample, but it 
provides a more realistic evaluation of the LOD, which takes into account the possible 
errors in the detection associated with the variability of the composition of the urine 
matrix. 
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Table 3.8: Comparison between SBC and PLS for the modelling of the ATR-FTIR determination of 
lidocaine in urine samples after chloroform extraction in terms of number of spectra required for 
performing the models and results obtained.  
Parameter PLS SBC 
Calibration Samples Used 30 0 
Standards Used 0 1 
Blanks Used 5 10 
RMSECV (mg L-1) 2.3 - 
RMSEP (mg L-1) 2.3 2.5 
RPD 3.9 3.6 
R2 0.96 0.96 
Note: RMSCV, root mean square error of cross validation; RMSEP, root mean square error of 
prediction; RPD, ratio prediction to deviation. 
 
The main disadvantage of the proposed method as compared with other classical 
methodologies is the lack of sensitivity, even though in this case a high-throughput 
detector (a mercury-cadmium-tellurium) was used. However, there is obviously still 
plenty of room for improvement, considering the optimization of the extraction 
parameters and the increasing of the volume of extract deposited.  
In spite of all, the presented approach based on IR spectroscopy achieves to detect the 
high and medium levels of lidocaine in urine from humans and horses reported by several 
studies, providing a fast and straightforward screening method, based on potentially cost-
effective, affordable equipment, with a minimum use of solvent (40µL per sample) and 
sample pretreatment.  
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3.3 Chemometrical approaches for extracting feasible clinical information 
from the FTIR spectra.  
Multivariate treatment is mandatory for extracting the target information of the IR 
spectra and exclude it from the “noise” introduced by the signal of other components of 
the matrix. When the aim is to quantify a compound of the matrix, the signal of the target 
analyte is isolated using a regression method, while in the case of diagnosis applications, 
the spectral patterns caused by the illness is detected using classification methods. In all 
cases three different critical steps are needed for extracting the information as is 
represented in the flow chart available at Figure 3.16. The first is the preprocessing of 
the data in order to adequate it for the modelling, with the aim of removing externals 
sources of variation such as baselines shifts, pathlengths (normalize), noise (smoothing) 
and other spectral artefacts related with the experimental procedure (atmospheric 
contributions, scattering or ATR correction). The pre-treatment of the data can also 
eliminate confounding variables or enhance the differences between the spectra by the 
use of derivatives or mean centering. Once the data is prepared, models based on 
regression or classification algorithms are applied, relating the spectral variations with 
biological changes on the samples. Then the model needs to be validated, especially when 
dealing with supervised methods, in order to obtain feasible conclusions about the 
relationship between the spectral data and the composition of the samples. 
Figure 3.16: Chemometric steps applied to an IR based clinical study 
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Whereas in the Section 3.2 efforts were focused on improving the IR clinical based 
method by improving selectivity and sensitivity through the use of a DF-ATR, the objective 
of this section was to improve the information extracted on the multivariate treatment of 
the direct measurement, covering the three aforementioned steps: 
i) Preprocessing. The first objective of this section was to introduce an algorithm for 
the elimination of the contribution of atmospheric gases as a pre-treatment step for 
clinical samples. Although in some cases water vapor and carbon dioxide can be 
integrated on the model, the elimination of the contribution of water vapor prior to 
the modelling is very useful on exploratory analysis and on the comparison of the 
position of the maximum bands, critical on the assignment of the bands to clinical 
compounds or protein structures.  
ii) Modelling. Since all the aforementioned IR-based applications deal with the 
multicomponent prediction of clinical parameters from a complex matrix, one of the 
objectives was to perform a comparison of available chemometrical methodologies 
for the multicomponent determination of several components from complex 
mixtures. Taking into account the large-scale purpose of the IR based clinical 
applications, this comparison should not be limited to the prediction errors, but also 
to other features of the algorithms, such as the cost of the calibration in terms of 
number of samples and reference data needed for the calibration, an important 
factor on the implementation of IR spectroscopy as a cost-effective alternative on 
the clinical routine analysis. 
iii) Validation. The aforementioned chemometric powerful approaches available on 
the literature, which have been established as an indispensable tool for the 
emerging application of IR spectroscopy to clinical diagnosis, could also lead to over-
optimistic results. Taking into account the important outcomes and risks related to 
diagnosis, it is mandatory that researchers validate their results on a reliable way, 
especially when the amount of samples is reduced and it is not possible to use a 
representative validation set. Figure 3.17 evidences the cross validation results 
from a PLS-DA performed over a simulated random dataset without any factor for 
differentiation between two hypothetical classes. Before the variable selection, PLS-
DA models does not show any prediction capability. However, after a variable 
selection is performed using the UVE approach classes are differentiated by the PLS-
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DA, indicating that the variables of the dataset could discriminated to those 
hypothetical classes which actually do not exist. This fact can be related to chance 
correlations on the dataset, which have been enhanced by the variable selection. 
 
Figure 3.17 CV y-predicted value obtained on the PLS-DA performed on a random dataset before (a) 
and after (b) UVE variable selection. 
 
Another of the objectives of this section was therefore to propose a method, based on 
permutation tests, for the determination of the effect of chance correlations on PLS-DA 
models after variable selection.  Although this method was tested on metabolomics 
dataset, its application can be also extended to IR data, and it has been used in order to 
validate the model performed on the study for the discrimination between 
chemoresistant/chemosensitive lymphoma tissues (Article 15). 
3.3.1 Pre-processing algorithm for the elimination of the atmospheric 
contribution on clinical sample spectra. 
Besides the interferences within the matrix, several other factors could contribute to the 
spectra, hindering the signal of the analyte under study or the pattern caused by an illness 
in case IR spectra is used for diagnostic purposes. For example, vapor water is also a 
strong MIR absorber and, since humidity is difficult to keep constant inside the 
spectrophotometer -especially when dealing with aqueous samples-, water vapor can 
became a strong problem which is expressed as a set of narrow bands between 1400 and 
1800 cm-1. Although this effect can be corrected by the models in some cases, a more 
straightforward approach is the correction of this bands in the spectra itself by using 
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compensation algorithms. In this thesis, a recently algorithm developed by Quintas et al. 
[179], has been firstly introduced for correcting the contribution of water vapor and 
carbon dioxide from clinical samples. Urine and serum samples were measured under 
different concentrations of water and carbon dioxide and then algorithm was applied 
using a water vapor and CO2 spectra measured on the same conditions. Visual inspection 
and univariate statistics were used for comparing the spectra of the sample without 
contribution of water and the spectra with atmospheric gases interferences before and 
after the correction of the proposed algorithm and the correction function available on 
the OPUS software. A detailed description of the results of the application is available on 
the paper referred as Article 9. 
Before starting the background correction process, the acquisition of a single reference 
spectrum for each interfering compound is necessary. The same reference spectrum 
might be used for the correction of spectra acquired on different days in different 
experiments, as long as the instrumental and experimental conditions are kept constant 
(e.g. temperature, spectral interval, resolution or zero filling factor). 
For each interferant, the compensation strategy can be split in five steps:  
 
Step 1: Calculation of the relative absorbance (34) at two previously selected 
characteristic wavenumbers (5 and 56) in the reference spectrum (378) and spectra 
to be corrected (  ) using the following equation, where 49  is the absorbance 
measured at each wavenumber in each spectrum. 
349 = 49(5) − 49(56)  (Equation 3.1) 
 
Step 2: The relative H2O or CO2 contribution (:) in each spectrum is calculated as: 
: = 34/34378  (Equation 3.2) 
 
Step 3: The reference and sample spectra are baseline corrected subtracting the 
absorbance measured at 56  ( 49(56))  from each spectrum where 9;<  stands for 
baseline corrected reference or sample spectrum and 5=−>  corresponds to all 
wavenumbers in the spectrum 9. 
9;< = 49(5=−>) − 49(56)  (Equation 3.3) 
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Step 4: The atmospheric compensation is carried out by subtracting the baseline 
corrected reference spectrum multiplied by the factor F from each baseline 
corrected sample spectrum: 
<55 = ;< − : · 378;< (Equation 3.4) 
 
Step 5: The baseline correction is reversed: 
<55 = 4<55(5=−>) + 4<55(56)  (Equation 3.5) 
 
Figures 3.18a and 3.18e show typical spectra of both, serum and urine samples before 
atmospheric gases compensation. Between 1900 and 2250 cm-1 a large quantity of noise 
can be appreciated, due to the strong absorption of the diamond in this region. Other 
significant detail evidenced in the figures is the intense spectral contribution of CO2 (g) 
and H2O (g) in the main regions of the spectra. The H2O (g) spectrum strongly overlaps 
with the spectral region between 1400 and 1800 cm-1, typically used for quantification or 
qualitative evaluation of serum and urine clinical samples. In the case of serum, The 
definition in highly informative regions including amide bands I, II, III and IV of proteins, 
urea bands and the carbonyl band of triglycerides (1380-1690 cm-1) are distorted. For 
urine, the size and shape of the carbonyl band associated with creatinine, urea or uric acid 
can be completely modified by the interfering effect of water. Therefore, accurate 
atmospheric compensation might be used to reduce the noise levels in those methods 
based on the use of CO2 (g) and H2O (g) mid-IR spectral overlapping regions. 
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Figure 3.18: Urea (a-d) and serum (e-h) spectra measured in an N2 purged atmosphere (dotted black 
line) and in the presence of an atmosphere with variable levels of CO2 and H2O (solid red, green and 
blue lines) before correction (a and e), after correction of H2O vapor using the proposed method (b and 
f), after correction of H2O vapor and CO2 using the proposed method (c and g) and after OPUS 
correction (d and h). Note: Spectra were shifted on the y axis.  
 
Figures 3.18b and 3.18f shows the aforementioned spectra after H2O (g) correction. 
Visual inspection of spectra confirms the correction of atmospheric H2O in both, the 
fingerprint region and in the interval between 3500 and 4000 cm-1. The remaining 
contribution of CO2 was then eliminated in a second correction (see Figures 3.18c and 
3.18g), obtaining spectra comparable to those acquired using N2 purge for the physical 
elimination of CO2 (g) and H2O (g). On the other hand, the same spectra corrected using 
the atmospheric compensation included in OPUS 6.5 are shown in Figures 3.18d and 
3.18h. These figures evidences that the contribution of water vapor was compensated to 
a great extent by both methods. However, the noise values found in the region between 
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2282 and 2398 cm-1 showed that the new method provided better correction of CO2 
contribution.  
3.3.2 Comparing multivariate chemometrical algorithms for the 
multicomponent prediction on complex mixtures. 
The most commonly regression method for isolate the signal of the analyte from the signal 
of the other components of the sample is PLS [180], a powerful regression method which 
has been employed in the modellings performed in Sections 2.1 and 2.2. However, PLS is 
not the only method available for the predictions of concentration from the IR spectra 
available on the literature, where it can be found a large amount of alternatives, including 
traditional methodologies as CLS and complex modern algorithms as SBC or multivariate 
curve resolution-alternative least squares (MCR-ALS). However, PLS regression requires 
a robust calibration data set based on a collection of well-defined and representative 
samples including linearly independent variations of concentrations of the analytes in the 
presence of any potential interferant. Considering the substantial efforts required for 
establishing reliable calibrations in PLS, especially on the clinical analysis, alternative 
multivariate calibration methods including SBC or MCR-ALS are increasingly adopted.  
Thus, in this thesis it is included a comparative study which was performed with the aim 
of evaluating the advantages and drawbacks of CLS, PLS, SBC, and MCR-ALS for the 
prediction of individual concentrations in complex mixtures. The study was made during 
a research stay at the institute of analytical and bioanalytcal chemistry in the University 
of Ulm (Germany), and its results were presented on the article indicated as Article 10 in 
this Thesis. In summary, mixtures of gases of Isobutylene, methane, CO2, butane, and 
cyclopropane were selected as exemplary samples. The mixtures were created from well-
known standards and introduced on a HGW for the measurement of the spectra. 
Isobutylene, methane, cyclopropane, butane, and carbon dioxide were mixed to obtain a 
calibration data set with 25 samples at concentration levels of 200, 600, 1000, 1400, 1800, 
and 2200 ppm, (named as XCAL), a validation sample set of 15 samples at concentration 
levels of 400, 800, 1200, 1600, and 2000 ppm (named as XVAL), 15 blanks of nitrogen, a 
reference spectrum of each analyte at 2000 ppm and six spectra of a mixture of the five 
analytes with a concentration of 1000 ppm. The spectra were used to evaluate the 
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prediction capability and repeatability of the selected chemometric methods which were 
validated with the same set of samples in different measurement scenarios: 
(i) A direct comparison without interferences. Calibrations were performed using 
XCAL and analyte reference spectra and validated with XVAL. The obtained results 
were quite comparable for all analytes in terms of prediction capability and 
repeatability (see Table 3.9). Performing three-paired t-tests (each algorithm with 
the other two) for comparing the RMSEP, no statistically significant differences were 
found (α=0.05). CLS and SBC revealed slightly higher similarity, thus evidencing the 
rather close relationship of both the two methods, if an appropriate artificial noise 
matrix was used in SBC. 
Table 3.9.  RRMSEP and repeatability values obtained for the direct validation of PLS, CLS and SBC.  
Note: The repeatability corresponds to the variation coefficient of the concentrations predicted for 6 
spectra with the same concentration (1000 ppm of each compound). 
 
(ii) In the presence of a known interference. Vapor water was used as known 
interference, and this time models were validated with validation sets with an 
increasing amount of water. Methods were evaluated again but correcting the effect 
of water by including the IR spectra of water on the calibration set. Figure 3.19 
shows the evolution of the prediction capability of the algorithms as a function of 
the concentration of water vapor, which was artificially added as a known 
interferant to the samples. Results evidenced that SBC and CLS, are more sensitive 
to the water interference, i.e., a known interferant, in IR-HWG measurements 
compared to PLS. However, this influence may be readily corrected, if the 
interference is known and the spectrum of the interferant may (a) either be 
measured using the IR-HWG sensor system, (b) or modeled, and (c) integrated into 
the calibration data set. It has to be noted that In this case water has been corrected 
Analyte 
PLS CLS SBC 
RRMSEP 
(%) 
Repeatability 
(%) 
RRMSEP 
(%) 
Repeatability 
(%) 
RRMSEP 
(%) 
Repeatability 
(%) 
Cyclopropane 3.8 1.3 3.2 1.1 3.3 1.0 
Methane 0.9 0.6 2.3 0.6 2.3 0.6 
Isobutylene 2.9 1.6 1.7 1.5 1.4 1.4 
Butane 2.5 1.6 1.9 1.6 1.8 1.6 
Carbon 
dioxide 5.5 1.2 7.9 2.7 7.9 2.6 
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by integrating its spectra on the model, but it can be also corrected on the spectra 
itself, by using correction algorithms such as the one applied on the Article 9. 
Figure 3.19: Evolution of the errors obtained on the validation of the PLS, CLS and SBC models under 
different addition of water vapor before (blue triangles) and after (red squares) correction for the 
analytes under study.  
 
(iii) In presence of an unknown interference. Cyclopropane was supposed to be the 
unknown interference and, therefore, its reference spectra was exclude from the 
calibration. In this case, the accuracy of CLS and SBC models is strongly affected, the 
validation errors were found to be more than three-times higher for all analytes 
compared to when these interferences (see Figure 3.20) are absent. However, in 
this case the spectrum of the interference is not available, and thus, cannot be 
integrated into the CLS calibration. Therefore, the interference cannot be corrected 
for this model. For SBC, the artificial noise matrix cannot be established either. 
Instead, a noise matrix composed of spectra of the interferences with a constant 
concentration of the analyte may be established. Once this matrix was used, the 
obtained SBC errors were equivalent to those obtained in the absence of 
interferences for CLS, SBC, and PLS (see Figure 3.20, green bar). As no information 
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on the interference was required for SBC modeling, these results confirm that this 
method may substitute PLS, if a noise matrix with the variations of all interferences 
and a constant concentration of the analyte is readily available.  
MCR-ALS was also tested for predicting the three considered analytes in the presence of 
cyclopropane. The obtained errors were between 40% and 100% higher than those 
obtained for the initial CLS and SBC models (see red bars in Figure 3.20). However, MCR-
ALS provided a predicted spectrum of the interference, which may prove useful for 
identification of an unknown interferant. For the evaluation of isobutylene, methane and 
butane, the predicted cyclopropane spectra were determined to be very close to the real 
spectra of this constituent with correlation values in the specific spectral region of the 
analyte under study of 0.9577, 0.9874, and 0.9886 for isobutylene, methane, and butane, 
respectively.  
 
Figure 3.20: Comparison of CLS, SBC, and MCR results obtained in different scenarios for isobutylene, 
methane and butane. Errors were computed as RMSEP and correspond to the prediction of the 
independent set by different models performed in this study. Violet bars and blue bars indicate the error 
obtained in the direct comparison without considering the presence of any interference. Red and green 
bars indicate the error obtained when considering cyclopropane as an unknown interference that was 
not included in the calibration progress, black bars indicate the error obtained in the validation of the 
SBC after correction using a measured noise matrix and orange bars indicate the error obtained by the 
MCR.  
 
The obtained results evidenced that there is no single best chemometric method, but that 
the complexity of the analytical scenario guides toward the most beneficial algorithm. 
Thus, the choice of the best chemometric method depends on practical considerations of 
each situation, such as the complexity of the matrix and the amount of interferences, the 
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cost in terms of money and time needed for obtaining calibration samples and reference 
data as well as the need of real time-monitoring. Despite the fact that substantial efforts 
are usually needed for establishing a representative calibration data set, PLS was found 
to be the most robust method, and the only algorithm that may deal with changes within 
the spectra due to e.g., interactions among the sample constituents. CLS provided a simple 
yet useful calibration, if all components of interest are known and well defined, with least 
computational efforts. However, CLS was found to be highly sensitive to any unexpected 
interferences within the sample. In this case, SBC readily competes with PLS, and the 
decision for either one of these techniques depends on whether it is experimentally easier 
to analyze a sizeable calibration data set or a noise matrix. The utility of MCR-ALS is 
particularly pronounced for unknown samples, as the algorithm provided a close 
estimation of the spectra of unknown interferences in well-defined samples, as well as 
qualitative and quantitative estimations of the constituents within unknown samples. 
Nevertheless, due to the iterative nature of this algorithm, extensive computational efforts 
may be required, thus decreasing the time resolution of an in-situ or continuously 
operating sensor system. The results of this study are useful to extend the advantages of 
the IR based clinical analysis.  
3.3.3 Improving the feasibility of the validation of PLS-DA through 
permutations. 
Dimensionality reduction methods are often employed to increase PLSDA classification 
accuracy. This apparent improvement, however, partly originates from the susceptibility 
of variable selection towards chance correlations depending on both the variable to 
sample ratio and the correlation structure of data [181]. 
Addressing the aforementioned concerns, a straightforward strategy based on 
permutation testing and 2CV was presented on the Article 11 to grade the effect of chance 
correlations on PLSDA model performance during variable selection. A graphical 
description of the procedure is shown in the Figure 3.21. Using the real classes, variable 
selection was performed and a cross validation error parameter was calculated. This 
error was then compared with those obtained after the permutation of the classes, which 
were used as a null models for evaluating the statistical significance of the model. In 
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addition, by including the variable selection on the validation set, the effect of the chance 
correlation is avoided on the calculation of the statistical p.  
 
Figure 3.21. Basic procedure employed for performing the calculation of the statistical significance of 
the model Note: X, spectra matrix; Y, class vector; V.S, variable selection. 
 
The number of misclassified samples (NMC) and the discriminant Q2 (dQ2) performance 
statistics, both calculated through a cross validation, were used as estimators of the 
goodness of the classification. It has to be noted that dQ2 increases on increasing the 
prediction capability [182]. The Simulated data sets with and without classification 
features set were used to demonstrate the potentials and drawbacks of the approach. 4 
datasets with 40 samples each were created with 250, 540, 1000 and 2000 random 
variables. The first 20 samples were arbitrarily assigned as Class 1 and the other 20 
samples to Class 2, simulating the classes ‘control’ and ‘pathological’ usually used on IR 
clinical based methods. Those datasets were named as NULL250, NULL540, NULL1000 
and NULL2000 respectively, and were used for the study of the impact of the chance 
correlations with different number of variables. PLS-DA models were performed over the 
datasets in order to classify among the hypothetical classes before variable selection and 
after variable selection using UVE and bcv as a variable selection methods, using leave one 
out cross validation as evaluation method. Then, the permutation test was performed and 
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the cross validation errors of the permuted classes were compared with this of the real 
one as depicted in Figure 3.21.   
As expected, before variable selection PLSDA models were not able to correctly classify 
more than the 50 percent of the samples (see Table 3.10). However, after variable 
selection, even though there was not any differences among the samples, variable 
selection methods choose some features as “informative” and errors decrease. The 
number of variables selected increased and figures of merit of the submodels improved 
on increasing with the numbers of variables in the original data set. For example, whereas 
the number of misclassified samples (NMC) for the Null250 variables is reduced from 22 
to 6 or 13, for the Null2000, the NMC can be artificially reduced from 24 to 0 after variable 
selection. This effect could be clearly seen using the bcv-PLSDA approach where a 
correlation among the number of variables in the original dataset, the number of retained 
variables and overoptimistic CV results were found. In spite of that, the permutation test 
showed the lack of statistical significance of the PLSDA submodels, expressed by the 
calculated p-values for both NMC and dQ2 obtained using real class labels in comparison 
to those obtained from permutation testing, all giving p-values > 0.05. Therefore, it is 
evident that whereas classic parameters (NMC and dQ2) provide over-optimistic results 
after variable selection, the p-value obtained from the permutation test clearly evidences 
that all the PLS-DA classifications performed on the NULL sets do not show any statistical 
significance. 
Table 3.10: Figures of merit of PLSDA models established by 2CV and calculated for different data sets 
before and after variable selection. Standard deviations were obtained from 4-fold 2CV results.  
 
Before variable 
selection After bcv-PLSDA After UVE-PLSDA 
Data set NMC  dQ2  Variables Selected 
NMC  
(p-value) 
dQ2  
(p-value) 
Variables 
selected 
NMC  
(p-value) 
dQ2  
(p-value) 
Null250 
(40 x 250) 22  0.22  7 6  (0.3) 0.54 (0.3) 3 13 (0.3) 0.06 (0.3) 
Null540 
 (40 x 540) 23  0.12  23 1 (0.1) 0.75 (0.2) 9 13  (0.3) 0.14 (0.3) 
Null1000 
 (40 x 1000) 24  0.17  34 2 (0.9) 0.78 (0.9) 5 16  (0.7) -0.02 (0.7) 
Null2000 
 (40 x 2000) 24  0.14  63 0 (0.7) 0.87 (0.8) 10 15 (0.7) 0.09 (0.8) 
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This fact can also be appreciated from Figure 3.22 for a Null540 data set which, confirms 
that also NMC and dQ2 values obtained for the same null data set are close to the mean 
value obtained for randomly permutated class labels, using both variable selection 
approaches.  
Figure 3.22. Histograms of the number of selected variables, misclassified (NMC) samples and 
discriminant Q2 in the simulated Null540 (40 x 540) and SIMUIN5, SIMUIN15 and SIMUIN25 after 
variable selection using permuted class labels and the bcv-PLSDA approach. Colored dots indicate 
values obtained using the original class labels.  
 
Moreover, the PLSDA modelling over datasets with induced differences among classes 
was also evaluated. Those datasets were integrated by 40 samples and 540 variables, but 
this time differences on the variables were added depending on the class. The number of 
variables artificially ‘spiked’ was 5, 15 and 25 for the datasets named as SIMUIN5, 
SIMUIN15 and SIMUIN25, respectively. For those datasets with real differences on the 
classes, the number of variables retained was higher than those kept using randomly 
permuted class labels, as depicted on Figure 3.22. Besides, statistically significant p-
values were obtained for the figures of merit of the submodels (see Table 3.11), thus 
indicating that the hypothesis that figures of merit using real and random class labels 
were equal could be rejected (α=0.05) and so, improvements were not exclusively due to 
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existing chance correlations in the original data set. Results also showed that the bcv-
PLSDA method retained percentages of a priori informative variables in the 53-60% 
range, and NMC as well as dQ2 values were substantially improved after variable 
selection.  
Table 3.11: Figures of merit of PLSDA models established by 2CV and calculated for different data sets 
before and after variable selection. Standard deviations were obtained from 4-fold 2CV results.  
 
Before variable 
selection 
Variable selection method: bcv-
PLSDA 
Variable selection method: UVE-
PLSDA 
Data set NMC  dQ2 
Variables 
Selected 
(Hits) 
NMC  
(p-value) 
dQ2  
(p-value) 
Variables 
Selected 
(Hits) 
NMC  
(p-value) 
dQ2  
(p-value) 
SIMUIN_5 
(40 x 540) 15  0.08  26 (3/5) 0 (0.001) 
0.87 
(0.001) 6 (0/5) 14 (0.7) 0.16 (0.5) 
SIMUIN_15 
(40 x 540) 12  0.20  24 (8/15) 0 (0.01) 
0.82 
(0.02) 9 (5/15) 6 (0.02) 
0.58 
(0.004) 
SIMUIN_25 
(40 x 540) 12  0.31  32 (15/25) 1 (0.05) 
0.82 
(0.01) 11 (7/25) 3 (0.001) 
0.67 
(0.001) 
Note: Hits; ‘spiked’ variables assigned as informative by the variable selection method. 
 
The elimination of variables irrelevant for classification is an important task that 
improves the predictive capabilities of multivariate models and facilitates their 
interpretation. Still, if the effect of chance correlations is unknown, variable selection 
must be performed in combination with an assessment of the obtained PLSDA models. 
Using simulated data sets as well as a real data set it could be shown that the inclusion of 
variable selection in the statistical validation process provides an estimation of its 
statistical significance, being useful when no external validation set is available. This 
procedure increases confidence in the variable selection process, which might be relevant 
for biological interpretation and development of further analysis methods (i.e. 
development of target methods) based on the obtained results. Furthermore, in spite of 
being computing intensive, this approach can also be useful to compare variable selection 
methods or conditions.  The utility of this technique in the IR field is evidenced in the 
Article 15, where the statistical significance of a PLS-DA performed on a reduced number 
(it was therefore impossible to use an external set for validation) of samples was validated 
using this approach.  In addition, a deep study is in due course for evaluate the ability of 
this technique for the determination of the statistical significance of IR based diagnosis 
models. 
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3.4 Versatility of IR based clinical applications. Solid, breath and microscopic 
measurements. 
As it has been evidenced on the Introduction, IR spectroscopy is a versatile tool that could 
extract information of several compounds in almost every sample of the human body. 
Figure 3.23 shows spectra acquired from the samples analyzed in this section together 
with the assignment of some bands. Green spectrum was acquired from a urinary stone 
through an ATR solid accessory, and the band at 1300 cm-1 clearly indicates that calcium 
oxalate is a main component of the stone. Red spectrum was obtained from pre-
concentrated breath using an iHWG, and the double band in the range 850-900 cm-1 
evidences the presence of isoprene on breath. Finally, in the blue spectrum, obtained from 
a microscopic measurement of a lymphoma tissue, it is evidenced the presence of high 
amounts of RNA, as evidences the phosphate bands at 1250 cm-1.  
 
Figure 3.23: Spectra of urinary stones, breath and lymphoma tissue measured using and ATR solid 
accessory, an iHWG and a FTIR microscope, respectively. 
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In order to corroborate this versatility, the last section of the thesis is focused on the 
application of IR spectroscopy on the analysis of different kind of clinical samples, present 
on solid and gas state. Those samples are not as common as blood and urine on the routine 
analysis, but they could contain essential information for the diagnosis, study and 
monitoring of several illness.  The complexity of the measurements varies depending on 
the sample and the analytical problem, on the following, the presentation of the results 
are shorted according to the complexity of the objective faced: 
i) Classical studies of identification and classification of urinary stones as a fast 
analysis technique. First, the simple and direct measurements of urinary stones 
using ATR combined with hierarchical cluster analysis was used for their 
characterization, evidencing that IR based analysis could accurately determinate the 
mean composition of the kidney stones, detecting discrimination errors induced by 
the chemical analysis performed on the hospital.  
ii) Analysis of volatile organic compounds on breath samples. The analysis of breath 
was a more complicated challenge, because target analytes of breath (organic and 
inorganic volatile compounds related with metabolic reactions) are at a low 
concentration -from ppt to ppb-, unattainable for conventional FTIR 
spectrophotometers. Because of that, it was necessary the use of a preconcentration 
system, hyphenated with a powerful but compact integrated hollow waveguide, for 
analyzing isoprene on breath at ppb level; thus proposing one of the first 
determination of an endogenous compound in breath using FTIR. This work was 
performed in collaboration with the institute of analytical and bioanalytcal 
chemistry in Ulm. 
iii) Analysis of tissues through chemical imaging. The versatility of the IR technique 
also allows the acquisition of microscopic information by the use of FTIR 
microscopes which permits the acquisition of hyperspectral images from samples, a 
very powerful tool for the clinical study of tissues and diagnosis of several illness, 
especially cancer. The main objective of those studies, performed in collaboration 
with the center for biospectroscopy from the University of Monash in Melbourne 
(Australia), was the differentiation of chemosentive from chemoresistant 
lymphoma samples using multivariate modelling of the IR spectra. Prior to that, 
since the measurements of the spectra were taken through transflection geometry, 
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a study was performed using transflection and transmission measurements of 
adjacent tissues in order to ensure that the transflection measurements are 
comparable to the transmission ones and they are not affected by artifacts such as 
the EFWS. After transflection measurements were validated, a new study was 
performed in order to evaluate whereas IR spectroscopy is able to discriminate 
lymphomas which show resistance to chemotherapy from lymphomas where the 
chemotherapy is effective. This work was performed with the aim of i) enlightening 
the mechanisms of the chemoresistance of the tissues and ii) proposing tools for the 
diagnosis of high chemoresistant tumors, thus avoiding the side-effects derived 
from chemotherapy when an inappropriate chemotherapy is applied. Although 
results were promising, a larger dataset should be acquired before allowing any 
conclusion about the IR capability to discriminate chemoresistant from 
chemosensitive tissues. 
3.4.1 Simple characterization of urinary stones form ATR-FTIR measurements. 
The determination of the main composition of urinary calculi is very useful for the correct 
evaluation of the etiology of the stone formation and consequently to orientate the 
diagnostic of diseases and to establish the appropriate therapies. In this Thesis, a study 
was performed for the development of a fast and reduced cost screening tool for the 
kidney stones characterization based on ATR-FT-IR measurements and HCA. 
111 samples of urinary stones, characterized in the hospital using classical chemical 
methodologies, were measured using an ATR solid accessory, and the spectra were 
treated using multivariate exploratory analysis (HCA). Results were compared with the 
traditional chemical methods used in hospitals and some mistakes in the characterization 
of samples were detected, as evidence the results of this study available on the article 
denoted as ‘Article 12’. 
A cluster classification was performed from all considered samples and standards spectra. 
The cluster analysis was made using the regions from 3662 to 2247 cm-1 and from 1956 
to 565 cm-1 after vector normalization of spectra data and using Ward’s linkage method 
and the Euclidean distance for the discrimination of the different sample groups (see 
Figure 3.24). 
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Figure 3.24. Hierarchical cluster analysis of kidney stone samples and standards using the Ward 
linkage method and the Euclidean distance applied to ATR-FTIR spectra and average spectra of the 
four classes obtained. Arrows indicate the location of the standards spectra inside the dendrogram (CF, 
calcium phosphate; UA, uric Acid; CO, calcium oxalate).  
 
Dendrographic classification provided four groups (see Table 3.12); class A, which 
corresponded to pure oxalate samples; class B, which included oxalates combined with 
calcium phosphate and traces of other compounds; class C, corresponding to oxalate and 
uric acid mixtures and class D, including oxalate mixed with other salts as calcium 
phosphate or ammonium and magnesium phosphate. Comparing the average spectra of 
each class with their respective pure standards spectra (see Figure 3.24), class A average 
spectra fitted perfectly with calcium oxalate spectrum and the class C average spectrum 
fitted perfectly with uric acid. For class B or D, average spectra of both classes fitted well 
with a mixture of calcium oxalate and calcium phosphate being the contribution of oxalate 
stronger in class B than in class D and the contribution of phosphate stronger in class D 
than in class B. This facts evidenced, the capability of this tool for urinary calculi 
discrimination. 
  
CF 
 
 
UA 
CO 
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Table 3.12: Classification of samples based of hierarchical cluster analysis of their ATR-FTIR spectra. 
 
 
 
 
 
 
 
Note: CO, calcium oxalate; UA, Uric Acid; AP, ammonium phosphate; AMP, ammonium magnesium 
phosphate; CP, calcium phosphate; PT, phosphate traces; 
 
For some samples the cluster classification carried out did not fit well with the chemical 
method results  and, as for example, in class C it was found samples classified as pure 
calcium oxalate by the chemical method although their spectra totally fitted with that of 
uric acid standard. In this regard, it was reported a couple of samples which were 
identified as calcium oxalate-uric acid mixture according by the Ecoline kit but on their 
spectra there was no evidence of the presence of uric acid. In addition, other samples 
classified by the chemical kit as ammonium phosphate showed spectra that matched well 
with a calcium phosphate-calcium oxalate mixture. 
The study showed that ATR-FTIR direct spectra measurements of kidney stones coupled 
with hierarchical cluster analysis provides a fast, low-cost and environmental friendly 
method to classify samples in order to establish the clinical origin of urinary calculi. It was 
also evidenced that ATR-FTIR methodology is free from the mistakes found in some cases 
using chemical kits, being suitable for rapid characterization of this type of alterations. 
3.4.2 Determination of isoprene in breath at ppb levels. 
The concentration of VOCs in breath ranges from trace levels (i.e., few hundreds of ppb) 
to ppt concentrations. Since in some pathological states, the pattern of concentration 
changes of some VOCs is characteristic, reproducible, and discriminatory, these 
compounds are understood as volatile biomarkers within the exhaled breath matrix. The 
development of IR methodologies for the determination of endogenous VOCs in breath 
would provide a generic sensor platform with several benefits including inherent 
molecular selectivity, adaptability to a wide range of molecules, and potential for on-chip 
miniaturization. However, the development of such sensors is challenging due to the lack 
Chemical Kit 
Classification 
Cluster Classification (Number of samples) 
A B C D 
CO-UA 2 0 15 0 
CO 13 1 3 0 
CO-AP 0 4 2 1 
CO-AMP 2 4 0 5 
CO-CP 5 13 0 10 
CO-PT 20 8 0 3 
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of sensitivity of IR, and only high-powerful lasers sources are able to detect those 
compounds. A study was performed, included on a scientific publication referred as 
‘Article 13’ in this Thesis, with the aim to evaluate whether the combination of a 
miniaturized preconcentration system with high performance iHWG could fundamentally 
be used for detecting isoprene in exhaled breath. Hence, a compact preconcentration 
system was coupled to an iHWG sensing module combined with a compact FTIR 
spectrometer. Using a gas mixing system and breath sampling bags, a robust calibration 
for isoprene was established and the utility of the sensing device for isoprene analysis in 
actual breath samples has been demonstrated. A scheme of the experimental set up is 
available in Figure 3.25. 
 
Figure 3.25: Images of the experimental set-up employed for the measurement of isoprene. 
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The measurement procedure was performed on four different steps as it is evidenced on 
Figure 3.26. Before any measurement, in order to remove any trace of isoprene or other 
impurities, pure nitrogen was introduced in the preconcentration tube meanwhile the 
column was heated during two minutes. Then, the standards or the breath sample were 
passed through the column for the absorption of the isoprene. In the case of the standards, 
the isoprene diluted with nitrogen provided by the gas mixing system was introduced in 
the column using the gas flow controllers of the gas mixing system. For the breath 
samples, a gas vacuum pump was used. 
Once the column was loaded with the isoprene, the thermal desorption was performed by 
isolating the preconcentration column and heating it at 120ºC during 1 minute. 
Meanwhile, using the gas mixing system, pure nitrogen was introduced in the iHWG for 
removing any impurity. At the end of this step a background of the iHWG flushed with 
nitrogen was obtained. Then, using the flow controllers of the gas mixing system, a 
pushing flow of 1 ml min-1 of nitrogen was inserted in the preconcentration column and 
the preconcentrated isoprene was introduced to the iHWG. Desorption and cleaning of 
the sorbent steps were performed in the opposite direction from the absorption step, 
following specifications of the manufacturer. Simultaneously with starting the pushing 
flow, the spectrophotometer started to acquire spectra. 
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Figure 3.26: Scheme of the measurement system and analysis pathways for the determination of 
isoprene in breath via an iHWG IR sensor coupled to a miniaturized thermal preconcentrator.  
 
The signals obtained for the calibration standards as a function of the time are shown in 
Figure 3.27. The concentration levels analyzed for the calibration were 0.15, 0.3, 0.5, 0.75, 
and 1 ppm, which all measured in quintuplicates. As evident, the IR signal linearly 
correlates with the concentration of isoprene. A linear regression function, (Figure 3.27c; 
pANOVA<0.001) covers the entire concentration range evaluated herein. The values 
calculated for the correlation coefficient, the slope, and the intercept were 0.9997, 
0.162±0.005, and -0.010±0.003 respectively. The negative offset was resulting from a 
baseline shift between the two regions considered for establishing the baseline for the 
peak integration. The LOD was estimated at 0.032 ppm (i.e., 32 ppb) corresponding to an 
analytical signal equal to at least 3-times the standard deviation of 5 blank measurements. 
In comparison to the LOD achieved with the iHWG without preconcentration, the 
introduction of the preconcentration step improved the LOD by a factor of 120. The limit 
of quantification (LOQ) calculated as the concentration corresponding to at least 10-times 
the standard deviation of the blanks was 106 ppb. While this LOQ value remains too high 
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for covering the entire range of isoprene concentrations presents in human breath 
according to the values published literature, it is clearly evident that without further 
system optimization already medium to high concentrations of isoprene may be detected 
and quantified with the proposed IR sensing method. The mean spectrum of three real 
breath samples of the same volunteer is shown in Figure 3.27d. As compared with the 
calibration samples given in Figure 3.27b, it is immediately evident that the real samples 
contained a concentration of isoprene well within the calibration range established 
herein.  
 
Figure 3.27: Evolution of the integrated peak area with time for different concentrations of isoprene 
standards. Average values for five replicate measurements are shown (a). Average spectra acquired 
between 100 - 216 s for differently concentrated isoprene standards (average of three replicates) (b). 
Calibration function calculated by averaging the integration values obtained from the spectra acquired 
between 100 - 216 s. Error bars indicate the standard deviation of five replicates measurements (c). 
Average spectrum of a real breath sample (smoking volunteer) acquired between 100 - 216 s (average 
of three replicates) (d).  
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The isoprene concentration found on the voluntary breath, calculated using the 
calibration curve was found comparable at 467±18 ppb to values reported in literature. 
Although the methodology is currently limited to studying VOCs present at high 
concentration levels, the potential utility of IR sensing technologies for the analysis of 
VOCs in breath is demonstrated. 
3.4.3 Microscopic analysis of lymphoma tissues. 
As it has been stressed before, prior to extracting conclusions about the differences 
between chemosensitive and chemoresistant tissues, it was necessary to detect if the 
presence of EFWS or other “artifacts” was critical on the transflection measurement. For 
this purpose a study in order to compare transflection and transmission FTIR images from 
the same tissue. Because transflection and transmission measurements require different 
substrates it is impossible to prepare the same sample for both measurement geometries. 
For this reason, following the same approach developed for performing three-
dimensional multivariate image analysis of adjacent tissue sections [183], two adjacent 
sections of the same tissue (lymphoma sample) were fixed onto a CaF2 window and a 
reflective slide and imaged using transmission and transflection geometries, respectively 
(see Figure 3.28). Lymphoma sample was very homogenous in terms of cell type and 
chemistry excepting for the central area where the fixative did not quite penetrate 
creating a chemical environment different to the periphery of the tissue. A third adjacent 
section was fixed on a regular glass slide for obtain visible image used as a reference. 
Images and spectra were compared using HCA and principal component analysis (PCA) 
in order to identify similarities and differences between transmission and transflection 
measurements modes to assess the effect of the EFSW and other ‘artefacts’ on the 
transflection spectral images. The comparison of HCA maps from fixed and sectioned 
canine lymphoma tissue was performed using transmission and transflection substrates 
by combining the data sets in the same matrix prior to HCA. Results are also included on 
the Article 14 of this Thesis.  
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Figure 3.28: Graphical explanation of the procedure employed for comparing transflection and 
transmission FTIR imaging measurements. 
 
In Figure 3.29 is available a comparison between the image of the dyed tissues and the 
images obtained from the cluster classification performed on the IR spectra, obtained 
from transmission and transflection measurements. IR images are superimposed over the 
dyed image, and the color of each pixel is colored according to the class defined by the 
cluster. The amount of tissue fixed on the three images it is not the same because of 
differences on the efficiency of the fixation, but it is clear that they correspond to adjacent 
cuts of the microtome. 
D. Perez-Guaita |Challenges in clinical analysis by infrared spectroscopy 
 
121 
  
 
Figure 3.29: Comparison between transflection and transmission measurements of two lymphoma 
samples: Visible image of dyed tissue sample (a), infrared image, measured by transmission, with the 
pixels colored according to the class determined by the cluster analysis (b), and infrared image, 
measured by transflection (c), with the pixels colored according to the class determined by the cluster 
analysis.  
 
From a direct visual inspection, it can be seen that the classification obtained by the 
cluster analysis evidences a radial distribution of the classes. For understanding better 
the composition of this radial distribution, in Figure 3.30 is available the mean spectra of 
each class. In both cases there is a group composed by spectra with low absorbance, 
colored on green, which corresponds to very poor-fixation area on the edges of the tissues. 
The red class correspond to the peripheral area of the tissue, and it is connected with the 
highest absorbance. The blue class correspond to the internal edge and the center of the 
tissue, and we assigned this area to a zones with a medium efficiency of fixation, as it 
evidences the spectra with a mean absorbance in the middle of the other groups of 
spectra. 
  
b) a) c)
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Figure 3.30: Mean spectra of the classes defined by the cluster analysis performed on the IR images 
of the two samples.  
 
In order to continue with the study of the differences between the transflection and 
transmission measurements avoiding the effect of the tissue thickness, a PCA (see Figure 
3.31) was performed but normalizing the spectra after the baseline correction.  In the 
case of the sample #1 the first score showed strong differences between the transflection 
and transmission spectra, but in the sample #2 those differences are not critical and are 
only shown on the score 2, which captures only the 17% of the variance. Loading plots 
corresponding to those scores (see Figure 3.31c) revealed that the main differences 
between transflection and transmission spectra are connected with a shift of the amide I 
band, as evidenced by the derivative shape in the region between 1600 and 1700 cm-1. 
Since the score values of the transflection are higher than those of the transmission, it can 
be concluded that the band in the transflection mode is shifted to higher wavenumbers. 
For the transflection spectra, the mean (± standard deviation) maximum of the band was 
located at 1656 ± 2 and 1655 ± 3 cm-1 for tissues #1 and #2 respectively, while for 
transmission measurements the mean maximum was located at 1653 ± 2 and 1654.6       
cm-1 for tissues #1 and #2, respectively. 
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Figure 3.31: PCA performed over the transflection and transmission spectra, after smoothing 
(polynomial order: 0 and smoothing points: 15), baseline correction, normalization (Whole area = 1) 
and mean centering: Score values for the first principal component for sample #1 (a) and second 
principal component for sample #2 (b) and loading spectra of the principal components (c). Note: 
Loading spectra were shifted on the y-axis. 
 
Thus, it has been evidenced that, in the case of the lymphoma tissue under study, the 
presence of the different transflection “artifacts” are not critical and transflection spectra 
are comparable to transmission spectra. An overall inspection of the hyperspectral 
images using cluster analysis showed that the regions of the tissue are grouped according 
to fixation issues instead of the measurement mode –transflection or transmission- 
employed for the image acquisition. A more detailed examination of the peripheral zone 
evidenced that the main differences between the transflection and transmission spectra 
are located on a small shift of the amide I of 2-3 wavenumbers, which can be connected to 
differences on the scattering of the tissues due to thickness variations or to reflection 
contribution on the transflection modes. However, those results cannot be extended to 
other regions of the spectra and other kind of tissues, so experiences are in due course to 
establish more valuable conclusions about the differences between the measurement 
geometries. Those experiences are focused on tissues with a clear diagnostic feature, 
which is not the case of the lymphoma tissue samples, where the main source of variation 
was the fixation efficiency. 
b) a)
c)
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Once the transflection measurements were evaluated, the deep study for the IR spectra 
capability for discriminating between chemosensitive and chemoresistant lymphoma 
tissues was performed. The preliminary results of this study are available in the Article 
15.  
The investigation of differences on this tissues is essential for improving chemotherapy 
outcomes and developing tailored treatments. Lymphoma is one of the most commonly 
diagnosed  canine neoplasms with an  estimated incidence at  13 to 30  per  100,000  dogs 
per year [184]. Without treatment, most dogs die within 4 to 6 weeks but nowadays 
different treatments are applied, which varies from inexpensive single-agent prednisone 
to the extreme measure of aggressive chemotherapy, radiation therapy, and even bone 
marrow transplantation [185]. Lymphoma  is  generally  a  chemosensitive  neoplasia  and  
complete remission is achieved in 60% to 90% of cases  treated with conventional  
chemotherapy [186]. In the study performed on this thesis it was used canine lymphomas 
to identify spectral features on the IR spectra for evaluating and anticipating the 
chemoresponse. 
Previous study indicated that, although artifacts associated to transflection geometry did 
not show any critical impact on the sample, the main variations were connected to fixation 
issues. Because of that, a preliminary study was focused on evidencing that the FTIR was 
also related with the composition of the tissue, by comparing IR spectra with a well-
established methodology for obtaining information about the peptide composition of 
tissues, MALDI (Matrix-assisted Laser Desorption/Ionization).  From 6 different 
lymphoma samples two tissues were fixed for the IR and MALDI analysis respectively. For 
comparing the two spectra matrix obtained, multivariate statistical test were applied. 
Mantel test and procrusters analysis showed that IR and MALDI response matrices and 
were statistically correlated, with p-values of 0.025 and 0.03 respectively. 
Furthermore, in order to ensure that the correlation of the data is located on high 
informative regions of the spectra, it was employed statistical heterospectroscopy (SHY), 
an algorithm used  for the co-analysis of multispectroscopic data sets acquired on multiple 
samples, which consider covariance between signal intensities related to molecules 
measured by different techniques on the same set of samples [187]. The correlation map 
obtained is showed on the Figure 3.32, where only are represented the correlations 
which fulfilled two requirements: a significative statistical correlation (p<0.05) and a 
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correlation coefficient with an absolute value higher or lower than 0.5. Red and blue dots 
indicate positive and negative correlations respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32: SHY correlation map obtained on the correlation of the MALDI and IR spectra of the 
lymphoma tissues under study. Only are showed the correlations with p<0.05 and /R/>0.5. Red and 
blue dots indicate positive and negative correlations respectively, and the size of the dots is proportional 
to the R value. In the X and Y axis are showed the mean spectra of each matrix. 
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As it can be seen, IR spectra are highly correlated with several MALDI-MS peaks, which 
are related with specific peptides. The correlation is higher on the amide I and II bands 
and on a shoulders located at 1270 cm-1 and 1870 cm-1, thus evidencing the capability of 
the IR bands for providing information about the main composition of the lymphoma 
samples. 
Once it was evidenced that the IR spectra is influenced by the composition of the tissue, a 
PLS-DA model was performed using the spectra of the tissues, computed as the average 
spectrum of 20 representative spectra of the image, randomly selected from the main 
class of the spectra calculated from a HCA.  
For each sample two replicates were measured. The number of samples was limited (10 
chemosensitive and 10 chemoresistant tissue) and the spectra of a sample was 
characterized as an outlier on a PCA and it was excluded from the model. Therefore, the 
validation of the models with an independent test set was impossible, and an internal 
validation was performed trough cross validation, using continuous blocks of two spectra 
in order to avoid an over-optimistic result induced by the replicates. In addition, in 
concordance with the results obtained in the “Article 11”, a permutation test was 
performed prior to any variable selection, in order to provide statistical significance of the 
modeling avoiding the effect of chance correlation. The statistical significance of the 
model was higher than 95% (p<0.05), thus evidencing that in the IR spectra are encrypted 
different features for chemoresistant and chemosensitive samples. 
Furthermore, a new model was built after a selection of spectra ranges performed using 
a visual inspection of the VIP scores and after elimination of a new sample of the model. 
The goodness of the classification, evaluated through cross validation, is evidenced on 
the receiver operating characteristic (ROC) curve, which shows a successful classification, 
and the confusion matrix available on the Figure 3.33. It can be seen that the model only 
fail to classify 4 replicates corresponding to a chemosensitive and a chemoresistant 
sample. 
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Figure 3.33. ROC curve and confusion matrix obtained for the model performed after variable 
selection. 
 
In Figure 3.34 is available the mean spectra of the sample, where each variable is colored 
as a function of the regression vector. Since a second derivative was used for the 
modelling, and chemoresistant and chemosensitive class were assigned respectively to -
1 and +1 on the PLS regression of the PLS-DA, positive values on the regression vector 
(red colors) are connected with the chemoresistant tissues (a high absorbance of the 
spectra on this region indicates chemoresistant behavior), while negative values on the 
regression vector (blue colors) are connected with the chemosensitive tissues (a high 
absorbance of the spectra on this region indicates chemosensitive behavior). It has to be 
noted that the regions with maximum or minimum values on the regression vector are 
similar to those that were correlated with the MALDI, such as the shoulder at 1275 cm-1. 
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Figure 3.34: Average spectra selected form the samples under study. Colors indicate high and low 
values of the regression vector of the PLS-DA performed.  
 
In summary, it has been evidenced that it can be found differences on the IR spectra of 
chemosensitive and chemoresistant lymphoma samples. However, this study remains 
incomplete since, there are some issues that should be addressed for extracting reliable 
conclusions. First, an extended set of samples is needed for the confirmation of the 
diagnostic capability of the proposed methodology based on FTIR-PLS-DA and secondly, 
a more detailed study of the spectral features and correlation with MALDI spectra should 
be performed in order to obtain a holistic comprehension of the system. New efforts 
should focus on obtaining and extended sample set and investigating the molecular origin 
of the spectral variations through SHY correlation. 
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4. CONCLUSIONS. 
From the results obtained in this thesis it can be concluded that: 
i. IR analysis could extract high quality information of solid, liquid or gas samples, 
including renal stones, tissues, breath, sera or urine. 
 
ii. Regarding the analysis of clinical parameters on serum samples, it has been evidenced 
that the nature of the samples integrated on the calibration set is critical, and it is needed 
a wide collection of samples with different ranges of concentration of both, analyte and 
interferences for providing good predictions of samples from different origins. 
 
iii. The main bottleneck of the determination is the sensitivity. The errors obtained are 
related with the concentration of the target analyte. For protein parameters, 
triglycerides and cholesterol, IR based techniques are ready to compete with the 
reference analysis; in the case of lipoproteins, glucose, immunoglobulin and urea the 
technique is limited as a screening complementary tool and for analytes less 
concentrated than 10 mg dL-1 is impossible to perform any reliable prediction. 
 
iv. The endogenous sensitivity problem can be solved by introducing modern sample 
preprocessings and measurement techniques.  A LOD around 1 ppm was measured for 
the determination of lidocaine in urine using ATR-FTIR measurements of DFs of organic 
extracts and a LOD of 32 ppb was calculated for the determination of isoprene in breath 
using a preconcentration column and an iHWG. 
 
v. ATR-FTIR measurements of DFs obtained from organic extracts is a straightforward 
approach for improving the selectivity and sensitivity of the clinical samples. This 
strategy improves the prediction of lipidic parameters in sera and this approach could 
be also used for establishing a cost-effective and fast back-up method for choosing the 
best protein precipitation conditions prior to liquid chromatography-mass 
spectrometry analysis. 
 
vi. Other chemometrical treatments are also useful to improve the quality of the 
information obtained from IR spectra of sera. Local models performed using LW-PLS 
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could improve those obtained from PLS, and using LDA or PLS-DA could detect most of 
the samples which are located in the “healthy” range of clinical parameters. 
 
vii. Nowadays there is a wide range of chemometrical algorithms, such as PLS, LW-PLS, SBC, 
CLS or MCR-ALS which can be applied to the determination of analytes in clinical 
samples. If all sample components of the system are known, CLS provides a sufficiently 
accurate solution; the selection between PLS and SBC methods depends on whether it is 
easier to measure a calibration data set or a noise matrix; and MCR-ALS appears to be 
the most suitable method for detecting interferences within a sample. In addition, the 
contribution of atmospheric gases can be easily compensated using a straightforward 
method based on eluent subtraction algorithms for liquid chromatography-IR. 
 
viii. The aforementioned powerful algorithms could lead over-optimistic results as a result 
of the presence of chance correlations, especially when a variable selection process in 
involved. The use of a permutation test before the variable selection or including the 
variable selection process on the permutation can be used to provide statistical 
significance to the model when an external validation set is not available. 
 
ix. Transflection and transmission measurements of lymphoma tissues shows comparable 
IR hyperspectral images. In the fingerprint region there is no evidence of the EFSW, and 
the main differences are connected with fixation issues. 
 
x. There are significant differences between the spectra of chemosensitive and 
chemoresistant samples. Although results are promising, for obtaining a PLS-DA model 
for diagnosis purposes or connect the spectral differences with biological explanations 
a more detailed study with more samples is required. 
This Thesis consolidates IR spectroscopy as a powerful technique for developing 
methodologies for extracting information about a large variety of clinical parameters in a wide 
range of samples. Nowadays, IR instrumentation is affordable and compactable and 
quantification of compounds at high and middle concentration can be performed trough 
chemometrics evaluation of direct or almost direct IR spectra measurements. Thereby IR 
provides a cost-effective and PoC alternative for the measurement of traditional clinical 
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samples as those commonly determined in blood or for the development of new diagnosis 
strategies based on minimum invasive analysis of breath. 
Although the technique lacks of sensitivity and selectivity, results obtained in this thesis 
evidenced that modern technologies concerning both, instrumentation –like ATR 
measurements of DFs or iHWG -and sample preparation -like microextraction - can be applied 
for correcting those drawbacks and improving the analytical features of the methods without 
renouncing to the benefits of the IR based methodologies. Among others, next challenges 
concern i) the introduction of the IR spectroscopy commercially on the determination of 
routine clinical parameters of blood and urine, which would imply the saving of resources and 
would move the analysis closer to the patients and ii) the extension of the application of the IR 
based methods to clinical studies, serving as a non-invasive technique for monitoring the 
concentration of compounds like biochemical parameters, pharmaceuticals and metabolites. 
Based on the fast and cost-effective, characteristics of IR based methods, hundreds of 
measurements could be do in a large number of samples at an affordable cost and nowadays 
there reason for the general use of IR in the clinical field. However, the most difficult task for 
convincing the clinical community about the advantages of IR methods is to perform clinical 
studies comparable to those everyday performed on using the reference methods, since the 
parameters used for evaluate those methods are normally based on univariate determination 
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7.2 Scientific outcomes of the Thesis. Communications on scientific 
symposiums. 
→ 13-15.10.2013 1st EuCheMS Congress on Green and Sustainable Chemistry, 
Budapest (Hungary). Near infrared: A sustainable tool for clinical analysis. (Poster) 
 
→ 25-29.8.2013 XVII Euroanalysis Warsaw (Poland). Use of infrared spectroscopy 
for a fast evaluation of sample preparation in LCMS-based metabolomics. (Poster) 
 
→ 16-18.6.2013 XVIII reunión de la SEQA, Úbeda (España). Determination of lipidic 
parameters in serum using ATR measurements of dry films of solvent extracts, 
(Poster and flash communication). (Awarded as best flash communication by 
ANALYTICAL AND BIOANALYTICAL CHEMISTRY) 
 
→ 15-17.5.2012 EUROPTRODE XI, Barcelona (Spain). Preliminary studies for clinical 
sensors based on vibrational spectroscopy, (Poster). 
 
→ 9-10.10.2011  V  Congreso  Nacional  del  Laboratorio  Clínico, Málaga  (Spain).  
Determinación directa de proteínas en suero y sangre total mediante 
espectrometría FTIR (Póster). 
 
→ 12–14.09.2011 International Workshop on Metabolomics  “Technology  and  
Applications“,  CIC bioGUNE, Bilbao (Spain).  Estimating  the  effect  of  chance  
correlations  in variable  subset  selection  using  UVE-PLS-DA  in  metabolomic  
datasets (Poster) 
 
→ 5-9.10.2011   International Conference on Materials and Technologies for Green 
Chemistry, Tallin,(Estonia).  A  green  tool  for  serum  analysis  based  on  Fourier  
transform  infrared spectrometry (Poster). 
 
→ 25-28.07.2011  XXXIII Reunion bienal de la Real Sociedad Española de Química, 
Valencia (Spain). La espectroscopia vibracional como herramienta para el 
desarrollo de una química analítica verde (Poster).  
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→ 6-9.07.2011  I  Simposio  de  Jóvenes  Investigadores,  Madrid  (Spain).  Medidas  
directas  por espectroscopia FTIR para el control de muestras clínicas (Oral 
Comunication). 
 
→ 29.06.2011 2st Workshop in Valencia “Green Analytical Chemistry” (Spain). Green 
analytical methods for clinical diagnosis (Oral communication). 
 
→  28.01.2011 1st Workshop in Valencia “Green Analytical Chemistry” (Spain). 
Vibrational spectroscopy as a green tool for clinical analysis (Oral 
communication). 
 
→   24-26.11.2010   3éme  Congrés  des  Sciences  Analytiques,  Casablanca  (Morroco).  
Attenuated total reflectance infrared spectroscopy  as  a  screening  tool  for  the 
urinary calculi characterization (Poster). 
 
→ 20-22.11.2010   IV Congreso Nacional del Laboratorio Clínico, Zaragoza (Spain). 
Determinación de parámetros bioquímicos en suero por espectrometría 
vibracional (Poster). 
